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 Inflammatory bowel disease (IBD) is a category of lifelong chronic illnesses that affect 
the digestive tract, including Crohn’s disease and ulcerative colitis. IBD has no cure and requires 
a high degree of self-management to keep symptoms in remission. Because of the chronic, 
relapsing-remitting nature of IBD, in addition to the stigma that coincides with the disease, 
people with IBD are at increased risk for distress. This dissertation sought to better understand 
experiences of and reduce disease-related distress among people with IBD through the use of 
social media data and an eHealth intervention. Computational analysis of over 80,000 public 
social media posts about IBD from Reddit and Twitter identified prevalent topics about IBD and 
distress, such as symptoms and nutrition. These findings informed the development of 
“Text4IBD”—a text messaging program designed for this dissertation. The program sent daily 
support messages about disease self-management to participants (N = 114) who were diagnosed 
with IBD over the course of a 2-week intervention. Participants were recruited to evaluate the 
program in a single group, pretest-posttest study in late 2020. Primary outcomes were IBD-
related distress and intervention feasibility and acceptability. Secondary outcomes were self-
efficacy, outcome expectations, perceived IBD support, use of coping strategies, and medication 
adherence. Analyses compared pretest-posttest changes in study outcomes and also examined 
participant quantitative and qualitative evaluations of the intervention (posttest only). Pre-post 
results showed participants reduced their IBD-related distress and improved most secondary 
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outcomes. In addition, nearly all participants were receptive to the intervention and perceived the 
program as acceptable. Results from this work highlight the feasibility of text messaging as a 
useful eHealth medium for providing information and support about IBD self-management, 
particularly for those who may struggle with disease-related distress. This dissertation also adds 
to literature through its interdisciplinary application of social media analysis and eHealth as 
complementary methods in the design, recruitment, and implementation of a health 
communication intervention. Future research should build on this work by integrating and 
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CHAPTER ONE: INTRODUCTION 
Inflammatory bowel disease (IBD) is a lifelong autoimmune disease characterized by 
severe inflammation of the gastrointestinal tract. The two major categories of IBD are ulcerative 
colitis (inflammation only affecting the colon) and Crohn’s disease (inflammation affecting the 
entire gastrointestinal tract). According to the Centers for Disease Control and Prevention, 
approximately 3.1 million US adults are currently living with IBD, with diagnoses often 
occurring in young and early adulthood (i.e., 18-35) (Dahlhamer, 2016; Kelsen & Baldassano, 
2008). To date, there is no cure for the disease and risk factors associated with IBD are complex 
(Ananthakrishnan, 2015).  
If managed properly (e.g., strict treatment adherence, active disease monitoring), an IBD 
diagnosis is often not life-threatening; however, disease symptoms can pose serious 
consequences to health. While symptoms vary from person-to-person, most experience chronic 
diarrhea, abdominal pain, weight loss, and rectal bleeding. Less frequent symptoms include night 
sweats, joint pain, and liver complications. In extreme circumstances, some people with IBD 
may require surgery to remove sections of the gastrointestinal tract to control intestinal 
inflammation.  
The onset of symptoms is often sporadic and uncontrollable, making it difficult for 
people with IBD to manage and maintain disease remission—a period of time in which IBD 
symptoms are not active. If symptoms are not regularly maintained or monitored, people with 
IBD run the risk of developing other, more severe, disease outcomes, such as colorectal cancer 
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(Eaden, Abrams, Ekbom, Jackson, & Mayberry, 2000). As such, disease self-management is a 
critical component to personal IBD healthcare. 
Unfortunately, taboo and perceptions of embarrassment linked to bowel-related functions 
(e.g., excessive flatulence) have resulted in considerable social stigma surrounding IBD (Guo, 
Rohde, & Farraye, 2020; Lenti, Cococcia, Ghorayeb, Di Sabatino, & Selinger, 2020; Saunders, 
2014; Taft & Keefer, 2016). Indeed, evidence from a nationally representative, general 
population survey in the US shows that IBD is a highly misunderstood disease, and that 
individuals attribute more stigma to IBD than other chronic diseases, including HIV/AIDS and 
diabetes (Groshek et al., 2017). Studies also show that people with IBD perceive a moderate 
amount of stigma from various interpersonal sources, including healthcare providers, family 
members, and close friends (Taft, Keefer, Artz, Bratten, & Jones, 2011; Taft, Keefer, Leonhard, 
& Nealon-Woods, 2009). The result of such perceived stigma can put those with IBD at risk for 
internalizing harmful attitudes and beliefs about their disease (i.e., believing they are of lesser 
status and deserving of stigma) (Taft, Ballou, & Keefer, 2013).  
The complexities associated with self-managing IBD—paired with harmful disease-
related stigma—can leave individuals at risk for experiencing a number of comorbid, deleterious 
health outcomes. For example, studies show many people with IBD perceive a high amount of 
distress (Chudy-Onwugaje et al., 2018; Graff, Walker, & Bernstein, 2009; Nahon et al., 2012; 
Reigada et al., 2015), with recent estimates indicating approximately 30% of those with IBD 
report symptoms of anxiety and depression (Byrne et al., 2017; Neuendorf, Harding, Stello, 
Hanes, & Wahbeh, 2016). Moreover, both qualitative and quantitative research suggest that 
people with IBD worry that their disease will hinder their ability to succeed in life, and that 
having IBD makes them a burden to others (Casati, Toner, De Rooy, Drossman, & Maunder, 
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2000; Daniel, 2002; De Rooy et al., 2001; Drossman, Patrick, Mitchell, Zagami, & Appelbaum, 
1989; Keeton, Mikocka-Walus, & Andrews, 2015).  
Distress can pose major consequences to other aspects of IBD health. For example, 
distress has been shown to negatively impact the disease course of IBD, which can increase risk 
for symptom relapse and disease flares (Graff, Walker, & Bernstein, 2009; Kochar et al., 2018; 
Nahon et al., 2012; Reigada et al., 2015). Furthermore, a number of studies show a relationship 
between distress and IBD symptom activity (Duffy et al., 1991; Levenstein et al., 1994; Porcelli, 
Zaka, Centonze, & Sisto, 1994; Sarid et al., 2018; Sexton et al., 2017). These outcomes can be 
partially explained by the mind-gut connection, which suggests that there is a strong reciprocal 
link between one’s mind (i.e., perceptions of anxiety, depression) and the body’s somatic state 
(Smith & Bryant, 2002). In an IBD context, an example circumstance would be people with 
Crohn’s disease stressing about potentially experiencing a disease flare and, as a result of this 
stress, manifesting physical symptoms in sections of their gastrointestinal tract. 
Increased distress can also hinder one’s ability to self-manage IBD, such as adhering to 
medication (Nahon et al., 2012). This outcome is particularly worrisome given that proper 
disease self-management can help treat disease-related symptoms, as well as keep IBD in 
remission. Finally, studies have shown a negative association between distress and quality of life 
(Tabibian et al., 2015; Zhang et al., 2013). As such, it is critically important that research identify 
ways to intervene and mitigate distress among those with IBD who may be at risk.   
One potential way to better understand and target perceptions of distress among those 
with IBD could be through social media. Studies show that individuals with IBD are active on 
social media platforms (Guo, Reich, Groshek, & Farraye, 2016; Reich et al., 2016), which is 
likely due to the fact that such platforms offer a variety of technological affordances that can 
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help people self-manage their disease (O'Leary, Coulson, Perez-Vallejos, & McAuley, 2020). 
For instance, research shows people with IBD use social media to both seek and provide 
informational and emotional support among a network of other like-minded people (Britt, 2017; 
Coulson, 2013; Frohlich, 2016; Frohlich & Zmyslinski-Seelig, 2012; Frohlich & Zmyslinski-
Seelig, 2016; Mukewar, Mani, Wu, Lopez, & Shen, 2013; Rademacher, 2018). Such support can 
include strategies and tips about how to cope with the many social, physical, and psychological 
outcomes associated with self-managing IBD. This is key, as researchers could synthesize this 
information to inform the development of a health intervention aimed at providing disease self-
management support to those with IBD who use these platforms and who may be in need of help. 
No studies in the IBD literature that I am aware of have sought to investigate such an important 
and emerging topic. 
Another approach to mitigating distress among those with IBD could be through eHealth 
(i.e., electronic health). eHealth refers to the use of information and communication technologies 
to improve health outcomes (Eng, 2001). Currently, a large number of digital tools, such as 
disease self-management smartphone apps, are publicly available for people with IBD to 
download and use at low-cost or for free (Con & De Cruz, 2016). The efficacy of these tools is 
largely promising, with several systematic reviews and meta-analyses of randomized controlled 
trials showing that eHealth applications tend to have a positive impact on a number of important 
IBD health outcomes, including distress, medication adherence, disease activity, and quality of 
life, among others (Jackson, Gray, Knowles, & De Cruz, 2016; Knowles & Mikocka-Walus, 
2014; Rohde, Barker, & Noar, 2021). These outcomes suggest that eHealth, if utilized properly, 
can serve to benefit people with IBD, particularly those who may experience and struggle with 
disease self-management and distress. It must be stated, though, that the eHealth and IBD 
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research field is still relatively nascent, and to fully understand the role that these digital tools 
can play in managing and improving IBD health outcomes requires additional empirical evidence 
(Bossuyt, Pouillon, Bonnaud, Danese, & Peyrin-Biroulet, 2017).  
Although literature has independently investigated the use of social media platforms and 
eHealth programs as key digital tools for people with IBD to seek support and acquire 
information about how to best self-manage their IBD, there has been no research integrating 
these two emerging areas. In other words, the question remains as to whether these two 
technologies can complement one another in a systematic investigation aimed at understanding 
and improving IBD health outcomes, most notably distress. For example, many social media 
studies report on content analysis findings from publicly available online discussions of IBD 
(Britt, 2017; Frohlich & Zmyslinski-Seelig, 2012; A. Khan et al., 2018; Mukewar et al., 2013; 
Rademacher, 2018). In the context of distress, could analysis of this discourse be applied to 
identify specific areas that people with IBD may struggle with? If so, could that information be 
used to inform the development of a targeted eHealth intervention aimed at providing disease 
self-management information and support to this population? 
Currently, the IBD literature lacks an understanding of the impact that a disease self-
management eHealth intervention informed by social media may have on those with IBD. The 
research from this dissertation sought to address this critical gap and contribute to improvements 
in IBD health. In doing so, this dissertation reports findings from the following three interrelated 
empirical studies: 1) analysis of social media posts about IBD and distress; 2) construction and 
pilot evaluation of IBD support messages; and 3) feasibility and acceptability testing of an IBD 
self-management eHealth intervention targeted toward people with IBD who experience disease-
related distress. The remainder of this dissertation is structured as follows: 
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In Chapter 2, I review the literature on distress and its associated effects on people with 
IBD. I also review literature on disease self-management, and highlight the important role that 
self-management plays in reducing distress among those with IBD. I then discuss several 
theoretical perspectives useful in understanding disease self-management processes, such as self-
efficacy and social support. Finally, I review literature on some of the digital tools that people 
with IBD use for disease self-management. 
In Chapter 3, I analyze two big data sets of public social media posts from Reddit and 
Twitter about IBD and distress. Specifically, I apply a term-based computational dictionary to 
characterize the prevalence of certain IBD topics in the data sets, as well as the extent to which 
certain IBD topics facilitated online discourse among multi-topic posts. 
In Chapter 4, I use the findings from the social media analysis to construct a selection of 
support messages about IBD self-management. I then test these messages in a pilot study with a 
sample of people with IBD. 
In Chapter 5, I develop an eHealth intervention called “Text4IBD,” which sends 
participants the IBD self-management support messages developed in the previous chapter via 
text message. I evaluate the feasibility and acceptability of this intervention in a pretest-posttest, 
single group study among a sample of participants with IBD who were recruited from social 
media. 
Finally, in Chapter 6, I summarize the findings of this dissertation. I then discuss the 
broader implications of these findings, highlight the various methodological limitations 
associated with this work, and provide an overview of future research questions and next steps. 
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CHAPTER TWO: LITERATURE REVIEW 
IBD and distress 
As briefly highlighted in Chapter 1, distress is a major problem among people with IBD. 
Throughout this dissertation, I broadly define distress as unpleasant perceptions of cognitive, 
behavioral, emotional, or social experiences (or a mix of these different experiences). This 
definition is derived from the National Comprehensive Cancer Network and was chosen in lieu 
of other disorder terminologies (e.g., psychosocial, psychiatric) because it is less stigmatizing 
and is more encompassing of the complex and numerous effects of chronic disease on health 
outcomes (Holland et al., 2013). In this definition, distress lies on a continuum where one end 
represents common/normative feelings of vulnerability and the other entails feelings of acute, 
disabling forms of distress, such as depression and anxiety.  
It also important to acknowledge that references to IBD- or disease-related distress 
throughout this dissertation are distinct from general experiences of distress. Instead, IBD-related 
distress is characterized by the emotional, physical, and social burdens resulting from managing 
IBD and its symptoms (Woodward et al., 2016). Examples of this disease-specific type of 
distress can include worries about seeking or being able to afford medical treatment, having to 
cope with the social stigma associated with IBD, and the effects of IBD symptoms on health, 
among others.  
Characteristics of distress have been recognized as comorbidities of IBD in the literature 
(Graff, Walker, & Bernstein, 2009; Mikocka‐Walus et al., 2007). Compared to general 
populations, people with IBD tend to experience higher rates of distress (Choi et al., 2019; Graff, 
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Walker, & Bernstein, 2009; Schwarz & Blanchard, 1990). Some estimates within the last several 
years suggest that approximately 30% of people with IBD report experiencing depression and/or 
anxiety (Byrne et al., 2017; Neuendorf et al., 2016). These estimates can substantially increase 
during periods of worsening symptom activity (e.g., disease flares) or relapses when people with 
IBD may be struggling to get their disease under control (Neuendorf et al., 2016). In addition, 
other studies show people with IBD tend to experience disease-related stress, and have also 
vocalized concerns regarding social isolation (due to not being able to control disease symptoms 
in public) and perceptions that they will be viewed as a burden to others because of their disease 
(Casati et al., 2000; Daniel, 2002; De Rooy et al., 2001; Dibley & Norton, 2013; Keeton et al., 
2015). This evidence demonstrates the vast characteristics and perceptions of distress people 
with IBD have to navigate.  
It is not surprising that people with IBD are at such high risk for distress. Adjusting to a 
chronic disease after a diagnosis is a complicated, scary, and deeply personal process. This is 
especially true for IBD because of its taboo and stigmatized disease characteristics, such as fecal 
incontinence and uncontrollable flatulence (Guo et al., 2020; Lenti et al., 2020; Saunders, 2014; 
Taft & Keefer, 2016). Indeed, investigations have shown a correlation between perceptions of 
stigma and distress among those with IBD (Taft et al., 2011; Taft et al., 2009). Moreover, IBD 
requires a high degree of disease maintenance, including adherence to medication, active 
symptom monitoring and tracking, and frequent medical checkups (Keefer & Kane, 2016). This 
involvement can be time consuming and frustrating to stay on top of when also having to balance 
the various physical, mental, and cognitive effects resulting from IBD symptoms (e.g., fatigue, 
reduced energy). This may explain why people with IBD who have active symptoms are at 
higher risk for depression than those in remission (Panara et al., 2014).  
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Unfortunately, distress has been shown to have a number of harmful effects on IBD 
health outcomes (Graff, Walker, & Bernstein, 2009). For example, IBD research suggests an 
association between stress and poor quality of sleep and sleep disturbance (Edman et al., 2017; 
Hood et al., 2018). Studies have also linked associations between distress and health-related 
quality of life among people with IBD (Engelmann et al., 2015; Naliboff et al., 2012; Tabibian et 
al., 2015). Zhang et al. (2013) conducted a cross-sectional survey of 105 individuals with IBD, 
one-fifth of whom experienced depressive symptoms. The authors found a significant negative 
association between these symptoms and participants’ health-related quality of life.  
Distress can also affect somatic manifestations of IBD, such as disease activity (Duffy et 
al., 1991; Porcelli et al., 1994). For instance, one recent longitudinal study of more than 4,000 
individuals with IBD found that those who reported depressive symptoms at baseline and who 
were in disease remission were at an increased risk of experiencing symptom relapse at a 2-year 
(approximately) follow-up assessment (Kochar et al., 2018). These findings are corroborated by 
another longitudinal investigation by Mittermaier et al. (2004), which found significant 
associations between depressive symptoms at baseline among people with IBD and symptom 
relapse at both 12- and 18-month follow-up assessments.  
Finally, some studies suggest that distress can have negative effects on behavioral IBD 
outcomes (Graff, Walker, & Bernstein, 2009). For example, a study by Gray, Denson, 
Baldassano, and Hommel (2012) examined barriers to treatment adherence among a sample of 
adolescents with IBD. Results from their study found that increases in anxiety and depression 
were negatively correlated with treatment adherence. This finding was also independent of self-
reported barriers to medication adherence (e.g., was not at home to take it, forgot to take it). A 
large volume of studies have also found similar evidence linking poor IBD treatment adherence 
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with distress (Nahon et al., 2012; Nigro, Angelini, Grosso, Caula, & Sategna-Guidetti, 2001; 
Shale & Riley, 2003; Tabibian et al., 2015). 
In a worst-case scenario, distress can be a life-threatening comorbidity of IBD. 
Longitudinal evidence from thousands of individuals in a sample of people with IBD in Canada 
found that 17% of those who experienced high rates of depression contemplated suicide in the 
past year (Fuller-Thomson & Sulman, 2006). Given the serious harm that distress poses to 
various IBD health outcomes, and for obvious reasons, treating distress among this population 
should be of critical public health concern.  
Disease self-management 
One promising approach to targeting and mitigating perceptions of distress among people 
with IBD is to educate and increase their involvement—and confidence—in the IBD 
management process. I refer to this involvement as disease self-management. According to 
literature, disease self-management is an active, task-oriented, and problem-based process (Lorig 
& Holman, 2003). There are a number of different operationalizations of the disease self-
management process; however, for this dissertation, I draw from Lorig and Holman (2003) and 
highlight three overarching tasks most useful in understanding and characterizing self-
management specifically among chronic disease populations. These tasks are: 1) medical and/or 
behavioral management, 2) role management, and 3) emotional management.  
The first of these tasks, medical and/or behavioral management, refers to one’s ability to 
manage or maintain the various medical and behavioral aspects of their chronic disease (Lorig & 
Holman, 2003). Common tasks in the category include taking prescribed medication on time or 
engaging in regular physical exercise. Role management, the second task, refers to one’s ability 
to modify behavior in a way that best suits or mitigates the problems resulting from chronic 
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disease. This could include replacing poor eating habits with healthier options or taking time out 
of the day for rest and relaxation. The last task, emotional management, refers to one’s ability to 
handle the emotional effects and burdens associated with chronic disease. Example tasks in this 
category could include learning how to cope with the social stigma of a chronic disease or 
engaging in different stress management techniques, such as breathing exercises and meditation.  
In the context of IBD, disease self-management can represent a myriad of important 
tasks, which can vary from person to person; though, common self-management tasks tend to 
include adhering to medication and a symptom mitigating diet, active IBD symptom monitoring, 
and scheduling regular medical check-ups and screenings (e.g., colonoscopies) (Keefer & Kane, 
2016; Plevinsky, Greenley, & Fishman, 2016).  
Unfortunately, disease self-management can be a difficult and frustrating process for 
people with IBD to learn and/or adjust to. According to Keefer and Kane (2016), this is due to a 
number of reasons. For example, people with IBD can play a highly active and motivated role in 
self-managing their disease, such as keeping a symptom diary and only eating foods low in fiber, 
and yet somatic symptoms can still periodically manifest. Another reason is that many IBD 
symptoms inherently pose a barrier to disease self-management, such as fatigue and chronic and 
acute intestinal cramping. One last notable reason has to do with the various sociocultural 
barriers that may hinder one’s ability to self-manage IBD. Examples of these barriers can include 
not having a reliable support system, the health literacy to understand important medical 
information, or access to necessary healthcare therapeutics and services.   
Educating people with IBD about useful disease self-management tasks and information, 
such as through a health intervention, should be of utmost importance among IBD researchers. 
Evidence from a general chronic disease literature highlights several benefits associated with 
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improving self-management confidence and ability (Lorig & Holman, 2003; Lorig, Sobel, Ritter, 
Laurent, & Hobbs, 2001). For example, a randomized controlled trial among a sample of 
approximately 1,000 individuals with different chronic diseases (e.g., heart disease, lung disease) 
tested the impact of a self-management program compared to a control arm (i.e., no exposure to 
the intervention) on several different health outcomes (Lorig et al., 1999). Results of this 
intervention showed that participants in the disease self-management treatment program 
improved their exercise and reduced their perceived distress and number of hospitalizations 
compared to those in the control condition. In addition, meta-analytic evidence from the 
literature has shown that chronic disease self-management interventions result in demonstrable 
benefits to psychological health and well-being (Brady et al., 2013).  
Importantly, there is also research supporting the implementation of disease self-
management interventions among those with IBD specifically. For example, a recent study by 
Barnes, Long, Kappelman, Martin, and Sandler (2019) investigated the effects of patient 
activation on health outcomes among a sample of nearly 1,500 individuals enrolled in an IBD 
clinical cohort. Patient activation is a similar concept to disease self-management and refers to 
patients’ ability to demonstrate the skills and knowledge needed to best self-manage their 
chronic disease. Results from Barnes, Long, et al. (2019) showed that IBD patient activation was 
associated with distress outcomes (e.g., depression, anxiety), as well as disease activity. More 
specifically, findings showed that people with IBD who had higher patient activation were more 
likely to be in clinical remission than those with low activation.  
IBD studies have also demonstrated the benefits of targeting and improving disease self-
management in health intervention contexts (Conley & Redeker, 2016). For example, one 
investigation randomly assigned participants to either an IBD self-management intervention or to 
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a standard care control condition (Robinson, Thompson, Wilkin, & Roberts, 2001). Participants 
in the intervention condition made significantly fewer visits to the hospital per year. Results from 
another IBD randomized controlled trial of a self-management intervention found similar effects 
on the number of participant hospitalizations compared to control (Kennedy et al., 2004). 
Finally, a recent systematic review of studies showed that IBD self-management interventions 
tended to improve quality of life and disease activity (Conley & Redeker, 2016). Only six studies 
were included in this review, however, which indicates that more investigations among this 
population are needed to fully understand the impact of self-management interventions on IBD 
health outcomes. Regardless, findings from these studies suggest that disease self-management 
can play a critical role in targeting and improving distress among people with IBD. 
Theoretical perspectives  
The review of literature thus far has highlighted the incidence and harmful effects of 
distress among people with IBD, and has proposed that improving IBD self-management 
confidence and ability among this population through a health intervention may help reduce their 
distress. Prior to developing such an intervention, however, it is important to understand some of 
the theoretical perspectives and mechanisms potentially underlying distress, and the key 
adjustments that people with IBD can make in order to best self-manage their disease.  
Social cognitive theory 
The first theoretical perspective important to the research throughout this dissertation is 
social cognitive theory (SCT). SCT was developed by Bandura (1977) as a framework for 
understanding how individual cognition, social/environmental factors, and behavior all exert 
influence on behavior change through a process of reciprocal determinism (Bandura, 2004; 
Kelder, Hoelscher, & Perry, 2015). That is, Bandura (1977) posited that individuals’ cognition 
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was influenced by social/environmental factors (and vice versa), and together, these domains 
collectively influence behavior. Since its conception, this theory has been applied across a 
number of research disciplines, ranging from psychology and public health to mass 
communication (Bandura, 2001; Kelder et al., 2015).  
 SCT is comprised of several theoretical constructs (e.g., knowledge, normative beliefs, 
intentions) that help us understand engagement in health behavior. For this dissertation, there are 
two key constructs that I believe lend themselves best to understanding adjustments to disease 
outcomes (including distress) and self-management among people with IBD. These constructs 
are self-efficacy and outcome expectations.  
Self-efficacy refers to the confidence in one’s ability to engage in a behavior or task. 
According to Kelder et al. (2015), self-efficacy is a core and unifying construct in SCT because it 
is directly related to the initiation of a behavior and the level of effort that is exerted from an 
individual to produce or sustain a behavior. In an IBD context, self-efficacy tends to be viewed 
as confidence in one’s disease self-management ability, such as adhering to treatments and 
symptom mitigating diets, active disease monitoring, and a number of other behaviors (Keefer, 
Kiebles, & Taft, 2011). According to Bandura (1997), there are four different components that 
influence perceptions of self-efficacy: 1) past personal experiences, 2) vicarious experiences, 3) 
social persuasion, and 4) emotional arousal.  
The past personal experiences component refers to one’s prior history of engaging in a 
behavior and the perceptions of the behavioral outcome (Kelder et al., 2015). For IBD, this could 
include one’s history of being able to take daily oral medication at the same time. Regarding 
self-efficacy and confidence, if past experiences completing this particular task were easy and 
successful, this would build self-efficacy and increase the likelihood that the person would 
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continue this behavior (i.e., adhering to IBD medication). The second component, vicarious 
experiences, refers to what is learned about a behavior through social observations. For example, 
if people with IBD witness their parents or close friends easily monitoring their own chronic 
disease symptoms, such as through a daily diary or digital application, then it is possible that 
they, too, might feel confident and capable of performing the behavior.  
Social persuasion is the third component and typically refers to the level of 
encouragement (or discouragement) that peers offer about a behavior (Kelder et al., 2015). In the 
context of IBD, this could include healthcare workers encouraging patients to actively monitor 
and track their symptoms when experiencing an IBD flare. Another example would include peers 
with IBD supporting one another to keep symptoms in remission. The last component is 
emotional arousal. One’s affective state plays a critical role in understanding confidence and 
ability to perform a behavior. For example, fear about not being able to perform a task 
appropriately (e.g., playing basketball) would likely result in avoiding this behavior altogether. 
People with IBD who are reluctant to undergo a colonoscopy because they are fearful of the 
process is an example of the impact of emotional arousal on self-efficacy.  
Importantly, self-efficacy is directly linked to disease self-management processes. 
Evidence from systematic reviews and meta-analyses investigating a number of different chronic 
diseases (e.g., coronary heart disease, diabetes) have identified self-efficacy as an integral 
component when developing effective self-management interventions (Foroumandi, Kheirouri, 
& Alizadeh, 2020; Katch & Mead, 2010; Krichbaum, Aarestad, & Buethe, 2003). Similar 
conclusions have been made in the IBD literature (Plevinsky et al., 2016). For instance, Keefer 
and Kane (2016) suggest that SCT concepts, such as self-efficacy, could be leveraged to create 
supportive and effective disease self-management tools for people with IBD. Indeed, evidence 
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from a recent study tested the effects of a 3-week IBD self-management and education program 
(Magharei, Jaafari, Mansouri, Safarpour, & Taghavi, 2019). Results from this investigation 
showed that, compared to a no-treatment control condition, those exposed to the self-
management program improved their self-efficacy. Finally, research has also shown a link 
between self-efficacy and other IBD health outcomes, most notably distress and health-related 
quality of life (Keefer et al., 2011).  
The second SCT construct important to this dissertation is outcome expectations. 
Outcome expectations refer to peoples’ judgements—good or bad—about the consequences of 
their behavior (Kelder et al., 2015). These judgements can inform illness perceptions, which, in 
turn, influence how people with chronic disease respond to a health-related issue (e.g., taking 
medication to treat the onset of symptoms).  
Health behavior consequences associated with outcome expectations can either be 
physical or social. For example, a person with IBD who adheres to a low-fiber diet may be doing 
so because they believe that this nutritional choice could lead to improvements in their disease 
activity (e.g., reduced intestinal cramping). This is an example of how physical consequences 
associated with an outcome affect and reinforce disease self-management behavior. Social 
consequences, on the other hand, correspond with peoples’ expected reactions to a behavior from 
their peers. For instance, people with IBD who are currently struggling with a disease flare might 
choose to stay at home to avoid experiencing the social stigma that might ensue from not being 
able to control certain IBD symptoms in public, such as flatulence or diarrhea.  
Some research has investigated outcome expectations as a component of chronic disease 
self-management (Reisi et al., 2016; Wu et al., 2007). Unfortunately, there has been no work—at 
least that I am aware of—that has explicitly examined outcome expectations as a measurable 
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construct in the context of IBD. There is, however, some evidence showing that people with IBD 
who hold negative perceptions about IBD outcomes tend to have sub-optimal disease self-
management skills (e.g., treatment adherence) (Hall, Rubin, Hungin, & Dougall, 2007). For 
example, one study by Moshkovska et al. (2009) examined predictors of medication adherence 
among a sample of 169 individuals with ulcerative colitis from Europe. Findings from this work 
showed that personal doubts about the need for IBD treatment were associated with non-
adherence. Research by Horne, Parham, Driscoll, and Robinson (2009) has corroborated the 
findings from Moshkovska et al. (2009), and suggests that outcome expectations may be 
important in understanding the processes underlying IBD self-management. Nonetheless, the 
lack of evidence of this construct in the IBD literature warrants additional investigation.  
Collectively, these findings suggest that targeting and improving both self-efficacy and 
outcome expectations among people with IBD should be a key goal of any disease self-
management intervention or other effort aimed at reducing IBD-related distress.  
Social Support 
Another important perspective in this dissertation is social support. Broadly, social 
support can be understood as any meaningful exchange of assistance or resources from one 
person (or group) to another with the intent to improve well-being. Some researchers have also 
operationalized support based on the type of assistance being provided, with example categories 
often being informational and emotional support, among others (E. B. Fisher et al., 2018; Holt-
Lunstad & Uchino, 2015). Depending on the context, distinguishing among support categories 
can be useful for different applications. For example, people who may have just lost a family 
member and are struggling could respond positively to emotional support, whereas those who 
want to simply learn more about a topic would likely benefit from receiving informational 
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support. Of course, these two types of support can also operate in tandem with one another. For 
example, people with IBD who experience distress may need emotional support to help them 
cope with the effects of disease symptoms on their mental health, as well as informational 
support to learn about different efficacious disease self-management behaviors. 
For the purposes of this work, it is important to also recognize that social support does 
not necessarily need to come from a human. Instead, support can be facilitated through a number 
of modalities, such as through a digital program that provides educational information and advice 
about disease self-management without social interaction from medical providers, researchers, or 
peers (more on this topic will discussed below). 
The effects of support on health are vast and can target biological, psychological, and 
behavioral aspects of health and well-being (Uchino, Bowen, Kent de Grey, Mikel, & Fisher, 
2018). For example, a landmark study by House, Landis, and Umberson (1988) found that lack 
of available social support (i.e., social isolation) was a significant risk factor in predicting 
mortality. Although published in the late 1980s, recent reviews and investigations corroborate 
findings from House et al. (1988), with robust meta-analytic evidence from over 100 studies 
suggesting that social isolation predicts mortality by approximately 30%—a number rivaling that 
of combustible cigarette smoking (Holt-Lunstad, Smith, Baker, Harris, & Stephenson, 2015; 
Holt-Lunstad, Smith, & Layton, 2010; Steptoe, Shankar, Demakakos, & Wardle, 2013). 
Research has also examined the beneficial impact of support on health. For example, evidence 
suggests that social support can act as a buffer against stress and can increase perceptions of self-
esteem (Cohen, 2004; Symister & Friend, 2003).  
Importantly, support has been shown to improve disease self-management abilities, such 
as adherence to treatment, among different chronic disease populations (DiMatteo, 2004; 
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Gallant, 2003). This is also true in the context of IBD. Indeed, literature suggests that support is a 
fundamental component to IBD self-management (Plevinsky et al., 2016). For example, Keefer 
and Kane (2016) propose that supportive disease self-management programs can optimize 
medical management and improve health outcomes and quality of life among people with IBD. 
In addition, a recent study by Kamp, Luo, Holmstrom, Given, and Wyatt (2019) tested 
associations between support and disease self-management skills. Results from this study 
showed a positive correlation between levels of received informational support and adherence to 
IBD medication.  
Literature has also shown effects of support on other IBD health outcomes. For example, 
Moskovitz, Maunder, Cohen, McLeod, and MacRae (2000) conducted a study among individuals 
with IBD who, at the time of their research, had recently undergone GI surgery. Participants 
were evaluated on their perceptions of support and postoperative quality of life. Results showed 
that perceived support was positively correlated with quality of life, and this association was 
irrespective of participant characteristics.  
A more recent study by Slonim-Nevo et al. (2018) examined associations between 
perceptions of support and disease activity, distress, and quality of life among people with IBD. 
Findings showed that participants who reported increased perceptions of support tended to have 
lower disease activity and distress, as well as increased quality of life. Previous work 
corroborates some of the findings from Slonim-Nevo et al. (2018), with results showing that 
satisfaction with social support can reduce distress among those with IBD (Sewitch et al., 2001). 
These findings suggest that support is not only a fundamental component to effective IBD self-
management, but that targeting and improving perceptions of support could reduce distress 




The last key theoretical mechanism useful in understanding IBD self-management and 
distress is coping. Coping refers to the use of cognitive and behavioral efforts to appraise and 
reduce a stressful situation, such as self-managing a chronic disease (Snyder, 1999). Broadly, 
coping can be broken down into both negative and positive coping strategies, which I refer to as 
adaptive and maladaptive coping, respectively. Example maladaptive coping strategies include 
avoidance and denial, while some adaptive coping strategies include actively seeking out 
support, planning, and acceptance (Carver, 1997). 
There have been a number of investigations examining the use of coping strategies 
among people with IBD (Goodhand & Rampton, 2008; A. M. McCombie, Mulder, & Gearry, 
2013). For example, studies show that individuals with IBD report high use of maladaptive 
coping strategies compared to control populations (Graff, Walker, Clara, et al., 2009; Jones, 
Wessinger, & Crowell, 2006; Parekh et al., 2015). Moreover, data suggest that the use of 
maladaptive coping strategies tend to be associated with worsened IBD health outcomes, 
including distress and poor quality of life (Danesh et al., 2015; A. M. McCombie, Mulder, & 
Gearry, 2015; Moskovitz et al., 2000). Fewer investigations have examined effects of adaptive 
coping strategies among those with IBD. There is some evidence, however, that suggests a small 
positive correlation between the use of adaptive coping strategies and quality of life (Parekh et 
al., 2015; Van der Zaag-Loonen, Grootenhuis, Last, & Derkx, 2004).  
Based on the extant coping and IBD literature, it is likely that coping strategies are vital 
mechanisms associated with the disease self-management process. Established health behavior 
theory supports this proposition. For example, the common-sense model of illness self-regulation 
posits that coping strategies mediate the relationship between beliefs about a health threat (e.g., 
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disease symptoms) and how that threat is eventually appraised (Diefenbach & Leventhal, 1996; 
Leventhal, Phillips, & Burns, 2016). In this same perspective, self-management literature has 
shown coping strategies to be a useful mechanism in predicting distress among populations with 
chronic disease (including IBD) (Cameron & Jago, 2008; Dorrian, Dempster, & Adair, 2009; 
Hagger, Koch, Chatzisarantis, & Orbell, 2017; Knowles, Wilson, Connell, & Kamm, 2011).  
To date, few investigations have examined coping in the context of disease self-
management interventions for people with IBD (A. M. McCombie et al., 2013). One randomized 
controlled trial by Kennedy et al. (2004) tested the effectiveness of an IBD self-management 
training session disseminated to outpatients across multiple hospitals in Europe. Immediately 
after exposure to the intervention, participants randomized to the self-management program 
reported feeling more confident in their ability to cope with their disease compared to those in 
the control condition (who received standard care). The primary goal of this intervention, 
however, was to test its impact on quality of life and the number of hospitalizations reported one 
year after exposure to the self-management program. Coping was not a focal point of this 
investigation and was not assessed at follow-up. As such, more work is needed to test whether 
coping as a central component can be useful in developing and disseminating effective IBD self-
management interventions.  
Framework for an IBD self-management intervention 
Based on the above review of different theoretical perspectives among health behavior 
and chronic disease literature, there is reason to believe that such perspectives could be 
integrated in a complementary and unifying framework that could be used to inform the 
development of a disease self-management health intervention for people with IBD—particularly 
those struggling with distress. For example, I propose that intervention efforts aimed at reducing 
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IBD-related distress should prioritize improving perceptions of cognitive-level constructs, such 
as disease-related self-efficacy, outcome expectations, and perceived support, as they are key 
determinants in the disease self-management process. Moreover, these constructs are likely to 
impact how people with IBD cope with and subsequently self-manage their disease, as has been 
suggested by some IBD research (Graff et al., 2016). In turn, the use of disease self-management 
coping strategies will likely lead to changes in IBD-related distress.  
Of course, it is also important to understand individual differences when examining 
adjustments to chronic disease. After all, people with IBD experience a wide gamut of 
symptoms, which can range both in intensity and duration. Moreover, the length that people have 
been diagnosed with IBD likely has an influence on their disease self-management knowledge 
and ability. In other words, someone who has been diagnosed with IBD for decades may know 
how to best mitigate and cope with the onset of an IBD flare, whereas someone newly diagnosed 
may not yet have the confidence and knowledge needed to self-manage such an event. Thus, it 
would not be appropriate to assume a single disease self-management intervention would be 
equally efficacious among all IBD sub-populations.  
Based on this overview of theoretical perspectives and individual differences, I propose a 
unifying conceptual framework for developing a disease self-management intervention targeting 
IBD-related distress. A visual of this framework and the association among determinants can be 
seen in Figure 1 below. In this framework, outcome expectations, self-efficacy, and perceived 
IBD support variables are posited to affect the use of coping strategies. In turn, coping acts as a 
mediator between the aforementioned theoretical variables and IBD-related distress. Finally, the 
direct effects of these posited associations are moderated by individual differences variables, 














































































































































































































































Digital tools for IBD self-management 
Prior to developing a theoretically-informed intervention using the above framework, it is 
important to review some of the extant tools that people with IBD have used for IBD self-
management and support. The literature has highlighted the efficacy of certain digital 
technologies in facilitating such support (Keefer & Kane, 2016). As briefly mentioned in Chapter 
1, I believe there are two distinct yet interrelated categories of these technologies most relevant 
to the research goals of this dissertation. These technologies are: 1) social media platforms and 2) 
eHealth applications. 
IBD and social media 
A large volume of published work has examined the construction and diffusion of IBD-
related content on the internet via social media platforms, such as Facebook and YouTube (Britt, 
2017; Frohlich, 2016; Mukewar et al., 2013; Rademacher, 2018). In addition, literature shows 
that people with IBD are active on social media (Guo et al., 2016; Reich, Guo, et al., 2019; Reich 
et al., 2016), and that such platforms foster active disease-related discourse (Chiang, 
Vartabedian, & Spiegel, 2016; A. Khan et al., 2018). This is likely due to the various features of 
these online platforms (Merolli, Gray, & Martin-Sanchez, 2013). A recent qualitative study by 
O'Leary et al. (2020) found that some people with IBD consciously use multiple social media 
platforms because of the different technological affordances provided by each. For example, 
people with IBD were more comfortable expressing themselves in closed communities on IBD-
dedicated Facebook groups compared to public facing social media threads on Twitter. 
Participants in this study also reported that features such as the hashtag on Twitter allowed them 
to readily find and share information about IBD and seek connections. 
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Of course, the specific purposes for social media use among people with IBD likely 
varies from person to person; however, findings throughout the literature suggest that many 
people with IBD use such platforms to seek or provide support about self-managing their 
disease. For example, a recent study found that people with IBD who were active social media 
users reported being highly interested in learning more about their disease from other sources, 
such as from online accounts operated by gastroenterologists or patient-related organizations 
(e.g., Crohn’s and Colitis Foundation) (Reich, Guo, et al., 2019). This finding is supported by 
social media content analyses showing that discussions of IBD frequently center on the provision 
or request of disease-related information from users (Britt, 2017; Coulson, 2015; A. Khan et al., 
2018; Rohde, 2018; Rohde & Barker, 2020). For example, studies show that individuals with 
IBD have used social media platforms to learn more about the efficacy of certain disease-
relevant diets (e.g., low fiber diet), as well as about the various types and side effects of different 
IBD medications (Britt, 2017; Martinez et al., 2017). Some work has even shown that people 
have used social media platforms to discuss information about IBD surgeries, such as ostomy 
procedures (Frohlich & Zmyslinski-Seelig, 2016).  
In addition to informational support about disease self-management, several studies show 
that people with IBD use social media for emotional support purposes, such as for uplifting other 
users who feel down (Britt, 2017; Frohlich & Zmyslinski-Seelig, 2016). For example, in an 
analysis of social media posts of photos of individuals with IBD displaying their ostomy bags (an 
external pouch connected to the abdomen used to collect stool), Frohlich and Zmyslinski-Seelig 
(2016) found that people frequently commented on the posts praising one another for being brave 
by publicly showing others their ostomy. Other IBD social media studies report similarly 
supportive themes (Britt, 2017; Coulson, 2015; Frohlich & Zmyslinski-Seelig, 2012; 
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Rademacher, 2018). For instance, one investigation found that people have used social media to 
dispel misperceptions of what it means to be diagnosed with IBD, as well as to validate one 
another’s feelings and disease-related struggles (Frohlich, 2016). Such support can be critical for 
people who may struggle to self-manage their IBD and who feel as though they have no one to 
talk to about their disease experiences. 
Finally, some research suggests that people with IBD use social media to establish 
support networks and to engage with online communities. For example, evidence from one study 
of nearly 250 individuals with IBD found that over 80% of participants reported that a major 
reason they used social media platforms was to find and connect with other individuals with 
shared life circumstances (Coulson, 2013). Moreover, a recent ethnographic study found that 
people with IBD tend to participate more in close-knit communities in order to reconstruct or 
develop new social identities (Frohlich, 2016). For example, although IBD is not to be taken 
lightly in the real world, those across online IBD communities sometimes joke about their 
symptoms with one another because they have all undergone similar disease-related experiences. 
The same study also found that people with IBD enjoyed being in online communities because it 
made them feel visible. 
Research examining the direct effects of social media platforms on IBD self-management 
is a developing area with little published work. One recent study by Zhao et al. (2021) 
investigated how the use of social media platforms for seeking health information among nearly 
500 individuals with Crohn’s disease affected their clinical course. Results from this study found 
that the information gained from social media platforms increased participants’ perceptions of 
support (e.g., informational, emotional). Importantly, findings also showed that such support had 
a further mediating and beneficial impact on disease self-management outcomes, including 
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improvements to treatment understanding and symptom management. This research further 
reinforces the notion that social media platforms can be useful digital tools for IBD self-
management—a notion that is also supported by other chronic disease and social media literature 
(Merolli et al., 2013). More work specifically examining whether data from social media 
platforms can be used in an IBD intervention context is still needed.  
IBD and eHealth  
 Another important category of digital technologies useful for self-managing an IBD 
diagnosis is eHealth. As stated previously in Chapter 1, eHealth refers to the use of information 
and communication technologies to improve health outcomes (Eng, 2001). Based on this 
definition, one could argue that social media platforms represent a type of eHealth technology 
because they are digital and because people with chronic disease use these platforms for various 
health-related reasons (e.g., seeking disease self-management support). For the purposes of this 
dissertation, however, I chose to distinguish these technologies for an important reason: social 
media platforms, such as Twitter and Facebook, are not explicitly designed for the self-
management of chronic diseases or to treat and improve health outcomes (at least for the most 
part). Instead, these tools have been appropriated for such purposes because of the technological 
affordances they offer their users (Merolli et al., 2013).  
eHealth technologies, on the other hand, are intentionally designed to improve health and 
are not often used by the general population. In contrast to social media platforms, eHealth 
applications tend to be tailored to the health audiences they are built to serve, such as people with 
chronic disease or those who are trying to quit smoking (Noar & Harrington, 2012). Common 
examples of eHealth technology include online disease self-management portals, digital 
cognitive behavioral therapy programs, and medication reminder text messaging applications. 
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Importantly, literature has recognized eHealth tools as a promising mechanism for facilitating 
IBD self-management and support (Con, Jackson, Gray, & De Cruz, 2017; Keefer & Kane, 
2016), and there are a number of these digital tools available to download via online stores, such 
as through the iPhone or Android mobile app stores (Con & De Cruz, 2016).  
 Evidence from a number of systematic reviews and meta-analyses have investigated the 
effects of eHealth applications on IBD health (Huang, Reich, & Fedorak, 2014; Jackson et al., 
2016; Knowles & Mikocka-Walus, 2014; Rohde et al., 2021). Results across these studies tend to 
suggest that these digital tools result in promising improvements to a number of health outcomes, 
including distress and disease self-management behaviors (e.g., medication adherence). For 
example, recent studies by Hunt et al. (2020) and Hunt, Rodriguez, and Marcelle (2017) tested 
the impact of digital-based cognitive behavioral therapy intervention programs on IBD distress. 
Results from these studies show that participants exposed to the therapeutic interventions 
reduced their perceptions of anxiety and depression compared to those in control conditions. 
Another study by de Jong, van der Meulen-de Jong, Romberg-Camps, Becx, et al. (2017) tested 
the efficacy of a multi-modal telemanagement program (i.e., “myIBDcoach”) through a 
randomized controlled trial. Over 400 participants with IBD enrolled in this 12-month 
intervention. Results showed that, compared to a no-treatment control group, participants 
exposed to the intervention reported greater adherence to medication, as well as fewer outpatient 
visits to their gastroenterologist.   
 A still-developing area in the IBD and eHealth literature is the use of text messaging as 
an intervention medium. A substantial body of evidence from the literature shows that text 
messaging is an effective tool for promoting behavior change (Head, Noar, Iannarino, & 
Harrington, 2013). This is particularly true in the context of chronic disease self-management 
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behaviors, such as medication adherence (Fjeldsoe, Miller, & Marshall, 2012; Thakkar et al., 
2016). Only a few studies to date have tested the efficacy of a text messaging self-management 
intervention among people with IBD. For example, a recent investigation by Riaz and Nielsen 
(2019) evaluated a pretest-posttest text messaging intervention that sent tailored disease self-
management messages to people with IBD. Results from this study showed that, compared to 
pretest, participants exposed to the intervention at a 12-week posttest reported improvements to 
their medication adherence and less concerns about IBD therapeutics.  
Another study by Miloh et al. (2017) sent frequent text messages to adolescents with IBD 
reminding them to take their medication. Results from this investigation showed that participants 
exposed to the intervention improved their adherence to medication at a 6-month follow-up 
assessment compared to those in a no-treatment control group.  
While the findings from both Riaz and Nielsen (2019) and Miloh et al. (2017) showed 
promise in their ability to facilitate disease self-management among people with IBD, there is 
also text messaging research positing null effects among this population. A randomized 
controlled trial by Cross et al. (2015) tested the efficacy of an intervention that sent educational 
support text messages about disease self-management to people with IBD. Results at a 1-year 
follow-up assessment showed that participants enrolled in the text messaging program showed 
no improvements to IBD activity, self-efficacy, or distress-related health outcomes; though, 
findings did show that the text messaging intervention had some effect on patient activation 
compared to control (Bilgrami et al., 2019; Cross et al., 2019; Schliep et al., 2020).  
The null findings from Cross et al. (2015) could be due to a number of reasons. First, 
there was a low message dose throughout the intervention. That is, participants enrolled in the 
study only received text messages from the program either once or twice weekly over the course 
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of one year. This low dose could result in participants forgetting the message content. Another 
explanation could be that the first assessment of the intervention took place six months into the 
trial. It is possible that the messages did have some impact; however, the magnitude of this 
impact tapered off before initial assessment of study outcomes. Finally, the messages themselves 
may not have been viewed as supportive or validating to people with IBD. This is because the 
messages themselves were designed to be educational or were used as a means to collect data 
about certain health outcomes (e.g., “How many liquid or unformed stools do you have per day? 
Please enter a number.”). 
 Inconsistent findings from the IBD text messaging intervention literature show that more 
research is needed to identify the processes and improve our understanding of the extent to 
which such applications can best facilitate disease self-management. Moreover, the IBD text 
messaging literature is relatively homogenous and additional evidence is needed to investigate 
whether text messaging as a disease self-management medium can be used to target other health 
outcomes, such as IBD coping strategies or outcome expectations. This is especially true for an 
intervention that is theoretically informed from health behavior and chronic disease self-
management literature. Examining reception of such an intervention among those with IBD 








 IBD is a highly stigmatized gastrointestinal disease (Guo et al., 2020; Saunders, 2014; 
Taft & Keefer, 2016). Evidence from a general population survey suggests people attribute more 
stigma to individuals with IBD than those with diabetes or HIV/AIDS (Groshek et al., 2017). 
Such stigma can have detrimental effects on IBD health and well-being and may cause some 
people with IBD to avoid going out in public and socializing with others (Casati et al., 2000; 
Daniel, 2002; Taft & Keefer, 2016).  
As a result of such stigma, many people with IBD use online social media platforms to 
cope with the various aspects of their disease (Frohlich, 2016). As highlighted in Chapter 2, IBD 
is widely discussed on social media (Chiang et al., 2016; A. Khan et al., 2018). Evidence shows 
that many individuals with IBD use social media platforms to seek informational support from 
others about how to self-manage their disease (Britt, 2017; Coulson, 2015; Frohlich & 
Zmyslinski-Seelig, 2016; Martinez et al., 2017). Examples of such support include learning 
about the efficacy of IBD treatments, best practices for maintaining a nutritional diet, and 
information about the many different gastrointestinal-related surgeries and procedures that some 
people with IBD undergo (e.g., colonoscopies).  
People with IBD also tend to use social media for emotional support purposes, such as 
uplifting others with IBD who feel down or validating one another’s disease-related struggles 
(Britt, 2017; Coulson, 2015; Frohlich, 2016; Frohlich & Zmyslinski-Seelig, 2016; Rademacher, 
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2018). Importantly, online emotional support can provide people with IBD—particularly those 
experiencing disease-related distress—with critical education and emotional guidance about how 
to cope with and self-manage some of the psychological comorbidities of IBD.  
Finally, some research suggests people with IBD use social media platforms for their 
various technological affordances (O'Leary et al., 2020). A recent qualitative study concluded 
that social media offer people with IBD different therapeutic features such as the means to 
connect with others with IBD, or the ability to share disease-related stories and narratives 
(O'Leary et al., 2020). These findings are corroborated by results from other studies indicating 
that people with IBD often use social media to network with likeminded individuals (Coulson, 
2013), or to reconstruct or develop new social identities as a means of self-expression (Frohlich, 
2016).  
Although a great deal of literature has examined social media as a tool for seeking IBD-
related support, the behavioral and psychological effects of this type of purposive social media 
use is a relatively new research area. One recent study by Zhao et al. (2021) found that not only 
did health information about IBD on social media improve Crohn’s disease patients’ perceived 
levels of social and peer support, but that such support had a further mediating impact on a 
number of important disease outcomes, such as symptom management and treatment 
understanding. In other words, the support afforded by social media could serve to improve 
disease self-management outcomes for people with IBD, which has been suggested in literature 
examining social media use and self-management behaviors among other chronic disease 
populations (Merolli et al., 2013).   
While the literature shows that individuals with IBD use social media for a variety of 
supportive purposes, and that such support can facilitate disease self-management and improve 
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some health outcomes, no systematic work that I am aware of has sought to leverage existing 
IBD-related social media discussions to identify specific areas in which those who are struggling 
with IBD may need support. In other words, are some aspects of living with IBD more stressful 
than others, such as treatment adherence or symptom management? It is important to identify 
these potential areas in order to better understand this population’s priority concerns. Moreover, 
this information would be useful for future health intervention efforts and research initiatives 
aimed at providing IBD self-management support. 
For the first empirical study of this dissertation, I aimed to build on some of my previous 
work (Rohde, 2018; Rohde & Barker, 2020) by identifying key topics associated with IBD 
through analysis of public discourse on social media. More specifically, I sought to examine the 
prevalence of different IBD topics among posts discussing IBD and distress (e.g., depression, 
anxiety, symptom struggles) in order to better understand what factors may be associated with or 
contribute to experiences of distress in this population.  
Method 
Data collection 
I collected data from the social media platforms Reddit and Twitter. Reddit is a forum-
based, pseudo-anonymous social media platform founded in 2005 (Anderson, 2015). Individuals 
on Reddit interact with one another via user-created, topic-based communities called 
“subreddits.” Subreddits are often monitored by one or more moderators to ensure that users 
posting in the subreddit are discussing community-relevant content. Reddit allows users to post 
long-form submissions of up to 40,000 characters.  
Twitter, on the other hand, is a microblogging social media platform founded in 2006 
(Kwak, Lee, Park, & Moon, 2010). User submissions to Twitter are referred to as “tweets.” One 
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important feature of Twitter is the hashtag, which is a convention used to categorize and track 
trending topics across the platform. Hashtags are denoted by the “#” symbol before a word or 
phrase in a tweet. For example, “#crohns” represents the indexing of a conversation on the topic 
of Crohn’s disease. In contrast with Reddit, Twitter only allows users to post content up to 280 
characters long; though, users can link multiple tweets and responses together in a single thread. 
I chose these two platforms because evidence shows people with chronic disease—
including those with IBD—use them for discussing health-related topics (De Choudhury & De, 
2014; De la Torre-Díez, Díaz-Pernas, & Antón-Rodríguez, 2012; A. Khan et al., 2018; Rohde, 
2018; Rohde & Barker, 2020). As of 2019, approximately 22% and 11% of American adults 
have ever used Twitter and Reddit, respectively, indicating they are modestly popular online 
platforms (Perrin & Anderson, 2019).  
For the Reddit data, I downloaded all available Reddit submissions and comments about 
IBD from PushShift—a publicly available archive of Reddit posts dating back to December 2005 
(Baumgartner, Zannettou, Keegan, Squire, & Blackburn, 2020). Reddit submissions constitute 
original posts published on a subreddit whereas Reddit comments constitute responses to 
published submissions. The data downloaded from PushShift also included several meta-data 
variables, such as publication timestamps (i.e., the date and time that a social media post was 
published) and what subreddit each post was published in. For the Twitter data collection, I used 
the Twitter Intelligence Tool (TWINT) to download publicly available tweets about IBD (Poldi, 
2020). Similar to the Reddit data, I also collected relevant tweet meta-data, including usernames 
and timestamps, for descriptive purposes. 
For both platforms, I extracted study-relevant social media posts based on whether they 
contained at least one of the following IBD keywords: “crohn,” “ibd,” “colitis,” “inflammatory 
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bowel disease,” “ileitis,” and “ileoceceal.” These keywords represent individual categories or 
umbrella terminology associated with IBD. It should also be noted that collection criteria were 
case insensitive. That is, “ibd” and “IBD” equally met eligibility. In all, the collection period of 
both Reddit and Twitter data sets spanned from September 2017 to August 2019. This collection 
provided a robust indication of how IBD was discussed on these two platforms over a long 
period of time, thus reducing potential cross-sectional analytic biases, such as large spikes of 
discussions about IBD in a short span, which can occur during coordinated IBD awareness 
events (e.g., World IBD Day).  
I applied several data cleaning procedures to both the Reddit and Twitter data sets. For 
example, I removed “retweets,” which are a feature on Twitter that allows users to repost tweets 
published by other users on their own profile, to ensure I only analyzed original content. I also 
removed duplicate posts that were published by the same user. Finally, I removed posts that were 
irrelevant to IBD or to the purposes of the current study. For example, I eliminated several posts 
discussing Investor’s Business Daily (which is often shortened to “IBD”), as well as posts 
discussing IBD in the context of animal diagnoses (e.g., “I just learned my dog has IBD”). After 
applying all data cleaning procedures, the sizes of the Reddit and Twitter data sets were N = 
100,417 and N = 260,110, respectively. 
Extracting distress-related social media posts 
I extracted only the Reddit and Twitter posts containing distress-related content to 
include in the analyses for the current study. For this process, I developed a list of approximately 
300 keywords associated with distress, such as “afraid” and “scared,” and then filtered for posts 
containing at least one of those words. Relevant phrases or word co-occurrences (i.e., bigrams) 
were also considered in the filtering process. Example word co-occurrences were “feel alone” 
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and “hard to manage.” Throughout this process, I tested the relevancy of the results of the 
distress filter by iteratively extracting and reviewing samples of posts that were identified by the 
computer. This step was important as it revealed additional keywords that needed to be added to 
the distress filter, as well as keywords that needed to be modified or removed altogether.  
Next, I extracted a random sample of 200 social media posts (representing both data sets) 
and two human coders (including myself) independently characterized posts as pertaining to 
distress or not. The purpose of this step was to ensure that the posts being identified by the 
computer were actually relevant to IBD and distress. Intercoder reliability (assessed using the 
Krippendorff’s alpha statistic via the ReCal2 software) of the categorical results between the two 
human coders was acceptable (α = .90; 95% agreement; Table 1) (Freelon, 2010). We also 
compared the human coding results (after normalizing discrepancies between the two 
independent coders) against the results of the computer classification. Results from this 
reliability analysis (i.e., human vs computer) were also acceptable (α = .90; 95% agreement). No 
additional changes were made to the distress filter after achieving acceptable reliability.  
The final iteration of the filter extracted N = 40,625 Reddit posts (including both 
submissions and comments) and N = 40,306 tweets, which represent 40% and 15% of the 
original Reddit and Twitter data sets, respectively. These two data sets were used in all 
subsequent analyses in the current study.   
Identifying dictionary topics 
I created a term-based computational dictionary using Python (version 3.8.1) (Python 
Software Foundation, 2020) to categorize the Reddit and Twitter posts based on the following 
eight IBD topics: 1) symptoms, 2) medication, 3) nutrition, 4) IBD procedures, 5) marijuana, 6) 
stigma, 7) ostomy, and 8) intimacy. I chose these topics because literature suggests they are 
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important concerns for people with IBD (Drossman et al., 1991; Jelsness-Jorgensen, Moum, & 
Bernklev, 2011; Moser et al., 1995; Stjernman, Tysk, Almer, Ström, & Hjortswang, 2010). In 
addition, some of the IBD topics were chosen based on preliminary descriptive, inferential 
analyses (e.g., word frequencies) of the data. For example, “FODMAP” and “weed” were 
common words in both data sets, thus suggesting that “nutrition” and “marijuana” were likely 
both important topics related to IBD and distress discourse on Reddit and Twitter. For the rest of 
this chapter, I will italicize all in-text mentions of the IBD topics for clarity.  
I chose to use a term-based dictionary method for classifying the social media data 
because it gave me control over the specific words representing each of the IBD topics. For 
example, this approach allowed me to preliminarily test and expand dictionary topic keywords 
on an as-needed basis, which is in contrast to other computational topic identification methods 
such as unsupervised topic modeling (e.g., latent Dirichlet allocation, k-means clustering) that 
algorithmically choose topics based on latent patterns among the text data. Although 
unsupervised topic modeling can be useful for some text analysis applications (particularly 
inductive analysis), using this method would not give me the ability to purposefully test for the 
presence of IBD topics important to people with IBD as evidenced from the literature. This 
limitation is especially apparent when investigating nuanced topics such as stigma and intimacy 
as some of the keywords and phrases associated with these topics are disparate from one another 
and would be difficult for a computer to identify and link latent text patterns of these topics 
together. 
Notably, the eight IBD topics are not mutually exclusive. That is, a single social media 
post from either Reddit or Twitter could have been categorized as discussing multiple IBD 
topics, such as medication, symptoms, and nutrition (e.g., “My medication is not helping my 
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Crohn’s disease symptoms so I may need to start cutting back on fiber in my diet”). This 
categorization approach gave me the ability to examine whether the IBD topics co-occurred with 
one another in social media posts and, if so, to what extent.  
Validating dictionary topics 
Similar to the method used for assessing the relevancy of distress-related posts, I 
iteratively tested the IBD topics dictionary on the Reddit and Twitter data sets and reviewed 
samples of the results—modifying, adding, and removing dictionary keywords as needed for 
each of the eight IBD topics. This process revealed some posts that were inaccurately labeled by 
the dictionary. For example, posts about how people were tired of explaining their disease to 
others were classified under the topic symptoms because of the word “tired.” To control for 
inaccurate classifications, I created a second term-based dictionary that categorized posts 
containing false positive keywords. I then eliminated the results from the false positives 
dictionary classification from the results of the main dictionary analysis. See Appendix A for the 
full list of keywords of each of the IBD dictionary topics, as well as corresponding false positive 
terms. 
Once the keywords in both the main IBD topics and false positive dictionaries were 
finalized, I extracted a purposive sample of 960 social media posts (a mix of both Reddit and 
Twitter data) to compute intercoder reliability and to evaluate the results of the computer 
classification. I chose this number of posts to ensure there was appropriate representation among 
each of the eight IBD topics in the sample. More specifically, I ran the dictionary analysis for 
both the Reddit and Twitter data sets. Using the computer classification results, I extracted 120 
random posts for each IBD topic—60 of which were classified by the computer as containing a 
respective topic and 60 that were classified as not containing the topic. It is important to note that 
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while the minimum number of posts classified as one of the topics in the reliability analysis data 
set would be 60, that does not mean this is the maximum number of posts (due to topic co-
occurrences). For example, extracting posts that were not classified as containing discussions 
about IBD and intimacy still could have contained mentions of other topics, such as symptoms or 
medication.  
These 960 posts were aggregated together and then assessed independently by two human 
coders (including myself), with each coder classifying the individual posts based on the eight 
IBD topics. The final dictionary exhibited acceptable reliability across all eight IBD topics 
between the two human coders (mean topic reliability: α = .92; range: α = .85–.96; Table 1), as 
well as between the human coders (after normalizing coder discrepancies) and the computer 
dictionary classification results (mean topic reliability: α = .85; range: α = .77–.95).  
 
Table 1. Intercoder reliability results of the social media data classification. 













Distress keywords 200 95% .900  200 95% .900 
Dictionary topics          
Symptoms 960 93% .849  960 89% .767 
Medication 960 98% .934  960 94% .772 
Nutrition 960 97% .896  960 95% .810 
IBD procedures 960 99% .951  960 98% .912 
Marijuana 960 99% .960  960 98% .872 
Stigma 960 98% .906  960 98% .886 
Ostomy 960 99% .930  960 99% .948 
Intimacy 960 99% .958  960 98% .810 




I used descriptive statistics to characterize the social media data and to order popular 
subreddits (Reddit data set only) and hashtags (Twitter data set only). To contextualize the IBD 
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topics, I extracted example Reddit and Twitter posts categorized under each topic and 
paraphrased the content of the posts. I chose not to publish verbatim posts to protect the privacy 
and confidentiality of the users (Ayers, Caputi, Nebeker, & Dredze, 2018). All descriptive 
analyses were computed using Python (version 3.8.1) (Python Software Foundation, 2020). 
I applied network statistics to assess IBD topic co-occurrences (e.g., two or more IBD 
topics present in a single social media post) and topic degree centrality for the Reddit and Twitter 
data sets. I created network sociograms to visualize the extent of topic co-occurrences using the 
igraph package in R (Csardi & Nepusz, 2006; R Core Team, 2019). The nodes in the sociograms 
represent each of the eight IBD topics. The sizes of the nodes are weighted based on their degree 
centrality score across the full topic co-occurrences network, with larger nodes indicating a 
higher degree centrality score. Degree centrality refers to the number of ties directed toward a 
node in a network from all other nodes (Wasserman & Faust, 1994). Similarly, the connections 
(i.e., edges) between nodes in the sociograms are weighted based on the frequency of co-
occurrences between topics, with thicker lines indicating more co-occurrences. All methods and 
procedures used in this study were approved by the University of North Carolina at Chapel Hill 
Institutional Review Board.  
Results 
Characteristics of the social media data 
 General characteristics of the Reddit and Twitter data are in Table 2. There were 18,893 
and 20,665 unique users who posted content in the Reddit and Twitter data sets, respectively, 
with users across both platforms posting an average of 2 times. Roughly 4% of Reddit posts and 
25% of tweets contained at least one hyperlink (i.e., web URL).  
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For Reddit, 95% of posts were comments and 5% were original submissions. These posts 
were published in 2,534 different subreddits (Table 2). The most popular subreddits based on 
frequency were r/CrohnsDisease (26%; Table 3), r/AskReddit (13%) and r/UlcerativeColitis 
(3%). For Twitter, there were 9,120 unique hashtags in the data set and 31% of tweets contained 
at least one hashtag (Table 3). Overall, the most used hashtags were #crohns (11%), #ibd (8%), 
and #colitis (3%); though, popular non-IBD hashtags included #anxiety and #pain (both 1%).  
 
Table 2. Characteristics of the Reddit and Twitter data sets. 
 Reddit; N = 40,625  Twitter; N = 40,306 
 n (%) or M ± SD  n (%) or M ± SD 
Users    
Unique users1 18,891  20,665 
Average posts per user 2.12 ± 5.03  1.95 ± 4.71 
Hyperlinks    
Posts containing hyperlinks 1,793 (4%)  10,177 (25%) 
Total number of hyperlinks 3,698  14,325 
Type of Reddit post    
Comment 38,633 (95%)  – 
Submission 1,992 (5%)  – 
Subreddits (Reddit)    
Unique subreddits 2,534  – 
Posts in IBD subreddits 13,303 (33%)  – 
Posts in non-IBD subreddits 27,322 (67%)  – 
Hashtags (Twitter)    
Total number of hashtags   51,065 
Unique hashtags  –  9,043 
Tweets with one or more hashtag –  12,363 (31%) 
Average hashtags per post –  1.27 ± 3.03 
Note. N = total sample; n = sample size; M = mean; SD = standard deviation; 1only includes users 
who posted at least once in the data sets, not those who were mentioned by others in posts; 
average length of Reddit comments in words: M = 143.64, SD = 150.84; average length of 
Reddit submissions in words: M = 208.33, SD = 210.30; average length of tweets in words: M = 





Table 3. Top 10 subreddits and hashtags in the Reddit and Twitter data sets. 
 n (%) 
Subreddit (Reddit)  
CrohnsDisease 10,529 (26%) 
AskReddit 5,098 (13%) 
UlcerativeColitis 1,172 (3%) 
IBD 1,030 (3%) 
ibs 751 (2%) 
AskDocs 532 (1%) 
Trees 399 (1%) 
AmItheAsshole 296 (1%) 
relationships 287 (1%) 
ostomy 282 (1%) 
Hashtag (Twitter)  
#crohns 5,490 (11%) 
#ibd 4,085 (8%) 
#colitis 1,766 (3%) 
#crohnsdisease 1,546 (2%) 
#ulcerativecolitis 1,184 (2%) 
#chronicillness 1,009 (1%) 
#anxiety 591 (1%) 
#pain 526 (1%) 
#spoonie 497 (1%) 
#depression 497 (1%) 
Note. n = sample size; hashtag text was normalized (e.g., lowercasing text, removing special 
characters) prior to analysis.   
 
 
Prevalence of IBD topics 
Paraphrased social media posts contextualizing each of the eight IBD topics are in 
Appendix B. The frequencies and proportions of the IBD topics are in Table 4. Most Reddit 
(79%) and Twitter (56%) posts contained at least one IBD topic. The order of topic occurrence 
was the same for the two platforms. That is, symptoms was the most prevalent topic (Reddit: 
57%, Twitter: 36%), followed by medication (Reddit: 30%, Twitter: 11%), nutrition (Reddit: 
27%, Twitter: 9%), and IBD procedures (Reddit: 17%, Twitter: 6%). All other IBD topics were 




Table 4. Proportion of IBD topics in the Reddit and Twitter data sets. 
 Reddit; N = 40,625  Twitter; N = 40,306 
 n (%)  n (%) 
Full data set    
At least one topic present 32,189 (79%)  22,398 (56%) 
No topic present1 8,436 (21%)  17,908 (44%) 
Individual IBD topic2    
Symptoms 23,295 (57%)  14,488 (36%) 
Medication 12,217 (30%)  4,515 (11%) 
Nutrition 11,040 (27%)  3,675 (9%) 
IBD procedures 6,798 (17%)  2,220 (6%) 
Marijuana 3,353 (8%)  1,912 (5%) 
Stigma 1,481 (4%)  1,250 (3%) 
Ostomy 1,346 (3%)  1,179 (3%) 
Intimacy 930 (2%)  141 (<1%) 
Single and multi-topic posts    
1 topic 13,705 (43%)  16,258 (73%) 
2 topics 11,134 (35%)  5,360 (24%) 
3+ topics 7,350 (22%)  780 (3%) 
Note. N = total sample; n = sample size; 1this variable represents the frequency of social media 
posts about IBD and distress that did not contain keywords matching any one of the eight IBD 
topics in the dictionary analysis; 2individual topics are not mutually exclusive so total category 
percent can be greater or less than 100%. 
 
 
IBD topic co-occurrences 
IBD topic co-occurrences varied by social media platform. Most Reddit posts (57%; 
Table 4) contained two or more topics. By contrast, only 27% of tweets contained multiple IBD 
topics. Among multi-topic social media posts, results showed that symptoms was the most 
integrated topic (based on degree centrality) for both Reddit and Twitter data sets. For Reddit, 
symptoms co-occurred with medication most frequently, followed by nutrition. For Twitter, 
symptoms co-occurred with medication and nutrition similarly. The least integrated IBD topic 
among multi-topic posts for both social media data sets was intimacy. Sociograms representing 
the distribution of IBD topic co-occurrences are shown in Figure 2. Matrices containing the 
frequencies and proportions of topic co-occurrences, as well as degree centrality network 



















































This study sought to identify key topics present among discussions of IBD and distress on 
social media. Drawing from over 80,000 posts with results spanning two years, this work shows 
that symptoms, medication, and nutrition were the most prominent topics among distress-related 
posts about IBD on both Reddit and Twitter. In addition, this work found that the symptoms topic 
acted as a central hub among multi-topic posts, highlighting its fundamental importance among 
IBD and distress-related social media discourse. Broadly, findings from this study add to a 
growing body of research investigating how IBD is discussed on social media (Britt, 2017; 
Frohlich & Zmyslinski-Seelig, 2012; A. Khan et al., 2018; Mukewar et al., 2013; Rademacher, 
2018). Moreover, this work expands upon the literature by empirically examining Reddit and 
Twitter IBD discourse in a distress-related context, thus positioning this study to be among the 
first to identify key areas potentially associated with IBD and distress. 
One of the major findings from this work was the varying degree to which discussions of 
IBD and distress on Reddit and Twitter mentioned different IBD topics. For example, this study 
showed that the IBD topics symptoms, nutrition, and medication are proximal to distress in 
online IBD discourse. In fact, 73% of Reddit posts and 48% of tweets mentioned at least one of 
those three topics. These findings may be explained due to the fact that disease activity tends to 
be associated with poorer distress and quality of life outcomes among people with IBD (Duffy et 
al., 1991; Knowles et al., 2018; Levenstein et al., 1994; Sarid et al., 2018; Sexton et al., 2017). 
Thus, it is highly possible that users vocalizing their distress online are doing so as a result of 
symptom activity and associated irritation. IBD symptoms are also affected by disease self-
management behaviors, such as adherence to medication and a symptom mitigating diet. This 
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may explain why both medication and nutrition were also prominent topics in the Reddit and 
Twitter data sets, as well as why these two topics frequently co-occurred with symptoms.  
The social media findings also showed a moderately-sized discourse concerning IBD, 
distress, and the topic marijuana. Approximately 8% and 5% of posts on Reddit and Twitter 
mentioned at least one keyword from the marijuana dictionary. While analyzing the underlying 
themes of this discourse was outside the scope of the current study, it is possible that the purpose 
of some of these posts was to seek advice about the medicinal properties associated with 
marijuana (see Appendix B for example social media posts categorized under the marijuana 
topic). The therapeutic use of cannabis (i.e., marijuana) to treat IBD has been discussed in the 
literature (Ahmed & Katz, 2016), and self-reported evidence from studies suggests people with 
IBD experience beneficial outcomes from using marijuana for symptom relief (Kerlin, Long, 
Kappelman, Martin, & Sandler, 2018; Ravikoff Allegretti, Courtwright, Lucci, Korzenik, & 
Levine, 2013); though, evidence is still developing in this area. Given that findings from this 
study indicate marijuana and IBD are being discussed on social media, future work should aim to 
investigate the specific nature of this discourse, such as by examining audience reception and 
attitudes toward cannabis as a potential disease self-management therapeutic.  
Notably, results from this work hint at potential platform effects among online IBD 
discourse. For instance, the topics IBD procedures, ostomy, or intimacy were collectively present 
in only 8% of tweets, whereas the same topics appeared in nearly one-fifth (19%) of Reddit 
posts. This discrepancy may be due to the varying technological affordances that these two 
platforms offer their users. Twitter, for example, is a relatively public facing online platform. 
Because of this, people with IBD may be less likely to publicly disclose or discuss distress 
concerning taboo topics, such as ostomy bags or their personal relationships on Twitter. Reddit, 
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on the other hand, is structured around the use of topic-based communities (i.e., subreddits) 
meaning that audience members in these communities likely have shared interest or connection 
with one-another. As such, discussing topics such as colonoscopy prep or ostomy maintenance 
may be commonplace and accepted unreservedly among subreddits such as r/UlcerativeColitis or 
r/ostomy. This notion is paritally supported by research from other IBD and social media 
investigations (Britt, 2017; Frohlich, 2016; O'Leary et al., 2020). 
It should also be stated that posts on Twitter are limited by a 280-character count and it is 
possible that this restriction influenced the proportion of IBD topics identified by the dictionary 
analysis in the Twitter data set. Reddit is far less restrictive in submission and comment length, 
which likely explains why 57% of Reddit posts discussed multiple IBD topics compared to only 
27% of tweets meeting the same criterion. This discrepancy brings to light a number of important 
research questions. For example, how do different platform features, such as anonymity and 
publishing medium (e.g., text vs image vs video), affect IBD discourse on social media? More 
research examining the effects of affordances on this type of discourse in a multi-platform 
comparison is warranted and would add further insight into the purposive roles that different 
social media sites may (and likely do) play in IBD self-management.  
A surprising finding from this research was how infrequent discussions of stigma were 
among social media posts about IBD and distress. While evidence suggests people with IBD 
often report experiencing disease-related stigma (Taft & Keefer, 2016), only 4% of Reddit posts 
and 3% of tweets discussed this topic. One explanation for this finding could be that people with 
IBD functionally use social media as a means to escape the experiences of offline stigma, and to 
instead seek/offer support and to share personal experiences among a network of other 
likeminded users (i.e., people with IBD), as evidenced by previous work (Frohlich, 2014; 
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O'Leary et al., 2020). Thus, it is possible that discussing stigmatizing aspects of life with IBD on 
social media platforms would trigger unwanted distress or defeat the purpose of using the 
affordances of online communities to establish IBD safe spaces.  
One last contribution that this study makes is that the data under investigation were from 
Reddit and Twitter, which are both under-researched social media platforms in the IBD 
literature. To date, most published IBD social media content analysis work has examined 
discourse on platforms such as YouTube (Frohlich & Zmyslinski-Seelig, 2012; Mukewar et al., 
2013) and Facebook (Frohlich & Zmyslinski-Seelig, 2016; Rademacher, 2018), and largely in 
the context of what type of support (i.e., informational, emotional) these platforms facilitate. No 
studies that I am aware of have examined IBD on Reddit, positioning this research to be the first 
to shed light on how this particular disease is discussed on a modestly popular, community-based 
social media platform. And while some work has examined the presence of general IBD content 
on Twitter, such as hashtag analysis (Chiang et al., 2016; Guo et al., 2016; A. Khan et al., 2018), 
this research substantively expands on that work by systematically exploring the presence of and 
relationships among IBD topics in Twitter discourse.  
In conclusion, social media platforms remain important tools for people with IBD to 
express themselves, seek informational and emotional support about disease self-management, 
and to network with others about their illness. This is particularly true for those with IBD who 
may feel isolated or who struggle coping with their illness. Findings from this study suggest that 
both Reddit and Twitter can serve as an outlet for people with IBD to express their disease-








There is a high rate of distress among people with IBD (Byrne et al., 2017; Neuendorf et 
al., 2016). This is a major problem as evidence shows that distress is associated with a number of 
harmful outcomes for people of this population, including a worse disease course and increased 
disease activity (Edman et al., 2017; Graff, Walker, & Bernstein, 2009; Kochar et al., 2018; 
Nahon et al., 2012; Porcelli et al., 1994; Reigada et al., 2015), as well as a poorer quality of life 
(Edman et al., 2017; Tabibian et al., 2015). Given that IBD is a lifelong, chronic illness that has 
no cure, identifying effective methods for reducing distress among this population should be of 
priority concern.  
One way to target distress could be through increasing personal involvement in the IBD 
management process. Most researchers define this involvement as “disease self-management.” 
As previously stated in Chapter 2, disease self-management refers to the degree by which people 
with chronic diseases can 1) medically manage their disease (e.g., treatment adherence), 2) 
maintain or create new behaviors that aid in the management of their disease, and 3) 
acknowledge and manage the psychosocial aspects of living with their disease (Lorig & Holman, 
2003). In the context of IBD, example disease self-management behaviors include adhering to 
IBD medication, active symptom tracking, and symptom mitigating diet and nutrition upkeep, 
among others (Keefer & Kane, 2016). A similar term to disease self-management is patient 
“activation,” which refers to patients’ ability to demonstrate the skills and knowledge needed to 
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manage aspects of their chronic diseases (Hibbard, Stockard, Mahoney, & Tusler, 2004). For 
clarity, however, I will refer to any process of personal involvement in the IBD management 
process (including patient activation) as “self-management.”  
The benefits of IBD self-management on health outcomes are vast. For example, a cross-
sectional study found that IBD self-management increased one’s odds of being in clinical 
remission and was negatively associated with self-reported anxiety (Barnes, Long, et al., 2019). 
Evidence from other self-management interventions also show positive impacts on IBD health, 
such as lowered distress and increased disease-related knowledge, treatment adherence, and 
social participation (Barlow, Cooke, Mulligan, Beck, & Newman, 2010; Conley & Redeker, 
2016). For example, one randomized controlled trial administered self-management training to 
people with IBD (the goal of which was to teach people with IBD how to recognize markers of 
symptom relapse) and found that, compared to standard care, those in the intervention group 
made fewer visits to the hospital (Robinson et al., 2001). Another randomized controlled trial 
found that people with IBD exposed to a self-management directed hypnotherapy intervention 
improved their confidence in their disease management ability (i.e., self-efficacy) compared to 
those in a control condition (Keefer et al., 2012). These findings suggest that efforts toward 
educating people with IBD about useful practices and adjustments to self-managing their disease 
could lead to improved health outcomes among this population, particularly those who may 
struggle with distress. 
Past IBD self-management investigations have utilized several different intervention 
delivery methods, such as online patient portals and cognitive behavioral therapy. To date, 
however, few studies have sought to test the efficacy of support-based messages as a means to 
provide self-management education and advice to people with IBD. This is surprising given that 
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evidence from recent studies indicates that supportive IBD interventions can improve disease 
self-management behaviors (e.g., increase treatment adherence) and reduce perceptions of 
psychological distress (Kamp, Luo, et al., 2019; Kamp, West, et al., 2019). Given the dearth of 
research in this area, more work is needed to understand how people with IBD might respond to 
support-based messaging interventions about disease self-management. Before such methods are 
developed, however, message topics need to be selected, and theoretically informed support 
messages need to be designed and evaluated among those with IBD. 
The current study aimed to fill the gap in this literature by constructing a series of support 
messages about IBD self-management. This study also sought to preliminarily test the perceived 
effectiveness and receptivity of the support messages in a pilot study among people with IBD. 
The goal of this work was to test and refine these messages in order to integrate them in a 
subsequent IBD eHealth text messaging intervention (see Chapter 5). 
Method 
Selecting support message domains and topics 
The purpose of creating messages in the current study was to reduce disease-related 
distress among people with IBD by providing educational information and support about disease 
self-management. To inform the construction of these messages, I first turned to the empirical 
findings from the social media analysis in Chapter 3. Briefly, the findings from this chapter 
showed that IBD and distress-related discourse on both Reddit and Twitter often discussed topics 
such as IBD symptoms, nutrition, and medication. By contrast, topics such as ostomies and 
intimacy were discussed less frequently. These findings suggest that messages containing 
supportive text about the best practices of IBD symptom management, as well as content about 
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adhering to a nutritious, symptom mitigating IBD diet and treatment regimen, would likely be 
well-received and have meaningful impact on people with IBD.  
I also turned to the literature to identify other areas of IBD self-management that might 
be important in constructing the messages. Results from this review showed that many people 
with IBD worry about the impact the disease will have on their social life, with concerns 
including fear of being alone or that they will be viewed as a burden to others (Casati et al., 
2000; Daniel, 2002; Drossman et al., 1991; Drossman et al., 1989; Pittet et al., 2017). Moreover, 
evidence shows that some people with IBD worry about not having a reliable support system of 
people to help manage some of the psychosocial aspects of IBD, such as emotional duress 
(Casati et al., 2000). These findings suggest that messages surrounding the social aspects of IBD 
self-management, such as content about building social networks, peer support, and advice 
seeking would likely resonate among people with IBD, most notably those who experience 
distress.  
Drawing from the results of both the social media data analysis and cursory literature 
review above, I opted to construct support messages centered around the following four IBD 
self-management domains: 1) general IBD symptoms, 2) social aspects of IBD, 3) IBD and 
nutrition, and 4) other aspects of IBD self-management (e.g., coping during COVID-19). Going 
forward, I will italicize in-text mentions of these domains in this chapter for clarity.  
Using the four self-management domains as a framework, I drafted an initial pool of five 
support messages per domain (i.e., 20 messages total). Each of the support messages was about a 
different topic related to the domain that they were constructed under. For example, messages in 
the General IBD symptoms domain covered topics related to managing psychological distress, 
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symptom discomfort, flare tracking, fatigue, and exercise. The full list of support message topics 
across the four self-management domains are in Table 5. 
Notably, I included an “other” domain (i.e., domain four) to capture additional support 
message topics that did not necessarily fall under the categories from the other three self-
management domains but were still considered important to evaluate. An example message in 
this domain included information about how to cope with IBD during COVID-19, which I 
viewed as a critical and timely topic given the ongoing pandemic in the US. Other example 
topics in this domain were messages discussing the importance of adhering to IBD medication or 
messages about setting daily medication reminders. I chose to categorize message topics related 
to medication under the other aspects of IBD self-management domain—as opposed to creating 
its own domain—because not everyone with IBD takes medication and, of those who do, there 
are a number of different types of medications that have different dosage frequencies and 
requirements.  
 
Table 5. IBD self-management topics of the support messages. 
General IBD  
symptoms 
Social aspects of 
IBD 
IBD and  
nutrition  








Importance of IBD 
medication 
Symptom discomfort Networking IBD diets Medication reminders 
Flare tracking Support systems Trigger foods Open communication 
Fatigue Advice seeking Helpful foods COVID-19 and IBD 




Constructing the support messages 
Each support message was constructed in two parts (i.e., a message pair). The purpose of 
the first part was to acknowledge and validate an aspect of disease self-management that some 
people with IBD may struggle with. I refer to this as the “validating message.” The purpose of 
the second message was to offer educational information, advice, and support directly addressing 
the struggle noted in the first message. I refer to this as the “advising message.” While previous 
IBD messaging studies have used a general educational format to construct messages about 
managing IBD (e.g., “Did you know…”) (Cross et al., 2015; Reich, Canakis, et al., 2019), this 
two-part approach sought to maximize perceptions of support by first validating what someone 
with IBD may be going through, and then advising them on what they could do about it. Below 
is an example of a draft validating/advising support message pair (the topic being “symptom 
discomfort”) categorized under the general IBD symptoms self-management domain:  
Message 1 (validating): It can be difficult managing irritating or uncomfortable IBD 
symptoms. 
Message 2 (advising): Small changes, such as using moist wipes instead of traditional 
toilet paper, can help reduce discomfort associated with frequent bowel movements and 
other related symptoms. 
 
In addition, the specific text of the support messages—particularly the advising message 
in each pair—was constructed to target different perspectives derived from health behavior 
theory and disease self-management literature. Constructs and behaviors targeted by the 
messages included IBD self-efficacy, outcome expectations, perceived support, and the use of 
coping strategies. As discussed in the literature review in Chapter 2, I structured message content 
to target these areas because evidence suggests they are fundamental to the disease self-
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management process and are likely to have an impact on distress among people with IBD 
(Boamah et al., 2010; Horne et al., 2009; Moradkhani, Kerwin, Dudley-Brown, & Tabibian, 
2011; Moshkovska et al., 2009; Wardle & Mayberry, 2014). For example, the text from the 
second message in the above example aims to improve on IBD outcome expectations by 
suggesting that engaging in certain disease self-management behaviors (i.e., using moist wipes) 
can improve health outcomes for people with IBD (i.e., reduce symptom discomfort). For clarity, 
I refer to a single message pair as a “support message” for the remainder of this chapter.  
The support messages were constructed to be short (~40-50 words) so that they could 
eventually be delivered and evaluated in an eHealth intervention using text messaging. I chose 
this format because studies show that text messaging can be a useful medium for effecting health 
behavior change, particularly among people with chronic disease (Fjeldsoe et al., 2012; Head et 
al., 2013; Riaz & Nielsen, 2019; Thakkar et al., 2016). Among an IBD population specifically, 
evidence from studies indicates that text messaging can improve adherence to medication and 
reduce perceived concerns about IBD treatment (Miloh et al., 2017; Riaz & Nielsen, 2019). 
These studies, however, did not investigate message effects on perceptions of disease-related 
distress and were conducted with small sample sizes. Moreover, text messaging remains an 
under-studied intervention medium in the IBD research field overall, thus warranting additional 
investigation.  
Support message resources 
The educational information included in the support messages was informed by publicly 
available content from prominent IBD research organizations, such as the Crohn’s & Colitis 
Foundation (n.d.) in the US and Crohn’s and Colitis Canada (n.d.). This ensured that the advice 
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being offered by the support messages was based on scientific and expert opinion by experienced 
IBD researchers.  
In addition, several of the support messages contained web links to external online 
resources from the same foundations. Example resources included tips about certain foods to eat 
when experiencing IBD symptoms, information about joining an online IBD community, and a 
video discussing IBD and malnutrition. The purpose of these external resources was to provide 
additional information about a given self-management topic beyond what was included in the 
text of the support messages themselves. Links to these external resources were in the form of a 
web URL attached at the end of the advising message (e.g., “For more information about this 
topic, check out this link: [resource URL here]”). To keep message length short, I modified the 
resource URLs using a third-party application called bit.ly. This application takes an original 
URL and creates a short-form version of the same link. Below is an example the bit.ly process 
used to shorten the online resources.    
Original URL: https://www.crohnscolitisfoundation.org/diet-and-nutrition/what-should-
i-eat (character count: 76) 
Modified bit.ly URL: https://bit.ly/3iZjBNB (character count: 22) 
 
Refining the support messages 
The initial pool of 20 support messages were reviewed and refined by several experts, 
including researchers who specialize in health communication message design and social support 
interventions, a gastroenterologist who treats people with IBD, and finally a person who has 
IBD. This refinement process not only increased the content validity of the support messages 
(DeVellis, 2016), but also ensured that they were appropriate for people with IBD to view 
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without triggering unwanted distress. After this expert review, I made all necessary changes and 
improvements to the initial draft of support messages, which included modifying language, 
reducing text length, and including additional supportive information about IBD self-
management. The refined support messages were ultimately approved by the experts and were 
carried forward to be evaluated by people with IBD in a pilot study. These 20 support messages 
(including the links to the external resources) are in Appendix D.  
Participant recruitment and inclusion criteria 
I used social media to recruit people with IBD to evaluate the support messages in a pilot 
study. I disseminated study information on several different IBD support groups on Reddit and 
Facebook, as well as on my professional Twitter account. The content of the recruitment posts 
contained general background information about the purpose of the study (e.g., that participants 
were expected to evaluate support messages about IBD) and included a web link for those who 
were interested in participating. Similar recruitment tactics have been used in past IBD studies 
(Coulson, 2013; Frohlich, 2016).  
Inclusion criteria for this pilot study were that participants had to be from the US (for 
incentive purposes), at least 18 years or older, and have some type of IBD (e.g., Crohn’s disease, 
ulcerative colitis). Because this was an exploratory pilot study that sought to refine the support 
messages, I aimed for a modest sample size. Recruitment efforts took place in Fall 2020 and 
yielded 44 participants. Those who participated were entered into a random drawing where they 
were eligible to receive one of three $50 Amazon gift cards. All methods and procedures used in 
the current study were approved by the University of North Carolina at Chapel Hill Institutional 




Participants first provided informed consent and answered background questions about 
their IBD, such as whether they have Crohn’s disease or ulcerative colitis. Next, participants 
were randomly assigned to one of four survey panels, each containing five support messages. 
The panels were grouped based on the four IBD self-management domains: 1) general IBD 
symptoms (n = 12), 2) social aspects of IBD (n = 11), 3) IBD and nutrition (n = 8), and 4) other 
aspects of IBD self-management (n = 13). Participants were shown each of the five support 
messages in their panel one at a time; though, it should be noted that for each support message 
they saw both the validating and advising messages at the same time.  
The stimuli used in this study were static images designed to look like text messages sent 
to a smartphone. This increased the ecological validity of the study by allowing participants to 
see how the support messages would look like in a text message format (see Figure 3 for 
example stimuli). The order that participants saw and evaluated support messages within panels 
was randomized. Participants evaluated each support message individually and also had an 
opportunity to evaluate the overall domain of support messages after exposure to all individual 
messages. Finally, participants answered questions about their demographics. The questionnaire 




Figure 3. Example stimuli for the message evaluation pilot study.  
Domain 1 support message  
 
Domain 2 support message 
 
Domain 3 support message 
 




IBD characteristics. Participants answered what type of IBD they had (ulcerative colitis, 
Crohn’s disease, indeterminate colitis, or other) and at what age they were diagnosed with IBD. 
Participants also answered questions about their IBD activity and general health. IBD activity 
was assessed with a single item that asked participants to rate their IBD activity over the past two 
weeks. Responses to IBD activity were on a 5-point scale ranging from “no symptoms (in 
remission)” (1) to “severely active” (5). General health was assessed with a single item that 
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stated, “In general, would you say your health is…” Responses to this item were measured on a 
5-point scale ranging from “excellent” (1) to “terrible” (5). Both IBD activity and general health 
items were adapted from IBD Partners (Long et al., 2012).   
Perceived message effectiveness. I created a brief measure of perceived message 
effectiveness (PME) for the current study; though, the structure of the items was modeled after 
PME literature and previous studies I have conducted (Noar, Bell, Kelley, Barker, & Yzer, 2018; 
Rohde, Noar, Prentice-Dunn, Kresovich, & Hall, in press). The measure began with the stem 
“How much does this message…” and included the following five items: 1) give you important 
information about IBD, 2) make you feel more confident in managing your IBD, 3) make you 
feel supported about your IBD, 4) give you ideas about how to better cope with your IBD, and 5) 
make you think that better managing IBD can improve your symptoms. Each of the five items 
tapped a different theoretical area relevant to the evaluation of the support messages. In a 
corresponding order to the above items, these areas are: 1) knowledge, 2) self-efficacy, 3) 
perceived support, 4) coping, and 5) outcome expectations. Each item was assessed on a 5-point 
scale from “not at all” (1) to “a great deal” (5). PME items were assessed immediately after 
exposure to each support message that participants viewed. Reliability of the scale across the 
four panels was acceptable ([Cronbach’s coefficient] α = .91).   
Additional message evaluation outcomes. For each support message, participants were 
asked to respond (in open-ended format) to the following three items: 1) please describe the main 
purpose of the message in one or two sentences, 2) what about the message did you like, and 3) 
what about the message could be improved. In addition, after exposure to all support messages, 
participants were asked if there was 1) anything else they would like to say about the messages 
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they just saw, and 2) if there was anything else about IBD management that they feel should be 
added. Responses to both of these questions were also in an open-ended format. 
Demographics. I assessed participant age, gender, race, Hispanic ethnicity, and highest 
level of educational attainment. 
Data analysis 
I used descriptive statistics to characterize participants and to evaluate the support 
messages using ratings from the full PME scale and each of the individual PME items (e.g., self-
efficacy, outcome expectations). I also averaged the PME ratings of the five individual support 
messages in each domain together to create an overall PME score for each self-management 
domain. I used qualitative analysis to categorize participants’ open-ended feedback about the 
individual support messages, as well as their feedback about the entire domain of messages they 
were shown. Finally, I used PME ratings and message feedback from participants to modify and 
improve the content of the support messages, where possible, or to create new messages. All 
statistical analyses were computed using R (version 3.6.2) (R Core Team, 2019).  
Results 
Participant characteristics  
 The average age of participants was 29. Most were female (68%; Table 6) and all 
identified as being White. Only one participant (2%) reported being Hispanic. A large majority 
had a bachelor’s degree or higher (80%). Regarding IBD characteristics, participants either had 
Crohn’s disease (52%) or ulcerative colitis (48%), and the average length of time since their IBD 
diagnosis was approximately six years; though, more than one-third of participants were 
diagnosed with IBD in the past year. Finally, average IBD activity (M = 2.95, SD = 1.22) and 
general health (M = 2.59, SD = 1.00) among participants was moderate. 
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Table 6. Demographic and IBD characteristics of the message evaluation pilot study sample; N = 
44. 
 n (%) or M ± SD 
Age 
[age range] 
29.25 ± 5.87 
[19-48] 
Gender  
Male 12 (27%) 
Female 30 (68%) 
Other/prefer not to say 2 (5%) 
Race (White) 44 (100%) 
Hispanic 1 (2%) 
Education  
High school or less 6 (15%) 
Associate’s degree 2 (5%) 
Bachelor’s degree 18 (40%) 
Graduate or professional degree 18 (40%) 
IBD type  
Crohn’s disease 23 (52%) 
Ulcerative colitis 21 (48%) 
Mean age at time of diagnosis 23 ± 7.94 
Length of time since diagnosis 6.23 ± 6.47 
One year or fewer 17 (39%) 
Between two and five years 10 (22%) 
More than five years 17 (39%) 
IBD activity 2.95 ± 1.22 
General health 2.59 ± 1.00 
Note. n = sample size; M = mean; SD = standard deviation.  
 
Message ratings of the general IBD symptoms domain 
PME ratings using the full 5-item scale for the support messages (as well as combined 
PME ratings for each domain) are in Table 7. Item-level PME ratings (e.g., self-efficacy, 
outcome expectations) and open-ended feedback for the support messages grouped by the four 
self-management domains are in Appendix F.  
Participants rated the general IBD symptoms domain of support messages as favorable (M 
= 3.31, SD = 1.01; Table 7). The highest rated support message was about flare tracking (M = 
3.80, SD = 1.01). Participants noted in the open-ended responses that they liked that the message 
offered a reminder for people with IBD to monitor their symptoms and also that it offered an 
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external resource they could use (i.e., a mobile IBD symptom tracking app). The main feedback 
offered about this message was that the text was “cluttered.” The next highest rated support 
message was about psychological distress and the use of breathing and muscle relaxation 
exercises (M = 3.35, SD = .91). Participants noted in the open-ended responses that they liked 
that the message discussed an overlooked topic and that it provided useful information. 
Suggestions to improve the message included modifying the resource URL at the end of the 
message so that it does not look like “spam.” The lowest rated message pair was about symptom 
discomfort (M = 3.05, SD = .88). Participants noted in the open-ended responses that they liked 
that the first message was written in a positive and validating tone, and they also felt that the 
information that the message offered was useful. Participants requested adding additional tools to 
help reduce symptom discomfort, with several suggesting including content about the use of 
bidets.  
 Participant feedback regarding the two open-ended questions about the general IBD 
symptoms domain as a whole was largely positive, with one participant stating, “I like the idea of 
it [referring to the messages]! Most people don’t really know where to look for information and 
doctors aren’t that helpful. It’s good to have ongoing support...” Participants suggested including 
more information about symptom management in future iterations of the support messages. 
Example topics offered by participants included messages about IBD diets, pain management, 




Table 7. PME ratings of the support messages. 
Support message domains and associated  
message topics  
PME 
M ± SD 
General IBD symptoms (overall domain) 3.31 ± 1.01 
Topic 1: Psychological distress 3.35 ± .91  
Topic 2: Symptom discomfort 3.05 ± .88 
Topic 3: Flare tracking 3.80 ±.88  
Topic 4: Fatigue 3.13 ± 1.15 
Topic 5: Exercise 3.22 ± 1.07 
  
Social aspects of IBD (overall domain) 2.46 ± .79 
Topic 1: Symptom management in public 2.18 ± .84 
Topic 2: Networking  2.53 ± .78 
Topic 3: Support systems 2.56 ± .88 
Topic 4: Advice seeking 2.44 ± .94 
Topic 5: Peer support 2.60 ± .52 
  
IBD and nutrition (overall domain) 3.01 ± .79 
Topic 1: General IBD nutrition 3.13 ± .76 
Topic 2: IBD diets 3.10 ± .70 
Topic 3: Trigger foods 2.80 ± .71 
Topic 4: Helpful foods 3.40 ± .97 
Topic 5: Balanced nutrition 2.63 ± .71 
  
Other aspects of IBD self-management (overall domain) 2.68 ± 1.02 
Topic 1: Importance of IBD medication 2.51 ± 1.06 
Topic 2: Medication reminders 2.78 ± .99 
Topic 3: Open communication 2.52 ± .82 
Topic 4: COVID-19 and IBD  2.43 ± 3.18 
Topic 5: Finding a doctor 3.18 ± 1.25  
Note. PME = perceived message effectiveness (outcome measured on a 5-point scale with higher 
values indicating a better rating; M = mean; SD = standard deviation; topics under each support 
message domain represent a message pair.  
 
Message ratings of the social aspects of IBD domain 
Participants rated the social aspects of IBD domain of support messages as sub-par (M = 
2.46, SD = .79; Table 7). The highest rated support message (M = 2.60, SD = .52) was about peer 
support and contained information about a program called “Power of Two” that matches people 
with IBD together. Participants noted in the open-ended responses that they liked that the 
message offered an external resource and also that the message was “to the point.” The main 
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suggestion to improve the message was to provide a resource for a community support program 
instead of a one-on-one peer support program. The lowest rated support message (M = 2.18, SD 
= .84) was about IBD symptom management in public. Participants noted in the open-ended 
responses that they liked that the message had a helpful tone and was not “pushy.” Participants 
noted that the advice being offered by the message was too “obvious” and suggested including 
additional information, such as how to handle IBD accidents (i.e., fecal incontinence) in public. 
Participant feedback regarding the two open-ended questions about the social aspects of 
IBD domain as a whole was mixed. Some participants vocalized their approval and optimism 
toward the content, and used words and phrases such as “straightforward,” “authentic,” and “not 
condescending” to describe what they liked about the set of messages. Other participants, 
however, suggested that the messages were not motivating enough. Moreover, one participant 
suggested that the length that one has been diagnosed with IBD may impact how the messages 
would be received, stating, “A newly diagnosed person may need different support than someone 
who has lived with it [IBD] for 20 years.” This statement partially corroborates the above 
feedback that some of the educational information in the support messages was too “obvious.” 
Finally, participants suggested including messages about breathing and relaxation exercises, tips 
about IBD diets, and information about how to identify and treat certain IBD symptoms.  
Message ratings of the IBD and nutrition domain 
Participants varied in their ratings of the IBD and nutrition domain of support messages; 
though, most rated the support messages above the middle point (i.e., a 3 out of 5) on the PME 
scale on average (M = 3.01, SD = .79; Table 7). The highest rated support message (M = 3.40, 
SD = .97) was about helpful foods to eat when experiencing an IBD flare. Participants noted in 
the open-ended responses that they liked that the message included specific food and some 
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acknowledged that they could relate to the message content. For feedback, one participant noted 
that symptom mitigating foods do not always work similarly for those diagnosed with IBD. 
Another participant recommended against using bit.ly links for resources because they look like 
“spam.” The next highest rated support message (M = 3.13, SD = .76) was about general IBD 
nutrition and how small dietary changes (e.g., staying hydrated) can help keep IBD symptoms 
under control. Participants noted in the open-ended responses that they liked that the message 
was concise and offered useful information. Suggestions to improve the message included 
changing the phrasing of the text and providing more informational examples. In addition, 
participants noted that the message could be viewed as “throwaway” advice to some people with 
IBD. The lowest rated support message (M = 2.63, SD = .71) in this domain was about balanced 
nutrition and how dietary changes can help reduce feelings of tiredness and fatigue. Participants 
noted in the open-ended responses that they liked the positive tone and information provided by 
the message, and some felt that the content was relatable and validating. In terms of feedback, 
one participant noted that the expectations from the advice in the message were too high, and 
that it is not easy for people with IBD to change their diets.  
Participant feedback regarding the two open-ended questions about the IBD and nutrition 
domain as a whole was neutral. For example, participants liked the general concept of the 
messages and enjoyed the educational information they provided; however, one person noted 
that the message language was too strong and suggested being broader about the efficacy of 
nutritional advice since people with IBD often react to foods differently. Another participant also 
liked the messages overall but felt they were designed for people who were newly diagnosed 
with IBD and stated that the messages should offer more motivational support. Finally, 
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participants suggested adding message topics about managing physical IBD symptoms, such as 
cramps and fatigue, as well as messages about managing IBD and mental health. 
Message ratings of the other aspects of IBD self-management domain 
Participants rated the other aspects of IBD self-management domain as sub-par (M = 
2.68, SD = 1.02; Table 7). Only one support message was rated above a PME score of three out 
of five. This message (M = 3.18, SD = 1.25) was about an online resource to help people find a 
doctor near them. Nearly all participants noted in the open-ended responses that they liked the 
utility of the external resource included in the message. Participants suggested modifying the 
bit.ly URL in the message so that it does not look like “spam.” The lowest rated support message 
(M = 2.43, SD = .92) was about COVID-19 and IBD coping. Participants noted in the open-
ended responses that they liked that the message stressed the importance of support and that it 
provided a useful resource. To improve the message, participants suggested making the text 
clearer, providing more resources, and modifying the bit.ly URL.  
Participant feedback regarding the two open-ended questions about the other aspects of 
IBD self-management domain as a whole was mixed. Some participants liked the support and the 
online resources that the messages offered while others noted that the educational information 
and advice was not useful. One participant stated, “The messages were pretty vague, and seemed 
like they were intended for people who know absolutely nothing about IBD.” Participants 
suggested adding messages about meditation, pain management, and the effects of IBD on 
mental health.   
Discussion 
The purpose of this empirical study was to construct and preliminarily evaluate support 
messages about disease self-management among people with IBD. Overall, results showed that 
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participants largely voiced their approval and satisfaction with most of the support messages and 
noted their optimism toward the idea of a study sending educational resources to people with 
IBD via text messaging. These findings are encouraging and suggest that research efforts aimed 
at implementing support messages in the context of a health intervention would be feasible and 
would also likely be well-received by people with IBD.  
One of the main findings from this study was how differently the support messages 
across the four disease self-management domains were evaluated. For example, participants 
tended to favor the messages in the general IBD symptoms domain. Not only did this particular 
domain score the highest (in terms of PME) overall, but open-ended feedback from participants 
assigned to evaluate support messages in the other three domains suggested adding symptom-
related informational content to the pool of messages (e.g., participants in the IBD and nutrition 
domain requesting support messages about how to handle disease-related cramps and fatigue). 
This finding speaks to how fundamentally linked symptoms are to overall quality of life among 
those with IBD.  
Participants also tended to evaluate the support messages in the IBD and nutrition 
domain as acceptable. Specifically, results showed that message topics about IBD diets and 
helpful foods were rated the highest. This finding suggests that people with IBD may value 
nutritional support, which is important given that adherence to a symptom mitigating diet can 
play a key role in the disease self-management process and is partially linked to symptom 
activity (e.g., lessening fiber intake can help reduce intestinal cramping).  
By contrast, support messages in the social aspects of IBD domain were evaluated as 
least favorable. The PME rating of this domain overall was only M = 2.46 (SD = .79), and not a 
single support message scored at or above a rating of 3. This finding is surprising given that 
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literature suggests people with IBD tend to worry about the social implications of an IBD 
diagnosis (Casati et al., 2000; Daniel, 2002; Drossman et al., 1991; Drossman et al., 1989; Pittet 
et al., 2017), such as concerns about self-induced social isolation due to the unpredictable nature 
of disease symptoms. As such, one would suspect that support messages targeting this domain 
would be well-received among people with IBD. Instead, many participants used language such 
as “obvious” to describe the educational information and advice offered by the support messages 
in this domain. This suggests that, while social aspects are likely an important part of the disease 
self-management process, people with IBD may already know how (or would rather develop the 
skills) to cope with this component of their disease on their own.  
Finally, support messages in the other aspects of IBD self-management domain were also 
rated low overall. This may be due to the fact that the specific topics of the individual support 
messages in this domain did not share a similar theme. Instead, these messages represented an 
amalgam of IBD self-management behaviors, covering topics such as medication adherence, 
coping during COVID-19, and information about how to find a local gastroenterologist.  
Although both the social and other aspects of IBD self-management domains were rated 
as sub-par, it should be noted that participant open-ended feedback in these domains did not 
always reflect their corresponding PME ratings. For example, some of the qualitative responses 
toward the support messages in these two domains were favorable and corroborated some of the 
broader findings from this study. For example, participants in both of these domains voiced their 
satisfaction with the IBD self-management external resources that were included in some of the 
support messages. These findings indicate that messages aimed at providing educational 




Changes to the support messages 
Based on the PME ratings and participant open-ended feedback, I made changes to three 
important aspects of the initial pool of support messages in order to improve their likely impact 
and reception among people with IBD. The first change has to do with message topics and the 
self-management domains that messages were categorized under. A large number of participants 
across domains suggested including more content about managing physical IBD symptoms, as 
well as messages stressing the importance of mental health when coping with an IBD diagnosis. 
Moreover, both the social and other aspects of IBD self-management domains received low PME 
ratings and mixed open-ended evaluations from participants. As such, I decided to restructure the 
support messages under the following three disease self-management domains: 1) physical IBD 
symptoms, 2) IBD and mental health, and 3) IBD and nutrition. This restructuring allowed me to 
place emphasis on topics requested by people with IBD while also eliminating those that were 
received poorly. The structure of the three new domains is discussed below.  
 The first self-management domain, physical IBD symptoms, is made up of five support 
messages. Four of these messages came from previous domains in the initial pool, such as the 
general IBD symptoms domain; however, several participants in the current study suggested that 
messages should include information about how to manage other physical IBD symptoms, such 
as cramps and bloating. Thus, I created a new support message about this topic, which stated:  
Message 1 (validating): It can be tough getting through the day feeling bloated because 
of IBD. 
Message 2 (advising): Eating smaller meals and avoiding caffeine and carbonated 




Another change in this domain included amending an existing message pair with a suggestion to 
use a bidet instead of toilet paper to reduce discomfort and irritation associated with frequent 
bowel movements. This change was made because multiple participants requested including 
information about using bidets for symptom relief.  
 The second self-management domain, IBD and mental health, was created as a response 
to a number of suggestions from participants recommending support messages about the effects 
of IBD on mental health. This new domain contains five support messages. Four of these 
messages came from previous domains. These messages either already discussed aspects of 
mental health and IBD self-management (i.e., managing stress, anxiety) or were modified to 




Support message text 
 Modified support message 
emphasizing mental health 
 
 
Message 1 (validating):  
Staying active while having IBD 
can be hard. 
 
 
Message 2 (advising):  
Short exercises, such as going on 
walks or riding a bike, can reduce 
stress and strengthen your immune 
system, which may help your 






Message 1 (validating): 




Message 2 (advising): 
Short exercises, such as going on 
walks or riding a bike, can improve 
your mental health and strengthen your 
immune system, which can help keep 





I also created a new support message for this domain. The topic of this message focused on self-
care, particularly for those who feel like self-managing IBD symptoms can be overwhelming. 
The new message states: 
Message 1 (validating): Staying on top of symptoms can feel overwhelming at times. 
Message 2 (advising): It’s important to tackle IBD one day at a time. If you’re feeling 
discouraged about IBD, try setting aside some time in your day to focus on self-care, 
such as by doing activities that you enjoy and bring you comfort.     
 
 The final self-management domain, IBD and nutrition, contained four support messages 
(thus making a total of 14 messages across domains). Three of these messages were from the 
initial IBD and nutrition domain. The two messages not included were eliminated due to either 
poor PME ratings or participant open-ended feedback suggesting that the message content was 
not appropriate for people with IBD. The messages from the initial pool that were retained were 
slightly modified based on participant feedback. For example, the text of one original support 
message stated that making “small dietary changes” would likely improve IBD symptoms; 
however, one participant noted that “small” could be viewed as ignorant. As such, this specific 
text was deleted from the message. I also created a new support message for this domain, which 
read:  
Message 1 (validating): No two people with IBD react the same to eating certain foods. 
Message 2 (advising): Keeping a food journal to track what you eat can help you figure 
out if certain foods make your symptoms worse. This can help eliminate trigger-causing 
foods from your diet.   
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The second major change I made to the support messages had to do with the external 
resources that some of the messages provided. Most participants liked that the support messages 
contained links to additional online information; however, many (across domains) noted that the 
URLs of those online resources looked like spam, and that, because of this, they would be 
hesitant to click on the resources. Thus, I customized the bit.ly URLs in the revised support 
messages so that they included a preview of what the resource would link to. For example, the 
resource URL that linked to a website about coping strategies during COVID-19 was modified to 
include “IBD_covid” in the URL text. Below is another example of a modified bit.ly URL:  
 
Original URL  Modified URL 
https://bit.ly/3j0uyys  http://bit.ly/IBDDiets 
   
The third and final broad change I made to the support messages had to do with the 
phrasing of some of the messages. As stated above, several participants noted in open-ended 
responses how important it was for the messages to be motivational and compassionate toward 
people with IBD. In addition, many stated that they were pleased that the messages they 
reviewed were not patronizing or condescending. As a result of this feedback, I went through 
each of the support messages and modified text—to the extent that I could and where 
appropriate—to ensure that the content was understanding of the experiences of people with 
IBD. For example, I added language to one message about how self-managing IBD can feel 
overwhelming and that it is ok to “tackle symptoms one day at a time.” In another example, I 
added text about how common it is for people with IBD to struggle with their mental health. This 
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change reinforces the notion that self-managing a chronic disease such as IBD is not easy and 
can have a serious impact on one’s mental well-being.   
In sum, I eliminated nine support messages from the initial pool. These messages were 
eliminated for a number of reasons, such as poor PME ratings or negative participant open-ended 
feedback. In addition, some messages were deleted because of poor fit (e.g., messages about 
medication adherence). The remaining 11 support messages were then revised based on 
participant suggestions and were categorized under three new self-management domains: 
managing 1) physical IBD symptoms, 2) IBD and mental health, and 3) IBD and nutrition. Three 
new support messages were also developed, one for each of the new domains. Finally, it should 
be noted that the set of both new and modified support messages were also reviewed by expert 
researchers familiar with this work, most notably a gastroenterologist who treats people with 
IBD. This final review was critical for validating that the content of the final pool of messages 
was both medically accurate and appropriate for people with IBD to read. The final support 




CHAPTER FIVE: FEASIBILITY AND ACCEPTABILITY OF AN IBD SELF-
MANAGEMENT TEXT MESSAGING INTERVENTION 
 
Introduction 
IBD is a chronic gastrointestinal disease that affects more than three million adults in the 
US (Crohn’s & Colitis Foundation, n.d.; Dahlhamer, 2016). The relapsing-remitting nature of the 
disease—coupled with its complex and stigmatized symptoms (e.g., bloody and uncontrollable 
diarrhea, excessive flatulence) (Groshek et al., 2017; Guo et al., 2020; Taft & Keefer, 2016)—
leaves those with IBD at increased risk for distress. In fact, evidence suggests that approximately 
30% of people with IBD report symptoms of anxiety and/or depression (Byrne et al., 2017; 
Neuendorf et al., 2016). If unaddressed, distress can lead to other harmful health outcomes, such 
as a worse disease course and increased disease activity, as well as a reduced quality of life 
(Edman et al., 2017; Graff, Walker, & Bernstein, 2009; Kochar et al., 2018; Nahon et al., 2012; 
Porcelli et al., 1994; Reigada et al., 2015; Tabibian et al., 2015). Thus, research should prioritize 
investigating effective methods to intervene and reduce perceptions of distress among this 
population.  
Adjustment to IBD and disease self-management 
One promising approach to targeting and reducing perceptions of IBD distress is to 
educate and promote active involvement in the IBD management process. As previously 
discussed in Chapter 2, this process is referred to as disease self-management, and typically 
involves tasks related to the self-management of medical and/or behavioral, role modification, 
and emotional aspects associated with chronic disease (Lorig & Holman, 2003). For people with 
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IBD, disease self-management behaviors tend to include adhering to medication, actively 
monitoring symptoms, and scheduling regular checkups with medical providers.   
Importantly, evidence has highlighted the beneficial impact of disease self-management 
on IBD health (Conley & Redeker, 2016). For example, research has shown an association 
between IBD patient activation (a similar term to disease self-management) and distress 
outcomes (including anxiety and depression), as well as disease activity (Barnes, Long, et al., 
2019). Moreover, findings from other investigations have suggested that IBD self-management 
interventions can improve health-related quality of life and medication adherence, as well as 
reduce the number of hospitalizations (Conley & Redeker, 2016; Kennedy et al., 2004; Robinson 
et al., 2001).  
Of course, the processes associated with adjusting to and self-managing a chronic disease 
are multi-faceted and challenging, representing a dynamic interplay of different emotional, 
physical, and cognitive aspects (Kiebles, Doerfler, & Keefer, 2010). This is particularly true for a 
chronic disease such as IBD due to its unpredictable symptoms and the various barriers that these 
symptoms pose to engaging in effective self-management behaviors (e.g., chronic fatigue 
affecting one’s regular treatment regimen) (Keefer & Kane, 2016). Although not always easy, 
health behavior and chronic disease literature point to a number of important theoretical 
constructs and perspectives that are useful in improving disease self-management, and for 
understanding health outcomes—including distress—among people with IBD.   
The first such construct is self-efficacy, which was developed by Bandura (2004) and is a 
fundamental component to SCT. Briefly, self-efficacy refers to the confidence in one’s ability to 
engage in a behavior or task (Kelder et al., 2015). In a chronic disease context, self-efficacy is 
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often used as a measure of peoples’ confidence in their ability to self-manage their disease, such 
as adhering to treatment plans or regularly exercising.  
Substantial evidence has identified self-efficacy as an integral component in developing 
effective self-management interventions (Foroumandi et al., 2020; Katch & Mead, 2010; 
Krichbaum et al., 2003). This is also true in the context of IBD (Keefer et al., 2011). For 
example, a recent investigation tested the effects of an IBD self-management program and found 
that participants enrolled in the intervention improved their perceptions of self-efficacy 
compared to a no-treatment control sample (Magharei et al., 2019). In addition, research has 
shown that self-efficacy tends to be associated with improvements to IBD health outcomes such 
as distress and medication adherence (Boamah et al., 2010; Graff et al., 2016).  
The second important theoretical construct relevant to understanding and improving 
disease self-management for people with IBD is outcome expectations. Outcome expectations is 
another component of SCT and refers to peoples’ judgements about the consequences of their 
behavior (Kelder et al., 2015). These judgements can inform illness perceptions, which, in turn, 
influence how people with chronic disease respond to a health-related problem. For example, 
people with IBD who do not believe that active disease monitoring can reduce their likelihood of 
experiencing flares will perceive that disease symptoms are out of their control. Empirical 
evidence of the impact that outcome expectations (treated as a measurable construct) has on IBD 
health outcomes is lacking; however, there is some evidence showing that individuals who hold 
negative beliefs about the efficacy of IBD treatment tend to report sub-optimal adherence to 
disease maintenance and worse quality of life (Hall et al., 2007; Horne et al., 2009; Moshkovska 
et al., 2009). This suggests that outcome expectations could be important to disease self-
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management and that targeting this construct in an intervention could improve IBD health 
outcomes. 
A third perspective relevant to disease self-management is social support. As already 
stated in Chapter 2, social support can be understood as any meaningful exchange of assistance 
or resources from one person (or group) to another with the intent to improve well-being. 
Literature has shown social support to be important in adjusting to a chronic disease and has 
been linked to improvements in some disease self-management outcomes, such as treatment 
adherence (DiMatteo, 2004; Gallant, 2003). In the context of IBD specifically, research has 
suggested that supportive disease self-management programs and health interventions can 
optimize medical management and reduce perceptions of distress (Kamp, Luo, et al., 2019; 
Kamp, West, et al., 2019; Keefer & Kane, 2016). Moreover, evidence from other investigations 
has suggested that increasing perceptions of social support can improve certain IBD outcomes, 
including distress, disease activity, and quality of life (Sewitch et al., 2001; Slonim-Nevo et al., 
2018).  
The last perspective important to understanding how people with IBD might adjust to and 
improve their disease self-management skills is coping. Coping is a core component of some 
health behavior theories, such as the common-sense model of illness self-regulation (Leventhal 
et al., 2016), and refers to the use of cognitive and behavioral efforts to appraise and reduce a 
stressful situation (Snyder, 1999). Literature has characterized a number of specific strategies, 
such as the use of humor, self-blame, or substance use as coping mechanisms (Carver, 1997); 
though, coping can broadly be categorized as either the use of adaptive (e.g., positive responses 
to stress) or maladaptive (i.e., negative responses to stress) strategies.  
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Coping has been roundly investigated in the IBD literature (Crane & Martin, 2004; 
Goodhand & Rampton, 2008; Graff, Walker, Clara, et al., 2009; Jones et al., 2006; A. M. 
McCombie et al., 2013; Parekh et al., 2015). Evidence from this work shows that people with 
IBD tend to use coping strategies, such as problem solving and support-based mechanisms, as a 
means to self-manage their disease (Graff, Walker, Clara, et al., 2009). Moreover, results suggest 
that using coping strategies can positively impact IBD health outcomes, including distress and 
quality of life (Danesh et al., 2015; Knowles et al., 2011; A. M. McCombie et al., 2015; 
Moskovitz et al., 2000; Parekh et al., 2015; Van der Zaag-Loonen et al., 2004). To date, 
however, few investigations have examined coping specifically in the context of disease self-
management interventions for people with IBD (A. M. McCombie et al., 2013). Thus, more work 
is needed to test the utility of such a mechanism as a key component in a disease self-
management intervention.  
IBD self-management intervention framework 
Drawing from the collective body of literature reviewed above, there is reason to believe 
that perceptions of self-efficacy, outcome expectations, and support, as well as the use of coping 
strategies, are complementary components useful in understanding disease outcomes among 
people with IBD. In addition, it is likely that these theoretical components influence how people 
with IBD self-manage some aspects of their disease. Based on this supposition, I propose that 
these constructs and mechanisms could be integrated in a unifying framework to inform the 
development of an IBD self-management health intervention aimed at targeting disease-related 
distress. In this framework, which was previously outlined in Chapter 2, self-efficacy, outcome 
expectations, and perceived IBD support variables are posited to affect the use of coping 
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strategies. In turn, coping serves as a key mediator variable between the associations of the 
psychosocial outcomes and IBD-related distress.  
It should also be noted that individual experiences, characteristics, and perceptions are 
integral to understanding disease self-management and health outcomes. For example, a person 
who has been diagnosed with IBD for several years and who has experienced a number of 
symptom flares in the past would likely use tested coping strategies to address the onset of future 
symptoms. Someone newly diagnosed with IBD, on the other hand, might struggle with coping 
and responding to the onset of IBD symptoms because they may not have the experience or 
knowledge about how to best self-manage their disease. This distinction in the adjustment to IBD 
has been discussed in the literature (Kiebles et al., 2010) and is an important component in 
characterizing one’s ability to cope with—both physically and psychologically—the dynamic 
nature of self-managing IBD. As such, I posit that the direct effects of the associations of the 
above theoretical variables (e.g., self-efficacy, outcome expectations) on IBD-related distress are 
likely moderated by individual differences variables, such as IBD activity and gender. A visual 
of this theoretically informed intervention framework is shown below in Figure 4. 
IBD eHealth interventions 
Notably, digital technologies could be instrumental in the development and dissemination 
of interventions that help people with IBD self-manage their disease (Huang et al., 2014; Jackson 
et al., 2016; Knowles & Mikocka-Walus, 2014; Rohde et al., 2021). Previous randomized 
controlled trials show that use of eHealth interventions, such as digital cognitive behavioral 
therapy or online patient portals, significantly reduce perceptions of distress when compared to 
standard care alternatives (de Jong, van der Meulen-de Jong, Romberg-Camps, Becx, et al., 
2017; de Jong, van der Meulen-de Jong, Romberg-Camps, Degens, et al., 2017; Elkjaer, Burisch, 
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Avnstrøm, Lynge, & Munkholm, 2010; Hunt et al., 2020; Hunt et al., 2017). Moreover, a number 
of studies show that people with IBD tend to be receptive to using eHealth tools for IBD self-
management (Del Hoyo et al., 2018; Elkjaer et al., 2010; A. M. McCombie et al., 2020). This 
suggests that digital technologies—if developed and utilized appropriately—could serve as a 
therapeutic outlet for people with IBD.  
Although extant eHealth interventions have utilized a number of different applications 
(e.g., web portals, symptom tracking applications), a promising yet under-researched technology 
in the IBD research field is text messaging. Evidence from different reviews shows that text 
messaging is an effective medium for modifying various health outcomes (e.g., medication 
adherence), particularly among people with chronic disease (Fjeldsoe et al., 2012; Head et al., 
2013; Thakkar et al., 2016). Moreover, text messaging is highly affordable (approximately one 
cent per message), thus lowering the economic burden on researchers interested in integrating 
this technology in their own scientific interventions or for replication purposes.  
To date, only a handful of studies have investigated the impact of text messaging on 
health outcomes among people with IBD. Recently, Riaz and Nielsen (2019) developed a pilot 
pretest-posttest single group intervention that sent tailored text messages (between one and three 
each day) to people with IBD. The purpose of these messages was to improve IBD medication 
adherence and treatment beliefs. At a 12-week follow-up, results showed increases in medication 
adherence and a decrease in concerns about IBD treatment compared to baseline. Another study 
by Miloh et al. (2017) randomly assigned adolescents with IBD to either a text messaging 
intervention that sent medication reminders to participants’ cell phones or to a standard care 
control. At a 6-month follow-up assessment, those in the text messaging arm of the trial showed 
improvements in their medication adherence compared to those in the control condition.  
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Although findings among some IBD text messaging studies have been promising, other 
similar interventions have had null effects. For example, one randomized controlled trial tested 
the impact of educational messages about IBD self-management compared to standard care 
(Cross et al., 2015; Schliep et al., 2020). At a 1-year follow-up, results showed no differences in 
depressive symptoms between participants receiving the text messages compared to control. 
These null findings could be attributed to low intervention dose, as participants only received 
educational messages either once or twice weekly. Another explanation for these findings could 
be that participants were first evaluated six months after beginning the trial, and it may be that 
message effects tapered off before initial assessment of intervention outcomes. One last potential 
reason for these insignificant findings could be due to the fact that the messages were designed to 
be strictly educational, and participants may not have viewed these messages as supportive or 
validating.  
These inconsistent findings indicate that more work is needed to investigate effective 
applications of text messaging as an eHealth intervention method. Moreover, the IBD text 
messaging literature is relatively homogenous, with most of the published studies focusing on 
sending messages that aim to modify medication adherence. To my knowledge, no interventions 
have sought to test whether similar messaging efforts could be utilized to target additional health 
outcomes, such as coping strategies and disease-related outcome expectations. Testing these 
messages in an intervention could have important implications for future efforts aimed at 
reducing disease-related distress among people with IBD.  
Study goals, hypotheses, and research questions 
The current study sought to develop and preliminarily evaluate the results of a single 
group, pretest-posttest eHealth intervention called “Text4IBD.” This intervention provided 
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educational information, advice, and support about disease self-management to people with IBD 
for two weeks via text messaging. Specifically, the support messages sent by the intervention 
targeted key determinants and self-management appraisal mechanisms known to impact 
behavioral and psychological health outcomes. The primary goal of this intervention was to 
reduce IBD-related distress and to assess whether participants viewed the intervention as feasible 
and acceptable. Based on dissemination and implementation literature (Brownson, Colditz, & 
Proctor, 2017), I am broadly defining feasibility as relating to the trialability and practicability of 
the program as evaluated by participants in this current intervention setting. Similarly, I am 
defining acceptability as participants’ perceived advantage of using the intervention, such as 
whether they view aspects of the Text4IBD program as satisfactory. Secondary goals of this 
study were to improve theoretical constructs and other aspects specifically targeted by the 
intervention, including medication adherence. Specifically, I hypothesized that: 
H1: Compared to pretest, participants exposed to Text4IBD will report lower IBD-related 
distress at posttest.   
H2: Compared to pretest, participants exposed to Text4IBD will report improvements to 
their a) self-efficacy, b) outcome expectations, c) perceived support, d) medication 
adherence, and e) use of coping strategies at posttest.  
H3: Text4IBD will be perceived by participants as a) feasible and b) acceptable. 
 
This study also sought to address a few exploratory questions. For example, given the 
dearth of IBD interventions informed by the theoretical perspectives identified above, it was 
important to not only test the pretest-posttest changes in the psychosocial outcomes targeted by 
the Text4IBD program, but also the relationships of those variables with the primary outcome of 
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IBD-related distress at posttest after exposure to the Text4IBD program. In addition, because 
individual differences play a major role in the disease self-management process, it was critical to 
test whether certain demographic or IBD characteristics (e.g., length of diagnosis) also exhibited 
influence on disease-related distress at posttest. Finally, evidence about the efficacy of text 
messaging interventions among people with IBD is still developing. As such, it was important to 
test whether increased engagement in the Text4IBD intervention had an impact on disease-
related distress at posttest. Thus, as an additional objective to this study, I sought to answer the 
following research questions:  
RQ1: Will posttest psychosocial and coping variables be associated with posttest IBD-
related distress?  
RQ2: Will demographics and IBD characteristics be associated with posttest IBD-related 
distress? 













































































































































































































































































Study overview  
The purpose of this intervention was to send educational support messages about disease 
self-management to people with IBD for two weeks using “Text4IBD”—a text messaging 
program I developed for this dissertation. This study utilized a single group, pretest-posttest 
intervention design. Pretest-posttest designs are recommended in the “treatment development” 
phase of eHealth interventions (Kumar et al., 2013). The current research fits into this category 
as a recent review I conducted found that the eHealth IBD research field is nascent, and that 
extant interventions posited variable effects on health outcomes (Rohde et al., 2021). Thus, a 
main goal of this study was to evaluate whether implementation of the Text4IBD program was 
feasible and whether people with IBD perceived it as acceptable, to inform future research and 
healthcare efforts. 
Participant recruitment 
The target audience for this study was people with IBD who experienced disease-related 
distress. I used the social media platforms Reddit and Twitter to both identify and recruit 
members of this audience. Reddit and Twitter are popular social networking sites and evidence 
from Chapter 3 of this dissertation suggests both platforms are used in online discourse about 
IBD and distress. In addition, these platforms offer free public access to their application 
programming interface (API), which allows researchers to collect data in real time and run 
platform-specific commands from third-party applications, thus making the platforms useful for 
identifying potential participants. 
I used Python (Version 3.8.1) (Python Software Foundation, 2020) to build a semi-
automated (prospective) participant identification program. This program implemented a set of 
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parameters to flag potential users of the target audience using real time social media data. The 
first parameter was that social media posts contained at least one of the following keywords: 
“ibd,” “crohn,” “colitis,” “inflammatory bowel disease,” “ileitis,” and “ileoceceal.” These 
keywords represent either disease categories or the associated umbrella terminology of IBD. This 
parameter was controlled for using API stream features from Tweepy and the Python Reddit API 
Wrapper (PRAW) (Boe, 2020; Roesslein, 2019)—popular Python modules with built-in 
functions for manipulating Twitter- and Reddit-specific features.  
The second parameter was that social media posts contained distress-related content (e.g., 
tweets about the effects of IBD symptoms on stress). For this step, I used the same list of 
keywords from Chapter Three to filter for posts discussing distress in real time. Example 
keywords included “stress,” “unhappy,” and “terrified.” I also included multi-word phrases in 
this filtering process, such as “looking for advice” and “need help.” 
The final parameter was that the social media posts were not published by established 
research organizations or by IBD advocate and support social media accounts. This parameter 
only applied to the data collected from Twitter. To control for these posts, I created a “block” list 
of Twitter usernames from IBD-related research institutions and support/advocate profiles, such 
as “@CrohnsColitisFn” and “@IBDSuperHeroes.” These usernames were filtered out during the 
identification process in real time.  
It should be noted that the purpose of this computational program was to only assist in 
identifying prospective participants for the current study. Human researchers evaluated all social 
media posts collected by the program and made the final determination if a social media post met 
study eligibility, as well as if the user should be contacted for recruitment. I tested the reliability 
of this human classification process on a 2-week pilot sample of 1,907 tweets and 2,268 reddit 
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posts collected from the participant identification program. I combined both data sets and 
randomly extracted 10% of the posts. These posts were reviewed by two researchers familiar 
with this work (myself included). We independently evaluated the posts and categorized each as 
either meeting eligibility criteria for the current study (i.e., posts published by people discussing 
distress-related content about IBD) or not. Intercoder reliability of the categorical results 
between the two researchers was acceptable ([Krippendorff’s coefficient] α = .76; percent 
agreement = 92%) (Freelon, 2010). In total, 22% of posts in the pilot sample were categorized as 
eligible for the study.  
I formally launched the participant identification program in late 2020. Recruitment took 
place on a rolling basis. The program ran continuously for approximately six weeks. Each day, I 
extracted the results of the previous day’s sample of identified Reddit and Twitter posts and 
classified whether the users of those posts were eligible to participate in the Text4IBD 
intervention. For the most part, if social media posts were from users discussing disease-related 
distress, they were categorized as eligible; however, I excluded those who expressed acute 
distress, such as users talking about suicide or other forms of self-harm because the Text4IBD 
program was not designed for those with acute distress. Users who met eligibility were 
individually contacted and sent information about the Text4IBD program via direct messaging 
(for privacy purposes) on their respective social media platform (i.e., Reddit or Twitter). 
Prospective participants interested in the program were instructed to click on a link that directed 




Inclusion criteria for the study were that participants needed to 1) be diagnosed with 
some form of IBD (e.g., Crohn’s disease, ulcerative colitis), 2) be living in the US, and 3) have a 
smartphone that could receive text messages. These criteria were assessed in the screener survey. 
 Those who passed the above criteria were then directed to fill out a 6-item measure of 
IBD-related distress (also used for screening purposes). The specific items used in the distress 
scale are discussed in the measures section below in greater detail. Briefly, the measure 
evaluated participants’ distress toward their perceptions of IBD-related support, disease self-
management ability, and psychological health (e.g., depression) over the past two weeks. 
Responses to IBD-related distress items were on a 5-point scale ranging from “not at all” (1) to 
“a great deal” (5). The scores of the six items were averaged together by the online survey 
platform (i.e., Qualtrics) and to qualify for the study, participants needed to score above a mean 
of 2 (“a little”) out of 5 on the scale. In other words, if prospective participants reported 
experiencing slightly more than “a little” amount of IBD-related distress over the past two 
weeks, they were eligible to participate. Reliability of the distress scale among those who 
completed this portion of the screener survey was acceptable ([Cronbach’s coefficient] α = .85).  
After passing all screening criteria, those still interested in participating were asked to 
provide informed consent and then immediately continued on to the pretest survey. In total, 207 
people were screened for eligibility. Of those, 114 ultimately enrolled in the Text4IBD program. 
One participant was removed from the study due to the Text4IBD program not being able to send 
messages to the phone number that was provided part way through the intervention. In addition, 
eight participants were lost to posttest. This attrition resulted in a total of 105 participants 
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completing the study. See Figure 5 for a flow diagram of the study recruitment, enrollment, and 
retention process.  
 






Once enrolled, the Text4IBD program sent daily support messages to participants’ 
smartphones for two weeks. The specific topics of these messages varied, but generally fell 
under the following three IBD self-management categories, which I refer to as message domains: 
1) physical IBD symptoms, 2) IBD and mental health, and 3) IBD and nutrition. The first and 
N=207 participants assessed for 
eligibility (Reddit: n=166; Twitter: 
n=40)
n=114 enrolled in intervention 
(Reddit: n=83; Twitter: n=31)
n=113 eligible for posttest
n=105 included in posttest 
analyses
n=93 ineligible to participate
• n=62 not in the US
• n=22 “very little” distress at 
baseline
• n=3 not in the US and under the 
age of 18
• n=3 did not provide informed 
consent
• n=2 under the age of 18
• n=1 did not have smartphone
n=1 removed during intervention
n=8 lost to posttest
 
 91 
second domains each contained five different support messages, and the third domain contained 
four different support messages, thus totaling 14 unique messages.  
The design of these support messages is discussed in detail in Chapter 4. Briefly, support 
messages were constructed in two parts (i.e., a message pair). The purpose of the first part was to 
acknowledge and validate an aspect of disease self-management that some people with IBD may 
struggle with. The purpose of the second message was to offer advice directly addressing the 
struggle noted in the first message. This two-part approach sought to maximize perceptions of 
support by first validating what someone with IBD may be going through, and then providing 
educational information and supportive advice on the matter. For clarity, I refer to each message 
pair as a singular “support message.”  
The text of the support messages was designed to target different theoretical constructs 
and mechanisms associated with IBD-related self-management and distress, including self-
efficacy, outcome expectations, perceived IBD support, and use of coping strategies (Figure 4). 
For example, one message provided support about IBD-related anxiety and offered information 
about how to integrate easy relaxation exercises as a strategy to improve mental health. The 
specific advice being offered by the support messages was informed by publicly available 
content from IBD research organizations, such as the Crohn’s & Colitis Foundation (n.d.) in the 
US and Crohn’s and Colitis Canada (n.d.). This ensured that the advice was based on scientific 
and expert opinion by experienced IBD researchers.  
Several of the messages also contained web links to external online resources from the 
same foundations. The purpose of these resources was to provide additional information about a 
given topic beyond what was included in the text messages themselves. Links to these external 
resources were in the form of a customized bit.ly URL attached at the end of the second message 
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in the message pair (e.g., “For more information about this topic, check out this link: [resource 
URL here]”). All of the support messages were reviewed by a gastroenterologist familiar with 
this research and were also evaluated by people with IBD in a pilot test prior to launching this 
intervention. See Appendix G for the entire pool of support messages used by the Text4IBD 
program (as well as the links to the external resources included in some of these messages). 
Support messages were sent to participants’ phones at their preferred time of day, in 15-
minute intervals, which they provided during the pretest survey. The order that participants 
received the 14 support messages was on a partially static schedule. That is, participants first 
received the five support messages from the physical IBD symptoms domain, followed by the 
five support messages from the IBD and mental health domain, and finally the four support 
messages from the IBD and nutrition domain; however, the order that participants received the 
support messages in each self-management domain was randomized. See Figure 6 for the text 
messaging schedule used by the Text4IBD program. 
Participants who reported currently taking daily oral medication to treat their IBD were 
also sent a medication reminder message once per day for the duration of the intervention. This 
message stated, “REMINDER: Be sure to take your IBD medication today.” Similar to the 
support messages, participants indicated a preferred time (also in 15-minute intervals) that they 
wanted to receive their reminder message. Participants could choose to receive (or not receive) 
the reminder message at the same time as the support messages each day. See Figure 7 for an 
example daily support message and medication reminder message sent by the Text4IBD 
program.  
I used Twilio (Lawson & Wolthius, 2020) to send participants the text messages during 
the intervention. Twilio is a popular communications platform that specializes in a variety of 
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media services (Iribarren et al., 2017). Twilio has been used in several research applications, 
including other chronic disease text messaging interventions (Haas, Martin, & Park, 2017; 
Osborn & Mulvaney, 2013; Polgreen et al., 2018). In addition to its low costs (less than one cent 
for most domestic text message sent), a major benefit of using Twilio is that it provides 
developers access to their API, which allowed me to integrate their text messaging services 













































































































































































































































































































































































































































































































The primary outcome for this study was IBD-related distress. Secondary outcomes were 
self-efficacy, perceived IBD support, outcome expectations, use of adaptive and maladaptive 
coping strategies, and medication adherence. These outcomes were assessed at screener/pretest 
and posttest. I also assessed intervention feasibility, acceptability, and engagement at posttest. 
Finally, I assessed perceived IBD stigma, and participants’ IBD characteristics and 
demographics to characterize who participated in the study. These variables were assessed at 
screener/pretest. Questionnaires for the screener, pretest, and posttest surveys are in Appendix H.  
IBD-related distress. IBD-related distress was assessed using six items adapted from the 
short-form version of the diabetes distress scale (Liu et al., 2020; Polonsky et al., 2005). The 
scale begins with the stem, “During the past two weeks, how much have you… ” Scale items 
were: 1) felt overwhelmed with the demands of living with IBD, 2) felt that you are often failing 
with your IBD routine, 3) felt discouraged to keep up with managing your IBD, 4) felt angry, 
scared, and/or depressed when thinking about living with IBD, 5) felt that your friends or family 
don’t appreciate how difficult living with IBD can be, and 6) felt that your friends or family 
don’t give you the emotional support that you would like. Responses to IBD-related distress 
were on a 5-point scale ranging from “not at all” (1) to “a great deal” (5). Reliability of the scale 
was acceptable (pretest: α = .72; posttest: α = .78). 
Self-efficacy. Self-efficacy was assessed using an adapted version of the Inflammatory 
Bowel Disease Self-Efficacy Scale (IBD-SES) (Keefer et al., 2011). To date, the scale has been 
applied in several IBD randomized controlled trials and evaluation studies and has high internal 
consistency (de Jong, van der Meulen-de Jong, Romberg-Camps, Degens, et al., 2017; Graff et 
al., 2016; Taft et al., 2013). The current study uses the following four adapted subscales from the 
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IBD-SES: 1) managing stress and emotions, 2) managing medication (referred to as “managing 
medical care” in the original scale), 3) managing symptoms, and 4) maintaining remission. All 
subscales were comprised of three items except for the “maintaining remission” subscale which 
contained 5 items. Self-efficacy subscales began with the stem, “In the past two weeks, how 
confident were you in your ability to…” Example items for each subscale were, “keep from 
getting discouraged,” “take medication at instructed times,” “reduce symptoms,” and “manage 
your disease,” respectively. Only participants who reported taking daily oral medication to treat 
their IBD were asked to answer the “managing medication” self-efficacy items. Responses to 
self-efficacy items were on an 11-point scale ranging from “not at all confident” (0) to “totally 
confident” (10). Reliability of the subscales were all acceptable (pretest: α range = .78 – .94; 
posttest: α range = .79 – .87).  
Perceived IBD support. Perceived IBD support was assessed using a single item 
developed for the current study. The item read, “When it comes to your IBD, how much support 
in general do you feel you have?” Responses to this item were on a 5-point scale ranging from 
“none” (1) to “a great deal” (5).  
Outcome expectations. Outcome expectations were assessed using four items developed 
for the current study. Scale items were: 1) if I actively monitor my IBD, it would reduce my IBD 
symptoms, 2) if I take care of my mental health, it would reduce my IBD symptoms, 3) if I watch 
my diet, it would reduce my IBD symptoms, and 4) if I manage my stress, it would reduce my 
IBD symptoms. Responses to outcome expectation items were on a 5-point scale ranging from 
“definitely wouldn’t” (1) to “definitely would” (5). Reliability of the scale was acceptable 
(pretest: α = .78; posttest: α = .84). 
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Coping strategies. I assessed five different coping strategies, all of which were single 
item questions adapted from the IBD-COPE instrument (A. M. McCombie et al., 2016). The 
instrument consists of two subscales: “good” and “bad” coping strategies, which I refer to as 
“adaptive” and “maladaptive” respectively in this study. All coping items began with the stem, 
“In the past two weeks, how much have you…” Adaptive coping items were: 1) used relaxation 
techniques to help with your stress, 2) altered your diet in an attempt to improve your IBD, and 
3) tried to think positively about your IBD (e.g., “it makes me a stronger person”). Maladaptive 
coping items were: 1) laid awake worrying about your IBD, and 2) blamed yourself for making 
your IBD worse. All coping items were measured on a 5-point scale ranging from “not at all” (1) 
to “a great deal” (5).  
IBD medication use and adherence. Participants were asked if they were currently taking 
daily oral medication to treat their IBD symptoms or for IBD maintenance. Those who 
responded “yes” to this question were then evaluated on their medication adherence. Adherence 
was assessed using the 5-item Medication Adherence Report Scale (MARS-5) (Chan, Horne, 
Hankins, & Chisari, 2020). The scale began with the stem, “Regarding taking your IBD 
medication over the past 2 weeks…” Scale items were: 1) alter the dose, 2) forget to take it, 3) 
stop taking it for a while, 4) decide to miss out on a dose, and 5) take less than instructed. 
Responses to adherence were on a 5-point scale ranging from “never” (1) to “very often” (5). I 
reverse-coded the scale so that higher values indicated greater adherence. Descriptive evaluation 
of the scale indicated most participants reported being completely adherent (i.e., score of 5 out of 
5) to most of the five items. Responses to item 2 (i.e., “forget to take it”), however, had the most 
variability among the scale so I used that single item as an indicator of medication adherence for 
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all relevant analyses in the current study. In addition, because the single adherence item 
exhibited skew, I dichotomized the variable (completely adherent vs not completely adherent).   
Intervention feasibility. Participants were asked how difficult or easy they found 
participating in the study to be, whether they would enroll in the study again, and if they would 
recommend the study to someone else with IBD. These items were each assessed on 5-point 
scales with a neutral middle point (e.g., “very difficult” to “very easy”, “definitely wouldn’t” to 
“definitely would”). Regarding the text messaging component of the intervention, participants 
were asked what they thought of the frequency of messages they received during the study (with 
response options being “too little,” “about right,” or “too much”) and how many of those 
messages they read (5-point scale ranging from “none” to “all of them”).  
Intervention acceptability. Participants were asked about their overall satisfaction with 
the content of the messages in the Text4IBD program (5-point scale ranging from “not at all” to 
“extremely”). Those who were currently taking daily oral medication were also asked how useful 
they thought the daily medication reminder text messages were (5-point scale ranging from “not 
at all” to “extremely”). Participants were also assessed on their attitudes toward the Text4IBD 
program. Attitudes were assessed using a 4-item scale developed for this study. The scale began 
with the prompt, “Overall, would you say participating in this study was…” Responses to 
attitude items were on 10-point bipolar scales. Response anchors were 1) not helpful–helpful, 2) 
not informative–informative, 3) not supportive–supportive, and 4) not useful–useful. Reliability 
of the scale was acceptable (α = .94). Finally, participants were asked what they liked about the 
content of the messages they received, what could improve the message content, if there were 
any message topics they felt were missing, and if there was anything else they wanted to say 
about the study. Responses to these questions were open-ended.  
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Intervention engagement. I assessed both message resource use and aided message topic 
recall as measures of intervention engagement. This was in lieu of evaluating engagement based 
on if participants opened and read the messages on their phones since it was not possible to 
collect these data through the Twilio text messaging API. Message resource use was assessed by 
asking participants to select (all that apply) the links that they clicked on during the Text4IBD 
program. Resources in this list were: 1) MyGut, 2) IBD nutrition and what to eat, 3) coping 
strategies to improve mental health, 4) special IBD diets, 5) COVID-19 and mental health, 6) 
online IBD communities, and 7) IBD expert Q&A. Aided message topic recall was assessed by 
asking participants to select (all that apply) the topics that they remember being messaged about 
from the Text4IBD program. This question included seven broad message topics that were part 
of the program. These seven topics were: 1) IBD and mental health, 2) IBD nutrition, 3) IBD 
diets, 4) IBD management, 5) exercise and stress, 6) IBD symptom tracking, and 7) food 
journaling. In addition, there were three message topics that were not part of the Text4IBD 
program (foil topics) that participants could also choose. These foil message topics were: 1) IBS 
vs IBD symptoms, 2) IBD procedures, and 3) IBD and ostomies. Participants could also choose 
that they did not recall seeing any of the above message topics.  
Perceived IBD stigma. Perceived IBD stigma was assessed using an adapted version of 
the 10-item Inflammatory Bowel Disease Perceived Stigma Scale (IBD-PSS). The scale was 
initially developed for individuals with irritable bowel syndrome (Jones et al., 2009) but has 
since been modified for research investigating those with IBD (Taft et al., 2011; Taft et al., 
2009). Participants answered perceived stigma items independently for their family members, 
friends, and significant other (if applicable). For each of those groups of people, perceived 
stigma was assessed using the following items: 1) my IBD symptoms are not taken seriously by 
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my [friends/family/significant other], 2) I keep my IBD symptoms hidden from these people 
because they will treat me differently: [friends/family/significant other], and 3) I do not feel I can 
be as open about my IBD symptoms as I’d like to be with my [friends/family/significant other]. 
Responses to perceived stigma items were on a 5-point scale ranging from “strongly disagree” 
(1) to “strongly agree” (5). Reliability of each subscale was acceptable (family: α = .71; friends: 
α = .74; significant other α = .73).  
IBD characteristics. Participants were asked what type of IBD they had (ulcerative 
colitis, Crohn’s disease, indeterminate colitis, or other), what age they were diagnosed with IBD, 
whether they currently had an ostomy, and whether they have a gastrointestinal specialist who 
helps treat their IBD. Those who did have a specialist were also asked how many times they had 
seen this specialist over the past year, with responses ranging from “never” to “five or more 
times.” Finally, participants answered questions about their IBD activity. IBD activity was 
assessed using the Manitoba IBD Index (Clara et al., 2009), which consisted of a single item that 
asked participants to rate their IBD activity over the past six months. Responses to this item were 
on a 6-point scale ranging from “I was well in the past 6 months, what I consider a remission or 
absence of symptoms” (1) to “constantly active, giving me symptoms every day” (6).  
Demographics. I assessed participant age, gender, race, Hispanic ethnicity, highest level 
of educational attainment, household income level, and gay, lesbian, or bisexual status.  
Study procedure  
In total, this study featured a 16-day intervention. Participants first completed the 
screener and pretest surveys (day 0) and were then enrolled in the Text4IBD program. After 
enrollment (day 1), participants received a two-part message welcoming them to the study. The 
messages read:  
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Message 1: Hi, [name of participant here]. Welcome to the Text4IBD program! For the 
next 2 weeks starting tomorrow, you will receive daily text messages from us. The 
purpose of these messages is to provide support about managing IBD. 
Message 2: Please note that this phone number is not actively monitored. If you have a 
medical question about IBD, please contact your doctor.  
 
Next (day 2), participants received IBD support messages each day via text message for 14 days. 
Finally, participants received one last text message (day 16) informing them that the Text4IBD 
program was complete and that they should receive an email containing a link to take a final 
survey within 24 hours. See Figure 8 for a timeline of the study procedures.  
Participants were eligible to earn up to $40 in the form of an Amazon gift card for 
participating in the study ($20 for completing the pretest survey and $20 for completing the 
posttest survey). The University of North Carolina at Chapel Hill Institutional Review Board 





















































































































































































































































































































































I used descriptive statistics to characterize participant demographics, IBD characteristics, 
and perceived IBD stigma. I assessed correlates of IBD-related distress among secondary 
outcomes using zero-order correlation analyses. All correlation tests were computed using data 
from the pretest survey only. I used paired samples t-tests to examine changes to primary and 
secondary study outcomes from pretest to posttest. Only participants who completed both 
surveys were included in this analysis. I calculated effect sizes for all paired sample comparisons 
using Cohen’s d. Based on common convention, I interpret effect sizes of d = 0.2 as small, d = 
0.5 as medium, and d = 0.8 or greater as large.  
I independently evaluated the associations between posttest secondary outcomes 
(excluding medication adherence and managing medication self-efficacy variables due to sample 
size restrictions) and participants’ posttest IBD-related distress using linear regression. 
Regression models were multivariable, controlling for pretest IBD-related distress, and the 
corresponding pretest independent predictor evaluated in the model. For example:  
Y (posttest distress) = β0 + β1X1 (pretest distress) + β2X2 (pretest predictor) + β3X3 (posttest predictor)   
 
I also computed the unique variance explained for each of the secondary outcome multivariable 
models. I did this by calculating the total variance explained (i.e., R2) from regressing pretest 
IBD-related distress on posttest distress, and the change in this variance explained when 
predictors (i.e., pretest and posttest secondary outcome variables) were included in the model 
(i.e., ΔR2). 
In addition, I tested the association of gender, age, number of years since IBD diagnosis, 
and disease activity with posttest IBD-related distress. I chose not to analyze differences in type 
of IBD diagnosis (e.g., Crohn’s disease vs ulcerative colitis) due to disproportionate sample 
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sizes. Gender (male vs female [reference category]) was treated as a dichotomous variable, and 
age, number of years since IBD diagnosis, and disease activity were treated as continuous 
variables. These analyses were computed using the same multivariable regression analysis 
described above (i.e., controlling for pretest IBD-related distress).  
I used descriptive statistics to assess feasibility, acceptability, and engagement toward the 
Text4IBD intervention. The variables ease of participation, would participate in the study again, 
would recommend the study to someone else with IBD, message frequency, usefulness of the 
medication reminder, message content satisfaction, and message resource satisfaction were 
dichotomized for ease of interpretation in categorical analysis. These outcomes were all scored 
on 5-point Likert scales with a neutral middle point (i.e., 3). For each variable, I combined 
participants who reported above the neutral middle point (i.e., scored either a 4 or 5) as 
perceiving that component of the intervention as acceptable/feasible. For the two intervention 
engagement variables (i.e., message resource use, message topic recall), I created composite 
scores of the number of resources/topics participants engaged with. For the aided message topic 
recall variable specifically, I subtracted the number of foil message topics that were selected 
from the composite score. That is, if a participant selected two real message topics and one foil 
topic, the composite aided recall score for this participant would be “2.” Literature on approaches 
to measuring aided message recall have used similar methods (Fisher, Keene, Huskey, & Weber, 
2018). I also assessed the association of the two intervention engagement variables (using the 
composite scores) with posttest IBD-related distress using multivariable regression analysis 
(controlling for pretest IBD-related distress).  
Lastly, I used qualitative analysis to examine participants’ open-ended responses about 
what they liked and disliked about the Text4IBD program as a whole, as well as about what 
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could be improved in future iterations of the program. All statistical analyses were computed 
using R (version 3.6.2) (R Core Team, 2019). 
Results 
Participant demographics and IBD characteristics at pretest 
Mean age of participants was 29 and ages ranged from 19-53 (Table 8). Most were 
female (60%), White (83%), and approximately 9% identified as Hispanic. A little over one-third 
(39%) of participants identified as gay, lesbian, or bisexual. A little less than half (46%) of 
participants had a bachelor’s degree or higher. Finally, household income over the past year 
varied, with 46% of participants making less than $50,000, 35% making between $50,000-




Table 8. Demographic characteristics of the Text4IBD study sample at pretest; N = 114. 
 n (%) or M ± SD 
Age 29.11 ± 7.28 
[age range] [19-53] 
Gender  
Female 68 (60%) 
Male 36 (31%) 
Other/prefer not to say 10 (9%) 
Race  
White 95 (83%) 
African American 2 (2%) 
Asian 2 (2%) 
Other/more than one race 15 (13%) 
Hispanic 10 (9%) 
Gay, lesbian, or bisexual 44 (39%) 
Education  
High school or less 12 (11%) 
Some college or associate’s degree 50 (43%) 
Bachelor’s degree 40 (35%) 
Graduate or professional degree 12 (11%) 
Household income, annual  
$0–$29,999 30 (26%) 
$30,000–$49,999 23 (20%) 
$50,000–$79,999 24 (21%) 
$80,000–$99,999 16 (14%) 
$100,000+ 19 (17%) 
No response 2 (2%) 
Note. n = sample size; M = mean; SD = standard deviation.  
 
 
Most participants were diagnosed with either Crohn’s disease (73%; Table 9) or 
ulcerative colitis (19%); though, a small proportion reported being diagnosed with a different 
type of IBD, such as lymphocytic colitis or collagenous colitis. The mean age at IBD diagnosis 
was 22, and about half (52%) of participants had been living with IBD for five years or fewer. 
Thirty-two percent of participants reported being in disease remission over the past six months, 
while only 7% reported experiencing IBD symptoms often or constantly in that same time 
period. Only 6% of participants had some type of ostomy (e.g., ileostomy, colostomy). Most 
reported currently taking some form of daily oral medication to treat or maintain their IBD 
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symptoms and of those people, about half (56%) reported complete medication adherence. Most 
participants (95%) had a gastrointestinal specialist who helped treat their IBD. Only 55% of 
participants reported knowing someone else who had IBD. Finally, perceived IBD-related stigma 
was relatively low from significant others (M = 1.93, SD = 1.06), and was modest from family 
members (M = 2.62, SD = 1.19) and friends (M = 2.68, SD = 1.17).  
 
Table 9. IBD characteristics of the Text4IBD study sample at pretest; N = 114. 
 n (%) or M ± SD 
IBD type  
Crohn’s disease 83 (73%) 
Ulcerative colitis 22 (19%) 
Other 9 (8%) 
Age at diagnosis 22.32 ± 8.32 
Years since diagnosis 6.80 ± 6.44 
One year or fewer 31 (27%) 
Between two and five years 28 (25%) 
More than five years 55 (48%) 
IBD activity1 4.68 ± 1.28 
Remission 36 (32%) 
Rarely active 34 (30%) 
Occasionally active 27 (24%) 
Sometimes active 8 (7%) 
Often active 6 (5%) 
Constantly active 3 (2%) 
Has ostomy  7 (6%) 
Takes daily oral IBD medication 73 (64%) 
Complete adherence2 41 (56%) 
Has a GI specialist  108 (95%) 
Times seen GI specialist last year  
Never 6 (6%) 
1-2 times 34 (31%) 
3-4 times 37 (34%) 
5 or more times 31 (29%) 
Knows someone else with IBD 63 (55%) 
Perceived IBD stigma  
Significant other  1.93 ± 1.06 
Family 2.62 ± 1.19 
Friends 2.68 ± 1.17 
Note. n = sample size; M = mean; SD = standard deviation; 1IBD activity based on the Manitoba 
index where higher values indicate worse disease activity; 2only assessed among people who 
currently take daily oral IBD medication. 
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Correlates of IBD-related distress at pretest 
IBD-related distress was negatively associated with managing stress and emotions self-
efficacy (r = -.37, p < .001; Table 10), maintaining remission self-efficacy (r = -.42, p < .001), 
managing symptoms self-efficacy (r = -.40, p < .001), and perceived IBD support (r = -.26, p < 
.001), as expected. In addition, IBD-related distress was positively associated with worrying 
about IBD symptoms (r = .42, p < .001) and blaming oneself for making IBD symptoms worse (r 
= .36, p < .001) maladaptive coping strategies, as expected. By contrast, IBD-related distress was 
positively associated with the altering diet to improve IBD symptoms coping strategy (r = .48, p 
< .001). Finally, IBD-related distress was not associated with outcome expectations (r = .00, p < 
.978), managing medication self-efficacy (r = -.05, p = .688), or the use of relaxation exercises (r 
= .14, p = .125) or positive thinking (r =.16, p = .098) adaptive coping strategies. Zero-order 













































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Differences between pretest and posttest outcomes 
Mean differences between pretest and posttest primary and secondary outcomes are in 
Table 11. For the primary outcome, participants at posttest reported lower IBD-related distress 
compared to pretest (M = 3.33 vs M = 2.86; p < .001). This change constitutes a medium-to-large 
effect size (d = .77) and supports H1. Scores for most secondary outcomes also significantly 
improved at posttest. Compared to pretest, participants at posttest reported increases in managing 
stress and emotions self-efficacy (M = 5.19 vs M = 6.45; p < .001), maintaining remission self-
efficacy (M = 4.94 vs M = 6.39; p < .001), managing symptoms self-efficacy (M = 4.21 vs M = 
5.53; p < .001), perceived IBD support (M = 2.89 vs M = 3.26; p < .001), and finally outcome 
expectations (M = 3.43 vs M = 3.80; p < .001). Changes to these outcomes also exhibited 
medium-to-large effect sizes (d range = .47 – .75). These results partially support H2a-c. 
Pretest-posttest changes to the use of adaptive and maladaptive coping strategies were 
variable. Compared to pretest, participants at posttest reported minor increases in their use of 
relaxation (M = 2.63 vs M = 2.93; p = .009; Table 11) and positive thinking (M = 2.47 vs M = 
2.69; p = .033) coping strategies. By contrast, participants at posttest reported worse scores for 
the altering diet to improve IBD symptoms coping strategy compared to pretest (M = 3.44 vs M 
= 3.18; p = .024). Changes for the adaptive coping strategy outcomes exhibited small effect sizes 
(d range = -.21 – .26). For maladaptive coping strategy outcomes, participants at posttest 
reported lower scores (i.e., improvements) for both lying awake worrying about their IBD (M = 
2.86 vs M = 2.39; p < .001) and blaming themselves for making their IBD symptoms worse (M = 
3.10 vs M = 2.66; p < .001) compared to pretest. Changes for the maladaptive coping strategy 
outcomes exhibited low-to-medium effect sizes (worry: d = .47; blame self: d = .40). These 
results lend partial support to H2d.  
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Finally, compared to pretest, participants currently taking daily oral medication for their 
IBD saw no improvements to their medication adherence (59% vs 66%; p = .453; Table 11) or to 
their managing medication self-efficacy (M = 9.32 vs M = 9.66; p = .487) at posttest. These 
findings fail to support H2e and partially reject H2a. 
 
Table 11. Pretest-posttest differences among study outcomes. 
 Pretest 
M ± SD 
Posttest 





IBD-related distress 3.33 ± .68 2.86 ± .73 <.001 .77 
Self-efficacy     
Maintaining remission 4.94 ± 1.94 6.39 ± 1.97 <.001 .75 
Stress/emotion management 5.19 ± 1.85 6.45 ± 1.76 <.001 .69 
Symptoms management 4.21 ± 1.96 5.53 ± 2.09 <.001 .58 
Medication management1 9.32 ± 2.23 9.66 ± 1.64 .487 .09 
Outcome expectations 3.43 ± .87 3.80 ± .88 <.001 .55 
Perceived IBD support 2.89 ± .92 3.26 ± .93 <.001 .47 
Adaptive coping strategies     
Use of relaxation techniques 2.63 ± 1.12 2.93 ± 1.07 .009 .26 
Think positively about IBD 2.47 ± 1.24 2.69 ± 1.14 .033 .21 
Alter diet to improve IBD 3.44 ± 1.26 3.18 ± 1.09 .024 -.22 
Maladaptive coping strategies     
Worry about symptoms  2.86 ± 1.17 2.39 ± 1.02 <.001 .41 
Blame self for worsening IBD  3.10 ± 1.31 2.66 ± 1.12 <.001 .40 
Complete medication adherence1 36 (59%) 40 (66%) .453 – 
Note. M = mean; SD = standard deviation; p = significance value; d = Cohen’s effect size 
estimate; 1variable only applies to participants who reported taking daily oral IBD medication at 
both pretest and posttest (n = 61). 
 
 
Associations with posttest IBD-related distress 
 Associations of most posttest secondary outcomes with posttest IBD-related distress are 
in Table 12. Results show that the maintaining remission (β = -.48, p < .001), stress and emotion 
management (β = -.39, p < .001), and symptoms management (β = -.32, p < .001) self-efficacy 
outcomes were negatively associated with IBD-related distress. These predictors explained 
approximately 18%, 17%, and 11% of variation in posttest IBD-related distress in their 
corresponding models, respectively (all ps < .001). Results also show that outcome expectations 
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(β = -.23, p = .025) and perceived IBD support (β = -.24, p = .013) were negatively associated 
with IBD-related distress. These two predictors explained approximately 8% (p = .001) and 5% 
(p = .017) of variation in posttest IBD-related distress, respectively. Finally, only the lying awake 
worrying about IBD symptoms maladaptive coping strategy was positively associated with IBD-
related distress (β = .34, p < .001), which explained approximately 8% of variation in the model 
(p <.001). No other coping strategy was significantly associated with IBD-related distress at 
posttest. These findings answer RQ1.  
 
Table 12. Associations between secondary outcomes and IBD-related distress at posttest. 
 Coefficient statistics  Model statistics 
 β SE p  ΔR2 p 
Self-efficacy       
Maintaining remission -.48 .03 <.001  .18 <.001 
Stress/emotion management -.39 .03 <.001  .17 <.001 
Symptoms management -.32 .03 <.001  .11 <.001 
Outcome expectations -.23 .09 .025  .08 .001 
Perceived IBD support -.24 .08 .013  .05 .017 
Adaptive coping strategies       
Use of relaxation techniques  .05 .06 .584  .00 .786 
Think positively about IBD -.10 .06 .297  .01 .578 
Alter diet to improve IBD  .04 .06 .669  .00 .702 
Maladaptive coping strategies       
Worry about symptoms  .34 .06 <.001  .08 <.001 
Blame self for worsening IBD  .18 .06 .067  .05 .094 
Note. β = standardized beta coefficient; SE = standard error; p = significance value; each row 
represents a multivariable analysis adjusting for IBD-related distress at pretest and the 
corresponding pretest predictor; ΔR2 = change in variance explained by the model. The ΔR2 
statistic is based on the variation explained solely by pretest IBD-related distress (R2 = .39, p < 
.001).   
  
Effects of individual differences on posttest IBD-related distress (also controlling for 
pretest IBD-related distress) were mixed. Results showed a significant gender effect, with males 
(M = 3.03) averaging higher distress than females (M = 2.79) at posttest (β = .29, p = .015; 
Figure 9). Results also showed a positive association between IBD activity and posttest IBD-
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related distress (β = .25, p = .002). Both age and length of time since IBD diagnosis were not 
significantly associated with posttest IBD-related distress (all ps > .05). These findings answer 
RQ2. 
 

























































Perceptions of Text4IBD: Feasibility, acceptability, and engagement 
 Nearly all (96%; Table 13) participants said it was easy to participate in the study, that 
they would participate again if given the option (93%), and that they would recommend the study 
to other people with IBD (94%). Most (86%) thought the message frequency during the 
intervention was about right and 91% reported reading all or a lot of the messages. Of those who 
received daily medication reminder messages, only 57% thought they were useful. In addition, 
overall attitudes toward the Text4IBD program were positive (M = 8.03) and most participants 
(71%) were either “very” or “extremely” satisfied with the content of the support messages. 
These findings support H3a and H3b.  
 Eighty-three participants (79%; Table 13) who took the posttest assessment accessed at 
least one resource included in the Text4IBD messages. Of those, most (63%) found the resources 
to be “very” or “extremely” useful. Participants reported that their most utilized resources were 
MyGut (IBD self-management mobile application) (43%), IBD nutrition and what to eat (43%), 
coping strategies to improve mental health (39%), special IBD diets (37%), and COVID-19 & 
mental health (36%). The resources about online IBD communities and the IBD expert Q&A 




Table 13. Text4IBD feasibility, acceptability, and engagement. 
 n (%) or M ± SD 
Easy to participate 101 (96%) 
Would participate again 98 (93%) 
Would recommend to others with IBD 99 (94%) 
Message frequency about right 90 (86%) 
Medication reminder useful1 37 (57%) 
Number of messages read  
All of them 76 (72%) 
A lot 20 (19%) 
Some 8 (8%) 
Very few 1 (1%) 
Overall attitude toward the intervention 8.03 ± 2.04 
Helpful 7.88 ± 2.29 
Informative 7.99 ± 2.24 
Supportive 8.33 ± 2.05 
Useful 7.91 ± 2.34 
Satisfied with message content 75 (71%) 
Satisfied with message resources2 52 (63%) 
Used at least one message resource 83 (79%) 
Message resources accessed2,3  
MyGut 45 (43%) 
IBD nutrition and what to eat 45 (43%) 
Coping strategies to improve mental health 41 (39%) 
Special IBD diets 39 (37%) 
COVID-19 & mental health 38 (36%) 
Online IBD community 32 (30%) 
IBD expert Q&A 24 (23%) 
Did not click any resource/no response 22 (41%) 
Note. n = sample size; M = mean; SD = standard deviation; 1only answered by people currently 
taking daily oral medication (n = 65); 2only answered by those who reported accessing on at least 
one message resource (n = 83); 3variable not mutually exclusive. 
 
 
Almost all participants (98%; Figure 10) reported recalling at least one of the various 
Text4IBD message topics sent during the intervention. The most recalled message topic was 
about IBD and mental health (80%), followed by IBD and nutrition (77%), IBD diets, (76%), 
and IBD management (71%). The least recalled message topics were about IBD symptom 
tracking (55%) and food journaling (52%). A modest percentage (18%) of participants reported 









































































































































































































Lastly, the number of message topics that participants recalled during the intervention 
was negatively associated with posttest IBD-related distress (β = -.16, p = .041). By contrast, the 
total number of message resources accessed (p = .052) was not associated with posttest IBD-
related distress. These findings answer RQ3. 
Open-ended feedback about Text4IBD 
In open-ended responses, participants stated that they liked the positive tone and 2-part 
structure of the text messages (i.e., validating and advising messages). Many described the 
messages sent by the Text4IBD program as “uplifting,” “easy to understand,” and “supportive.” 
More specifically, one participant stated about the program, “It was thoroughly enjoyable and 
beneficial to feel like I had support that was unwavering and consistent. It was nice to feel like 
someone cares and is there for me.” Participants also expressed their satisfaction with the 
external resources and IBD self-management suggestions offered by some of the Text4IBD 
support messages. For example, one participant noted, “I liked the links sent as I have never 
come across those pages before, so that was helpful to find new sites.” Finally, participants 
expressed that they liked having the ability to choose what time of day to receive the messages as 
opposed to them being sent at a standardized time.  
Participant feedback about how to improve the messages and the overall Text4IBD 
program varied. Some participants suggested future iterations of the program include 
customizable features, such as being able to choose how many messages and what message 
topics to receive. For example, one participant stated, “It would be nice if we could specifically 
choose which topics are important to us as individuals since IBD can be different for everyone.” 
Others stated that the messages were broad and provided information they already knew about. 
One participant also suggested including two-way communication (i.e., a monitored text 
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messaging protocol) in future iterations of the program. Message topics that some participants 
thought were missing in the program included IBD and dating, information about the side effects 
of different IBD medications, and how to talk about IBD with people who do not know about or 
understand the disease.  
Discussion 
This study sought to develop and preliminarily evaluate the results of an IBD self-
management eHealth intervention called Text4IBD. Results showed improvements in several 
different health outcomes—including IBD-related distress—from pretest to posttest. Results also 
demonstrate that delivering an IBD support intervention by text message was feasible, and that 
those enrolled in the intervention were receptive to the idea of support messages being sent to 
their smartphones and viewed the Text4IBD program as acceptable. These findings largely 
support my hypotheses and contribute much-needed empirical evidence to the ongoing debate 
about the utility of eHealth in personal IBD healthcare (Bossuyt et al., 2017; Huang et al., 2014; 
Jackson et al., 2016; Kelso & Feagins, 2018; Knowles & Mikocka-Walus, 2014; Rohde et al., 
2021), and suggest that digital technologies, when systematically and theoretically designed, can 
play an important role in the IBD management process.  
One of the primary goals of this study was to test whether a text messaging intervention 
informed by multiple different theoretical constructs and mechanisms such as self-efficacy and 
coping would be useful in targeting disease-related distress. Compared to pretest, participants 
who completed the Text4IBD program reported lower disease-related distress at posttest. Results 
also showed improvements in the use of adaptive coping strategies from pretest to posttest, as 
well as decreases in the use of maladaptive coping strategies. These findings speak to the utility 
of the theoretical framework developed for this study and support implementation of similar 
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models in future disease self-management interventions among this population. This is especially 
important given the serious threat that disease-related distress poses to IBD health (Edman et al., 
2017; Graff, Walker, & Bernstein, 2009; Nahon et al., 2012; Porcelli et al., 1994; Reigada et al., 
2015; Tabibian et al., 2015).  
Participants enrolled in the Text4IBD program also reported pre-to-post improvements in 
other outcomes targeted by the intervention, such as self-efficacy constructs (e.g., emotion 
management) and outcome expectations, as well as perceptions of IBD support. These results 
underscore the complementary nature of different health behavior and chronic disease self-
management theories and mechanisms when situated in a unifying framework, and provide 
empirical support for the use of multi-perspective intervention designs when targeting 
psychosocial health outcomes among people with IBD.  
Collectively, pre-to-post findings on the theoretical constructs indicate that participants, 
became more confident in their ability to self-manage certain aspects of their IBD, reduced some 
of their negative expectations associated with self-managing symptoms, and felt more supported 
about their IBD. In addition, participants’ use of adaptive coping strategies improved from 
pretest to posttest. These were all key target areas of the Text4IBD support messages and 
therefore may explain why participants reduced their disease-related distress from pretest to 
posttest. 
An important goal of this study was to assess whether people with IBD would be 
receptive to the idea of a support-based text messaging intervention. Results on this front were 
also promising. Nearly all participants evaluated Text4IBD as acceptable across multiple aspects 
of the program, including satisfaction with message content and the number of messages 
received each day. Moreover, attitudes toward Text4IBD typically scored above an 8 out of 10, 
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and almost all participants reported that they would participate in the study again if given the 
opportunity to. Notably, these findings held true regardless of participants’ IBD characteristics, 
such as disease activity. This broad level of acceptability toward the program speaks to how 
valuable offering support to people with chronic disease can be.  
Participants also engaged in the content that was offered by the Text4IBD program. 
Indeed, 79% reported accessing at least one external resource, aided message topic recall was 
high overall, and few participants reported recalling a foil message topic. It was also encouraging 
that increased engagement with the Text4IBD program was negatively associated with IBD-
related distress at posttest. These findings corroborate other eHealth and IBD literature showing 
that people with IBD tend to be receptive to the idea of eHealth interventions for disease self-
management (Con et al., 2017; Del Hoyo et al., 2018; Elkjaer et al., 2010; A. M. McCombie et 
al., 2020; Reich, Canakis, et al., 2019) and that digital technologies can be used for therapeutic 
purposes (Hunt et al., 2020; Hunt et al., 2017; A. McCombie, Gearry, Andrews, Mulder, & 
Mikocka-Walus, 2016). 
This work set out to answer whether participant health characteristics or other 
demographic variables influenced changes to IBD-related distress from pretest to posttest. 
Results showed a small gender effect, with males reporting higher distress at posttest than 
females. Notably, this effect held true even when controlling for pretest IBD-related distress. 
This finding suggests that females with IBD may be more welcoming and receptive to a support-
based intervention than males. In addition, results showed that IBD activity had a positive 
association with IBD-related distress at posttest. This finding is expected though, as increased 
disease activity is likely to result in a number of negative effects on IBD health, and literature 
shows that distress and IBD activity tend to be correlated (Edman et al., 2017; Graff, Walker, & 
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Bernstein, 2009; Kochar et al., 2018; Porcelli et al., 1994; Reigada et al., 2015). No other health 
characteristics—including length of time since IBD diagnosis—were associated with changes in 
IBD-related distress. These null interaction effects suggest that the intervention may be valued 
for the support it provides regardless of whether someone is newly diagnosed with IBD or if 
someone has had the disease for several years. This notion is perhaps illustrated best by an open-
ended evaluation of the Text4IBD program from a participant who has been living with IBD for 
more than six years: 
I don’t have a lot of people in my life that understand the true severity of what it’s been 
like, and on more than two or three of those text messages it led me to pause for a 
moment and remember how to cope. The one [referring to a support message] talking 
about taking extra time in the morning hit home. My previous partners always gave me a 
hard time for how long I would need in the morning before starting my day.  
 
A surprising result of this study was its null findings on medication-related outcomes. In 
contrast with other similar IBD and eHealth research in this area (Miloh et al., 2017; Riaz & 
Nielsen, 2019), participants at posttest showed no improvements to their managing medication 
self-efficacy or their medication adherence compared to pretest. Regarding the self-efficacy 
outcome, this finding is likely explained by the fact that scores of this variable on average were 
high to begin with (i.e., M = 9.32 out of 11). Thus, there was little room for improvement at 
posttest. Medication adherence, on the other hand was modest at pretest (59%) but only 
improved a small degree at posttest (66%). This insignificant change could be due to the fact that 
the medication reminder messages participants received were only sent once per day. This 
messaging frequency can be problematic for people with IBD who are currently taking multiple 
medications at separate times during the day. This circumstance is exemplified by one participant 
who noted in open-ended responses, “I have to take my medication with breakfast, lunch and 
dinner, so the one time per day medication reminder was minimally useful.”  
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It should be stated, however, that these null findings on adherence do not suggest that 
reminder messages about IBD medication serve no role in future IBD interventions. In fact, the 
opposite is the case, as evidence generally shows positive effects on disease self-management 
outcomes in similar interventions among people with chronic disease (Fjeldsoe et al., 2012). 
Instead, future work should improve on the reminder message component of this intervention, 
such as by better tailoring messages to participants’ needs (e.g., frequency that reminders are 
sent each day).    
One last noteworthy finding has to do with changes in the use of the altering diet to 
improve IBD symptoms coping strategy among participants. Compared to pretest, participants 
reported lower likelihood of using this adaptive coping strategy at posttest (i.e., indicating a 
worse heath outcome). There are two plausible explanations for this finding. First, it is likely 
that, prior to exposure to the Text4IBD program, participants experiencing IBD-related distress 
may have already been actively trying to change their diet to reduce symptoms. Thus, after the 
intervention, it is possible that as their disease-related distress decreased, so too did their need to 
alter their diet. The second explanation could be that altering an IBD diet is not a regular disease 
self-management behavior, meaning that once people with IBD have altered their diet to 
satisfactory results, they likely will not continue to modify and experiment with different diet 
options. Regardless, work examining nutrition and eHealth among an IBD population is lacking 
and warrants future investigation. 
  In sum, the Text4IBD program used in this intervention sought to reduce disease-related 
distress and improve other health outcomes among people with IBD through providing support 
messages about IBD self-management. Notably, the text messaging intervention medium was 
low-cost, feasible, and highly acceptable among the study sample. Given that people with IBD 
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are at a high risk of experiencing disease-related distress, the results from this research are 
encouraging and support the future use and development of other digital technologies aimed at 




CHAPTER SIX: DISCUSSION AND CONCLUSION 
This dissertation sought to investigate processes associated with IBD-related distress and 
to test whether emerging eHealth and social media tools could be used to better understand and 
improve the health and well-being of people with IBD. In doing so, this research developed and 
preliminarily evaluated the feasibility and acceptability of an IBD self-management support 
intervention called “Text4IBD.” 
Broadly, the findings from this dissertation support the use of digital tools in personal 
IBD healthcare and suggest that these tools can be positively received by individuals among this 
population—particularly those who may be struggling and need support. In addition, the 
interdisciplinary application of social media analysis and eHealth methods used throughout this 
dissertation illustrate that these research areas are not only complementary but can be 
strategically integrated to develop more meaningful and informed chronic disease interventions. 
These findings are critically important to future disease self-management efforts and other 
initiatives aimed at improving IBD health and overall quality of life. Moreover, the high degree 
of participant receptivity toward the Text4IBD program in the Chapter 5 intervention suggests 
similar tools could be developed and tested among populations with other chronic diseases that 
also require active involvement in the disease self-management process, such as HIV/AIDS and 
diabetes. 
The remainder of this chapter is structured as follows: I first provide a brief summary of 
the findings from this dissertation. After, I discuss the scientific contributions of this work and 
detail some of the broader implications that this dissertation poses on IBD research and 
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healthcare. I then discuss the strengths and limitations of the different methods from each of the 
three empirical studies and, before concluding, highlight potential next steps and future research 
opportunities of this dissertation.  
Summary of findings 
In Chapter 2, I comprehensively reviewed literature on factors and effects of distress on 
people with IBD. I also discussed research on chronic disease self-management, and the potential 
role that self-management played in targeting and reducing distress among people with IBD. 
Next, I highlighted a number of key theoretical perspectives that literature suggested were 
important to the disease self-management process, and for understanding and addressing distress 
among people with IBD. Example perspectives included self-efficacy and coping. Drawing from 
these perspectives, I developed an overarching conceptual framework for an IBD self-
management intervention that guided some of the research in this dissertation. This adapted 
framework can be seen in Figure 1. Briefly, it hypothesizes that constructs such as outcome 
expectations and perceived support can modify how individuals with IBD cope with their 
disease. In turn, participants’ use of different coping strategies (i.e., adaptive, maladaptive) affect 
their IBD-related distress. After introducing this framework, I reviewed literature on some of the 
digital tools that have been used for IBD self-management. Results of this review showed that 
social media and eHealth technologies are popular and are often used as therapeutic outlets for 
people with IBD.  
 In Chapter 3, I created and tested a term-based computational dictionary to analyze IBD 
and distress-related discourse on two popular social media platforms—Reddit and Twitter. Social 
media posts from these platforms were characterized based on eight different IBD topics. 
Analyses of over 80,000 public social media posts showed that topics such as IBD symptoms, 
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medication, and nutrition were prominent in discussions of IBD and distress on both platforms. 
By contrast, few posts on Reddit and Twitter discussed the IBD topics ostomy, stigma, and 
intimacy. Lastly, I analyzed the extent of IBD topic co-occurrences among the social media posts 
and found that the IBD topic symptoms served as a central hub facilitating multi-topic posts. This 
finding was similar for both of the social media platforms; however, topic co-occurrences overall 
were far less frequent among posts on Twitter compared to Reddit.   
 Chapter 4 used the findings from the social media analysis to construct a series of support 
messages that covered various IBD self-management topics. The specific text of these messages 
was informed by perspectives from health behavior theory and chronic disease literature, and 
was designed to target and improve areas associated with IBD self-management, such as self-
efficacy, outcome expectations, and the use of coping strategies. The support messages were 
evaluated by people with IBD in a pilot study (N = 44). Results from this study showed that 
participants tended to voice their support for and satisfaction with the messages. In addition, 
findings identified message topics that were favorably evaluated by participants (e.g., messages 
about IBD and mental health), as well as those that were rated as sub-par (e.g., messages about 
the social aspects of IBD management). Ultimately, the feedback left by participants in the study 
was used to improve on and refine the support messages.  
Lastly, Chapter 5 utilized the refined pool of support messages to develop a theoretically 
informed IBD self-management intervention called “Text4IBD.” People with IBD were recruited 
in this single group intervention using social media (via Reddit and Twitter). Those who enrolled 
(N = 114) were sent daily support messages about various IBD self-management topics for two 
weeks, and analyses compared pretest and posttest health outcomes. Outcomes included disease-
related distress, multiple self-efficacy subscales, medication adherence, and perceived IBD 
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support, among others. Results showed that participants improved their IBD-related distress (and 
many other targeted outcomes) from pretest to posttest. In addition, most participants were 
receptive to the intervention and evaluated the Text4IBD program as feasible and acceptable.   
Research contributions and implications 
The collective results of the three empirical studies (Chapters 3-5) in this dissertation 
substantively add to the literature in a number of ways. The first, and perhaps most important, 
contribution of this work is its interdisciplinary application of social media analysis and eHealth 
as complementary methods in the design, recruitment, and dissemination of a health 
communication intervention. As discussed throughout this dissertation, a substantial body of 
literature shows that people with IBD use social media platforms for supportive purposes, and 
that such platforms can influence IBD symptoms and self-management behaviors (Frohlich, 
2016; O'Leary et al., 2020; Reich, Guo, et al., 2019; Zhao et al., 2021). Evidence from other 
literature also supports the use of eHealth applications as useful tools for facilitating IBD self-
management (Jackson et al., 2016; Knowles & Mikocka-Walus, 2014; Rohde et al., 2021). This 
dissertation integrated concepts and methods from both of these literatures into a single scientific 
study and tested whether such technologies could work together in improving our understanding 
of and ability to reduce IBD-related distress.  
Findings from this dissertation support the integration of these emerging research 
methods and technologies. For example, the social media data analyzed in Chapter 3 offered 
insight into some of the key topics associated with IBD and distress discourse on Reddit and 
Twitter. These topics were then used to inform the construction of support messages about IBD 
self-management, which were ultimately evaluated in a pretest-posttest intervention disseminated 
through the Text4IBD eHealth program. Most participants who enrolled in the study were 
 
 129 
receptive to the intervention and perceived the program as acceptable (e.g., 71% of participants 
reported being satisfied with the content of the support messages). This high degree of 
acceptability is encouraging as a recent study showed people with IBD expressed a desire for 
mobile tools that provide education about their disease (S. Khan et al., 2016). Engagement with 
Text4IBD was also high, with a large proportion of participants remembering at least one 
message topic (98%) and using at least one resource (79%). These results show that social media 
data can be used for targeted, prosocial purposes, such as developing digital interventions aimed 
at improving health outcomes among people with chronic disease.  
This dissertation also showed that social media data can complement eHealth 
interventions in recruitment processes. Identifying and recruiting targeted audiences for 
interventions is a critical component of health research. Recruiting targeted participants allows 
investigators to maximize impact by focusing resources on study-relevant audiences (Adams, 
Karlin, Eisenman, Blakley, & Glik, 2017; Boslaugh, Kreuter, Nicholson, & Naleid, 2005; Kelley 
et al., 2016; Slater, 1995). The Chapter 5 intervention used real time social media data to identify 
prospective participants who would likely stand to benefit the most from the Text4IBD program 
(i.e., people with IBD who experienced disease-related distress). Similar methods have been used 
in prior investigations (Deb et al., 2018), but not in the context of recruitment for a chronic 
disease eHealth intervention.  
Over the course of several weeks, I was able to identify and recruit a sizable number (N = 
114) of participants who met eligibility for the Text4IBD intervention. Moreover, approximately 
92% of participants completed the full intervention, including the 2-week posttest assessment. 
These recruitment and retention findings support the notion that social media data can be used to 
not only identify participants who are part of a target audience, but that such methods can also be 
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successful in retaining those participants. This is important because implementing more 
traditional target audience identification and recruitment methods can be cost prohibitive in 
research (Slater, Kelly, & Thackeray, 2006). This is especially true for studies investigating 
small-scale, niche, or otherwise hard to reach audiences, such as in the case of the Text4IBD 
intervention. Thus, the results from this dissertation indicate that social media data could be 
integrated in subsequent eHealth intervention recruitment processes.  
Another important aspect to address is the replicability of the research methods used in 
this dissertation. The social media data analyzed in Chapter 3 were public data and were free to 
collect, and the two social media platforms (i.e., Reddit and Twitter) both currently offer free 
public access to several useful API features, including real time data streaming and collection (at 
least at the time this research was conducted). Moreover, the Text4IBD program utilized text 
messaging as an intervention medium, and the individual messages sent to participants using the 
Twilio platform were highly affordable (approximately one cent per message) (Lawson & 
Wolthius, 2020). The openness and accessibility of this work affords researchers the ability to 
conduct their own investigations at low-cost using similar methods, or to replicate the methods 
used here on other samples. In addition, the highly affordable and accessible methods associated 
with this dissertation research play a small but meaningful role in advancing the science on 
testing the continued feasibility of digital technologies as tools for improving IBD outcomes. 
The results from this dissertation also pose important implications for IBD healthcare. 
First, the social media analyses from Chapter 3 suggest that more work is needed to understand 
distress-related experiences of people with IBD. The computational filter applied in that study 
extracted a sizeable number of social media posts discussing content about distress. Indeed, 40% 
of Reddit posts and 15% of tweets about IBD from the original data set (prior to filtering for 
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distress) met the criterion for this filter. This finding is in line with evidence showing a large 
incidence of distress among people with IBD (Byrne et al., 2017; Neuendorf et al., 2016). 
Notably, the dictionary analysis in the same chapter identified several key IBD topics associated 
with these discussions of distress, such as symptoms, medication, and nutrition.  
Medical providers can use these social media findings to, in part, inform their approaches 
to healthcare. For example, providers should ask their patients if they use social media to talk 
about their IBD, and if they have questions about any of the content or advice they received 
online regarding IBD self-management, such as concerns about handling symptom flare-ups, 
medication side effects, and complex IBD diets. Based on their responses, providers could offer 
medical information and support that best addresses patient concerns. This communication can 
help bridge the patient-provider divide and would benefit patients by ensuring they are receiving 
accurate medical advice.   
Results from the Text4IBD program also have potential implications in helping people 
self-manage their IBD. For example, studies could be integrated in healthcare environments 
where providers offer Text4IBD to their patients. Indeed, several participants in both the Chapter 
4 message evaluation pilot study and the Chapter 5 intervention stated that the content of the 
support messages would be useful for people newly diagnosed with IBD. Though, it is critical 
that when promoting eHealth applications among healthcare environments that efforts are made 
to educate providers and listen to their concerns about the technology for a more seamless 
integration (Stiles-Shields & Keefer, 2015). Failure to do so could result in providers 




Debate about the use of eHealth in IBD self-management has grown in recent years 
(Bossuyt et al., 2017; Fortinsky, Fournier, & Benchimol, 2012; Guo et al., 2016; Kelso & 
Feagins, 2018; Reich, Guo, et al., 2019). In their report, Bossuyt et al. (2017) conclude that 
although eHealth technologies are promising in their ability to help people with IBD self-manage 
their disease, the current scientific evidence is still too nascent and the results of IBD eHealth 
interventions are inconsistent. A recent meta-analysis I conducted partially supports the 
conclusion by Bossuyt et al. (2017) as results showed variable (albeit significant) effects of 
eHealth technologies on health outcomes among IBD populations (Rohde et al., 2021). Although 
this dissertation does not end the debate on the use of digital technologies in IBD healthcare, the 
results from this work speak to the potential value of such tools. That is, that eHealth 
applications—when theoretically informed and systematically developed—can offer valuable 
contributions in understanding some of the physical and psychological adjustments to IBD. 
Going forward, concerns over the use of these digital tools should be placed front and center in 
promoting and advancing this research field, and efforts should be made to ensure that 
technology created for the purposes of IBD self-management have considered the potential for 
unwanted harm.   
Some studies have also highlighted concerns over the quality of IBD information on 
social media platforms (Fortinsky et al., 2012; Mukewar et al., 2013). These concerns are 
warranted as mis- and disinformation pose a major threat to the perceived validity of online 
information. In a content analysis of online videos, Mukewar et al. (2013) concluded that 
YouTube is a poor source of education about the self-management of IBD. Most of the videos 
analyzed in Mukewar’s study depicted IBD in a negative tone. Topics of these videos tended to 
be about failure or poor side effects of medical therapies, and many discussed alternative 
 
 133 
treatments. This content can be damaging as it can cause some people with IBD who watch these 
videos to be skeptical of seeking advice from medical providers about their symptoms. While 
investigating the accuracy of the content discussed throughout the social media data in the 
Chapter 3 analyses was out of the scope of this dissertation, these concerns are important to 
acknowledge for future studies interested in extending this work in growing research areas such 
as online health ethics and informatics.  
In that vein of thought, the ethical implications of this dissertation also require 
discussion. As highlighted by Bossuyt et al. (2017), a chief concern when developing and 
disseminating eHealth technologies for IBD healthcare is patient privacy. This concern becomes 
even more critical when analyzing social media data as it possible to reverse identify users and 
other personal characteristics from social media posts and associated meta-data (e.g., discovering 
geographical locations of users based on IP addresses) (Ayers et al., 2018; Hunter et al., 2018; 
Zook et al., 2017).  
Privacy was placed at the forefront of the methods used throughout this dissertation. To 
assuage concerns linked to privacy and confidentiality, the social media data collected and 
analyzed in Chapter 3 reported no personal identifiable information and the example social 
media posts reported in Table 14 were paraphrased to prevent people from discovering user 
information. Moreover, the personal data collected by the Text4IBD intervention in Chapter 5 
was replaced with non-identifiable markers. This information includes both the phone numbers 
and names provided among those who enrolled in the intervention. Although privacy should 
always be a primary concern in healthcare research, the work in this dissertation shows that 
stringent measures can be implemented to protect user information, privacy, and confidentiality 
without significant risk to scientific rigor. 
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Strengths and limitations 
Strengths of the Chapter 3 empirical study include the use of two big data sets from 
separate social media platforms (Reddit and Twitter), a long data collection period, and robust 
computational procedures applied to the term-based dictionary analysis. A limitation of this 
study is that I was only able to analyze public Reddit and Twitter posts. Because of this, results 
may not reflect how IBD is discussed among users on these platforms who have private 
accounts, which is likely a sizeable number of active social media users. Another limitation has 
to do with the method I used for filtering for distress-related social media posts. Distress is a 
complex phenomenon, and it is possible that the filtering process did not capture all posts related 
to IBD and distress. For example, posts where distress may be implied in subtext (e.g., 
“managing my IBD is just so fun”) may have been missed during the distress filtering step. The 
same limitation can be said for some of the IBD topics in the dictionary analysis, such as stigma 
and intimacy, which are both complex topics and are often paired with context cues that the 
computational dictionary classification method was not equipped to identify. Future studies 
looking to expand on this work might wish to use other methods to filter for distress-related posts 
or to identify complex IBD topics, such as by using a supervised machine learning algorithm and 
training a computer to capture certain nuances in language.  
 Strengths of the Chapter 4 empirical study include the use of social media evidence, 
existing literature, and theory to construct support messages. Another strength is that the 
messages were pilot tested by people with IBD. The primary limitation of this study has to do 
with the sample size. Only 44 individuals participated in the message evaluation pilot study, 
which is not a large representation of the broader population of people with IBD. Moreover, 
because participants were randomized to evaluate support messages in one of four disease self-
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management domains, this resulted in only between eight and 13 participants each evaluating a 
set of five messages. This means that a single person choosing to rate an individual support 
message poorly could have considerable influence on the overall PME score of that particular 
message (or overall domain of messages). While this was designed as a pilot study to test and 
refine the content of the support messages, future work in similar fashion may wish to enroll a 
larger sample of participants. Another limitation is that the messages were only evaluated via an 
online survey platform, and users did not directly interact with the primary investigator or with 
one another. As such, efforts should be made in the future to conduct cognitive testing of the 
support messages in qualitative focus groups or interviews with members of the target audience. 
One last limitation has to do with message relevancy. The support messages were designed to 
reduce disease-related distress among people with IBD. Recruitment criteria for this study, 
however, did not require participants to be distressed before evaluating the messages. Future 
iterations of this work may want to, instead, test these messages among people with IBD who 
experience disease-related distress, as they may evaluate the content of the messages as self-
relevant. 
 For the final empirical study in Chapter 5, strengths of this research include the 
implementation of a theoretically informed health intervention, a high retention of participants 
(92%) at a 2-week posttest assessment, a diverse set of support messages about IBD self-
management that were evaluated in a pilot test, and a customized program that allowed 
participants to choose when to receive these support messages each day during the intervention. 
Another strength of this study was its use of social media data to identify and recruit a targeted 
audience of people with IBD who experienced some levels of disease-related distress at pretest, 
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as opposed to recruiting from a general population of people with IBD who may not as directly 
benefit from the Text4IBD program.  
The main limitation of the final study in Chapter 5 is that it features a single group, 
pretest-posttest intervention design. This design limited my ability to attribute changes in study 
outcomes to exposure to the intervention alone due to the absence of a control condition. In fact, 
it is possible that other factors—beyond exposure to the Text4IBD messages—may have played 
some role in changes exhibited by participants from pretest to posttest. Example threats to the 
internal validity of the study could have included the temporal threats of participant history and 
maturation (Shadish, Cook, & Campbell, 2001). Regarding history, it may be that some external 
events (not associated with the Text4IBD program) could have occurred in participants’ lives 
between pretest and posttest assessments that influenced changes to their health outcomes, such 
as receiving new advice from their doctor or being awarded a job promotion. For maturation, it is 
possible that participants during the course of the 2-week intervention reduced their disease-
related distress due simply to passage of time and not because of the support messages and 
resources offered by the Text4IBD program. It is also possible that measurement effects (e.g., 
testing or instrumentation) contributed to improvements on posttest measures compared to 
pretest. While I purposefully implemented this design because this study was conducted at the 
early stage of intervention development (Kumar et al., 2013), future work should aim to build on 
this research and test it in a randomized controlled trial. Another limitation is that participants 
were recruited from two social media platforms (Reddit and Twitter) through a convenience 
sampling method using public data, meaning results may not generalize to all people with IBD. 
One last limitation of this study is the modest sample size (N = 114), which reduced my ability to 
test conceptual pathways and other relationships among health outcomes using robust 
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multivariable analytic methods. The next iteration of this research should seek to evaluate the 
Text4IBD program among a larger sample size and test the predictive power of the proposed 
conceptual framework (Figure 1) on the primary outcome of disease-related distress. 
Next steps  
It is important to acknowledge that the research in this dissertation is not finished. The 
findings illustrated by each of the three empirical studies—although important in their respective 
contribution to understanding disease-related experiences among people with IBD—only sought 
to test and answer a narrowly-focused selection of hypotheses and research questions. As such, it 
is critical that research and healthcare initiatives continue to build upon the foundations 
established here. In doing so, there are several next steps associated with the methods and results 
of this dissertation that I believe warrant investigation. I highlight some of these opportunities 
below.  
As emphasized throughout this research, people with IBD use social media platforms for 
networking and community support (Coulson, 2013; Frohlich, 2016; O'Leary et al., 2020). The 
effects of communities and social networks on health among those with chronic disease are vast 
(Vassilev, Rogers, Kennedy, & Koetsenruijter, 2014; Vassilev, Rogers, Kennedy, Oatley, & 
James, 2019), yet there has been little work on this topic in the context of IBD. The social media 
findings from Chapter 3 showed a sizeable number of dedicated IBD communities in the Reddit 
data set. For example, the subreddit r/CrohnsDisease made up more than 26% of all published 
comments and submissions in the analysis. Moreover, as of early 2021, the same subreddit 
boasted more than 34,000 subscribed users.  
Based on those findings, a next step to further this work should be examining discourse 
of IBD-dedicated online communities and comparing the results to general public discussions 
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about IBD. For example, do online IBD communities offer more support than general public 
social media discussions about self-managing IBD? Does the type of support (i.e., informational, 
emotional) offered by online IBD communities vary in form and, if so, to what extent? Answers 
to these questions would not only add much-needed evidence to IBD self-management and social 
support research, but would also contribute theoretical insight to literature on social networks 
and health. The theory of functional specificity posits that different types of individuals in a 
network, such as friends, family members, and healthcare workers, can offer different types and 
degrees of support (Perry & Pescosolido, 2010; Weiss, 1969). For example, people with chronic 
disease often turn to close family members and friends for emotional support while medical 
providers, on the other hand, tend to be used for informational support (i.e., advice about a new 
medication and its potential for side effects). Analyzing online IBD discourse in the context of a 
functional specificity theoretical framework could improve our understanding of some of the 
mechanisms that best facilitate disease self-management and support among people with IBD. 
Moreover, findings from this type of work could be used to develop network-focused health 
promotion efforts for this population. 
Dovetailing the above opportunity, another next step for the research in this dissertation 
should be to test the feasibility, acceptability, and efficacy of an IBD intervention that integrates 
elements of community support through digital technologies. Self-managing a chronic disease 
such as IBD can be isolating at times (Casati et al., 2000; Daniel, 2002; De Rooy et al., 2001; 
Drossman et al., 1989; Nicholas et al., 2007). Having a peer support network to turn to when 
struggling can be vital in helping people develop the skills and confidence required to cope with 
aspects of their chronic disease (E. B. Fisher et al., 2018). Indeed, research on the effects of peer 
support on IBD health outcomes and disease self-management behaviors is promising (Rogala et 
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al., 2008; Rubin et al., 2017). To date, however, few IBD studies have integrated peer support 
and digital tools in a single intervention package. An example of this type of intervention could 
be a mobile app that provides information about self-managing IBD (similar to Text4IBD) while 
also allowing its participants to communicate with one another, such as through a community 
forum or direct messaging feature.  
Some extant IBD eHealth studies have tested two-way modes of communication in 
randomized controlled trials (Cross, Cheevers, Rustgi, Langenberg, & Finkelstein, 2012; de 
Jong, van der Meulen-de Jong, Romberg-Camps, Becx, et al., 2017; Del Hoyo et al., 2018; 
Elkjaer et al., 2010); however, these features have tended to be patient-to-provider (i.e., sending 
a message to a medical provider when experiencing an IBD flare) as opposed to peer-to-peer. 
Given the receptivity and acceptability of the Text4IBD support messages in this dissertation, 
developing a similar intervention with an added community support feature could importantly 
extend the impact of this work on IBD health and overall quality of life, and would also 
substantively contribute to social/peer support and social network literature. Moreover, this type 
of intervention would allow researchers to investigate whether community support components 
of eHealth tools contribute an additive (or independent) effect on different IBD health outcomes 
when tested in conjunction with other eHealth tools (e.g., online self-management portals). 
One last area that this dissertation research should build on is to explore the potential 
impact of health communication concepts such as tailored messaging and customization among 
people with IBD. The messages sent by the Text4IBD program—although theoretically informed 
and pilot tested—were the same for all participants involved (excluding the welcome message 
which included participants’ names, and also the medication reminder messages which were only 
sent to a sub-group of participants). Health communication research suggests that tailoring 
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message content can increase the magnitude of intended message outcomes by affecting 
individuals’ attention and processing of message content (Hawkins, Kreuter, Resnicow, Fishbein, 
& Dijkstra, 2008; Noar & Harrington, 2016), and can have effects on behavior change (Noar, 
Benac, & Harris, 2007). Using Text4IBD as an example, if a participant self-reported high levels 
of disease activity at the pretest assessment, then a tailored version of the program would send 
messages about how to best treat IBD flares. On the other hand, if a participant reported 
experiencing no symptom activity, then the Text4IBD program would send messages about how 
to best maintain disease remission. Only one pretest-posttest IBD intervention that I am aware of 
used message tailoring to some success (Riaz & Nielsen, 2019). This work was a pilot study 
though, and thus more work evaluating the efficacy of tailored messages in IBD interventions is 
needed. 
A related concept to tailored messaging that is also under-researched in the 
gastrointestinal research literature is customization as an affordance of IBD eHealth tools. 
Customization provides users a degree of agency in the media consumption process (Sundar & 
Marathe, 2010). Evidence from eHealth research has shown support for the use of customization 
as a feature of health messages (Kim, Shin, & Yoon, 2017). Text4IBD afforded a small amount 
of customization by allowing participants to select what time of day they wanted to receive 
support messages. To expand on this research, future studies should test whether additional 
customization features, such as allowing users to select message content (e.g., nutrition- vs 
symptom-focused messages) and how many messages they want to receive (e.g., daily, weekly), 
have any impact on receptivity of the Text4IBD program. This work could also be done 
experimentally by randomizing participants to a customized vs non-customized version of 
Text4IBD. This approach would give researchers the ability to test direct effects of 
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customization as an eHealth feature, and results from this work could be used to inform the 
selection of features on other IBD eHealth interventions or among studies testing messages for 
other chronic disease populations. 
It must be stated that the research questions and next steps discussed above do not 
represent an exhaustive list. Instead, a chronic disease such as IBD requires continued efforts and 
interdisciplinary advancements across a number of fields, including medicine, public health and 
communication, to best improve quality of life among this population.  
Conclusion 
 This dissertation sought to better understand experiences of and reduce disease-related 
distress among people with IBD through the use of social media data and eHealth tools. Results 
from this work show that digital technologies can be used to provide information about IBD self-
management. Moreover, findings indicate that people with IBD are highly receptive to digital 
interventions, and that text messaging is a feasible eHealth medium for supporting people who 
may struggle with self-managing their IBD. Importantly, these findings contribute much-needed 
empirical evidence as to the utility of these tools in personal IBD healthcare and suggest future 
scientific efforts could be made by medical providers and other researchers to build on and 




APPENDIX A: DICTIONARY KEYWORDS 
Topic 1: Symptoms 
• Symptoms_exact = ['ache', 'acid reflux', 'am week ', 'bleeding', 'bloat', 'bloody', 'changing 
weight', 'complications', 'constipat', 'cramp', 'diarea', 'diareah', 'diarhea', 'diarrhea', 
'diarrhoea', 'digest issue', 'digest problem', 'digesting issue', 'digesting problem', 'digestive 
issue', 'digestive problem', 'discomfort', 'diverticulit', 'dont have energy', 'dont have the 
energy', 'dysphagia', 'energy disappear', 'energy is depleat', 'energy is gone', 'energy is 
gone', 'energy is nonexistent', 'energy is sapped', 'exhaust', 'fart ', 'farting ', 'farts ', 'fatigue', 
'feel weak ', 'fever', 'fissur', 'flair up', 'flare', 'flatulen', 'fluctuating weight', 'gain weight', 
'gain weight', 'gained some weight', 'gained weight', 'gaining some weight', 'gaining 
weight', 'gaining weight', 'gerd', 'granuloma', 'headach', 'hurt', 'im week ', 'inflamed', 
'inflammation', 'insomnia', 'issue with digest', 'issue with sleep', 'issues with digest', 'issues 
with sleep', 'lack of energy', 'lose weight', 'losing appetite', 'losing some weight', 'losing 
weight', 'losing weight', 'loss of appetite', 'lost appetite', 'lost some weight', 'lost weight', 
'lost weight', 'low energy', 'mucus', 'muscle stiff', 'nause', 'no appetite', 'no energy', 'pain', 
'physical problem', 'problem with digest', 'problem with sleep', 'problems with sleep', 
'sleep issue', 'sleep problem', 'sore', 'stomach problem', 'symptom', 'tired', 'tiring', 'ulcer ', 
'ulcers ', 'upset stomach', 'upset tummy', 'vomit', 'weight change', 'weight fluctua', 'weight 
gain', 'weight gain', 'weight loss', 'weight loss'] 
 
• Symptoms_nonMatch = ['feel your pain', 'tired of', 'ulcers colit', 'ulcer colit', 'pain med', 
'pain free', 'pain in the ass', 'painful', 'pain in the arse', 'pain in the butt', 'feveris', 
'feverroot', 'feverw', 'pain kill', 'painless', 'painstak', 'paint', 'a symptomatic', 
'asymptomatic', 'retired', 'pain dr', 'pain doctor', 'good pain', 'pain clinic', 'adrenal fatigue', 
'not painful', 'pain relief', 'pain reliever', 'kind of a pain'] 
 
Topic 2: Medication 
• Medication_exact = [' med ', ' meds ', ' pill ', ' pills ', 'acetaminophen', 'adalimumab', 
'advil', 'aleve', 'aminosalicylate', 'anti inflammatories', 'anti inflammatory', 'antibiotic', 
'antiinflammatories', 'antiinflammatory', 'asacol', 'asacol', 'azasan', 'azathioprine', 
'balsalazide', 'biologic', 'budesonite', 'citrucel', 'codeine', 'colazal', 'corticosteroid', 
'cyclosporine', 'delzicol', 'diclofenac', 'dipentum', 'entyvio', 'gengraf', 'golimumab', 
'humira', 'ibuprofen', 'immodium', 'imuran', 'infliximab', 'infusion', 'injections', 'lactaid', 
'lialda', 'medicat', 'medicine', 'mercaptopurine', 'mesalamine', 'methotrexate', 
'methylcellulose', 'metronidazole', 'midol', 'miralax', 'motrin', 'naproxen', 'narcotic', 
'natalizumab', 'neoral', 'nsaid', 'olsalazine', 'paracetamol', 'pentasa', 'prednisone', 
'purinethol', 'purixan', 'remicade', 'sandimmune', 'simponi', 'stelara', 'stelera', 'steroid', 
'suppositor', 'thioguanine', 'trexall', 'tylenol', 'tysabri', 'uceris', 'ustekinumab', 
'vedolizumab', 'voltaren'] 
 
• Medication_nonMatch = ['aleveate', 'spill', 'medicine unit', 'anti inflammatory diet', 





Topic 3: Nutrition 
• Nutrition_exact = [' bran ', ' egg', ' fish ', ' gin ', ' lime', ' meal ', ' meal ', ' meals ', ' meals ', ' 
meat', ' oats', ' pear', ' peas ', ' rice', ' rum ', ' rye ', ' soy ', 'alcohol', 'almond', 'apple', 
'apricot', 'artichoke', 'arugula', 'asparagus', 'avocado', 'banana', 'barley', 'beer', 'bok choy', 
'bread', 'broccoli', 'butter', 'cabbage', 'caffei', 'calcium', 'calori', 'candies', 'candy', 
'cantaloupe', 'carbohydrate', 'carbs', 'carrot', 'cashew', 'cauliflower', 'cheese', 'chicken', 
'cognac', 'collard', 'corn ', 'cucumber', 'dairy', 'diet', 'edamame', 'eggplant', 'electrolyt', 
'fasting', 'fatty acid', 'fiber', 'fodmap', 'folate', 'food', 'fruit', 'gluten free', 'glutenfree', 
'grape', 'greasy', 'green bean', 'hazelnut', 'herring', 'high fat', 'highfat', 'hydrat', 'juice', 'kale', 
'kefir', 'kimchi', 'kiwi', 'lemon', 'lettuce', 'liqor', 'liquor', 'low fat', 'low fiber', 'lowfat', 
'lowfiber', 'lowfodmap', 'lychee', 'mackerel', 'magnesium', 'mannitol', 'margarin', 'melon', 
'milk', 'millet', 'mineral', 'miso', 'noodle', 'oatmeal', 'okra', 'onion', 'paleo', 'paleolithic', 
'papaya', 'pasta', 'peanut', 'pecan', 'pepper', 'pineapple', 'pistachio', 'plum', 'polyol', 
'popcorn', 'pork', 'potassium', 'potato', 'poultry', 'protein', 'quinoa', 'saccharide', 'salmon', 
'sardine', 'sauerkraut', 'sesame seed', 'soda', 'sorbitol', 'sourdough', 'spelt', 'spice', 'spicy', 
'spinach', 'sprouts', 'sugar', 'sunflower seed', 'tempeh', 'tequila', 'tequilla', 'tofu', 'turkey', 
'vegetable', 'vermouth', 'vodka', 'walnut', 'watercress', 'wheat', 'whiskey', 'whisky', 'wine', 
'yoghurt', 'yogurt', 'zucchini'] 
 
• Nutrition_nonMatch = ['spice girl', 'pizza express', 'blood sugar', 'nutritionist', 'chickened', 
'apple iphone', 'apple product', 'greapevine', 'spicegirl', 'fiberglass', 'fiber glass', 
'fiberboard', 'fiber optic', 'fiberoptic', 'fiberotom', 'fiberscop', 'fruitful', 'milkiest', 
'milkmaid', 'milky', 'food service', 'go bananas', 'alcoholism'] 
 
Topic 4: IBD procedures 
• IBD_procedures_exact = ['anastomosis', 'colectomy', 'colonosco', 'endoscop', 'post op ', 
'post operati', 'postop ', 'procedure', 'proctocolectomy', 'resection', 'strictureplasty', 
'surgeri', 'surgery', 'surgical', 'tracheostom', 'transplant'] 
 
Topic 5: Marijuana 
• Marijuana_exact = [' thc ', 'bong', 'canna butter', 'cannab', 'cbd', 'dab', 'dabbed', 'edible', 
'hash', 'herb', 'indica ', 'marijuana', 'mary jane', 'maryjane', 'sativa', 'stoner', 'strawberry 
cough', 'weed'] 
 
• Marijuana_nonMatch = ['rehash', 're hash'] 
 
Topic 6: Stigma 
• Stigma_exact = [' bias ', ' biased', 'ableism', 'ableist', 'bully', 'demean', 'discriminat', 
'disrespect', 'embarrass', 'faked it', 'faking it', 'humiliat', 'its no joke', 'its not a joke', 
'labeling', 'made fun of', 'make fun of', 'making it up ', 'misconstru', 'misinterpret', 
'misknown', 'misperceiv', 'mispercept', 'mock ', 'mocked', 'mocking', 'poke fun', 'poked 
fun', 'prejudice', 'ridicule', 'single out', 'singled out', 'stereoty', 'stigma', 'teased', 'treat 





Topic 7: Ostomy 
• Ostomy_exact = ['colostomy', 'ileostomy', 'illeostomy', 'jpouch', 'j pouch', 'ostomate', 
'ostomy', 'stoma ', 'wafer '] 
 
Topic 8: Intimacy 
• Intimacy_exact = [' dating ', ' hinge ', ' sex ', 'blind date', 'boink', 'bumble', 'canoodl', 
'coffee meets bagel', 'coffeemeetsbagel', 'coitus', 'copulat', 'doing the dirty', 'fornic', 
'frisky', 'grindr', 'hook up', 'hooking up', 'intamacy', 'intamate', 'intercourse', 'intimacy', 
'intimate', 'kiss', 'knocking boot', 'made out with', 'make out with', 'making love', 'making 
out with', 'making whoop', 'mating', 'ok cupid', 'okcupid', 'on a date', 'penetration', 'plenty 
of fish', 'plentyoffish', 'ravish', 'romance', 'romancing', 'romantic', 'scissoring', 'scissr', 





APPENDIX B: EXAMPLE SOCIAL MEDIA POSTS BY IBD TOPIC 
Table 14. Example social media posts by IBD topic. 
IBD topic Example social media posts by topic 
Symptoms • New to Crohn's & need for advice on flare ups! 
• IBD sucks so much. My stomach has been in pain all day today.  
Medication • Anyone with Crohn’s using Stelara? Does it cause psoriasis? I'm 
getting scared, because I saw a red stuff on my face. 
• My Prednisone steroids are done. Unfortunately, so have the 
effects of using them. Talking to my IBD nurse soon.  
Nutrition • I needed to stop drinking alcohol since the beginning of the year 
because of my IBD. I love the taste of it, but I get so sick 
afterward. Looks like I’ll be staying with water. 
• I saw people talking about the low-FODMAP diet. That diet was 
truly the most awful thing I’ve gone on.  
IBD procedures • I have Crohn’s. I got the surgery because they found that the nerves 
in my colon and rectum don’t function. Dealing with it all was 
awful. 
• Feeling emotional after this. I’m also scared for my surgery.   
Marijuana • It makes me so mad! We could’ve made medical marijuana legal 
for Crohn's, but it was rejected by congress. 
• I need to see a doctor since I need medicinal weed for my IBD 
symptoms. My doctor isn’t the best though so I’m going to finally 
try and find a new one who understands how much all of this 
sucks.  
Stigma • I’m trying to move past the stigma of discussing digestive and 
reproductive issues with doctors. I have UC and I just feel 
uncomfortable about it. 
• Can’t we make bowel problems less awkward because everybody 
poops…  so many people have IBD and IBS. It shouldn’t be taboo 
to discuss what’s normal. 
Ostomy • The incredible fear of needing another ostomy placement. IBD is 
so awful. 
• I’ll soon get my ostomy reversed. I’m currently excited, skeptical, 
and nervous… 
Intimacy • I have Crohn's and got over my bathroom fears. I get out a lot 
more, but I don’t want to date anyone because I can’t stand having 
to discuss my IBD with them.  
• Ugh, what’s worse than your stomach making noises on a date? 
Has anyone else with IBD experienced similar situations while 
dating? 
Note. Text from example social media posts is paraphrased from real posts to protect the privacy 
and confidentiality of users. 
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APPENDIX C: NETWORK STATISTICS FOR CO-OCCURRING IBD TOPICS 
Results in Table 15 shows the undirected degree centrality values for the IBD topics 
networks for both Reddit and Twitter. As stated in Chapter 3, degree centrality refers to the 
number of connections that a node (i.e., an IBD topic) has to all other nodes in a network 
(Wasserman & Faust, 1994). Higher degree centrality values for an IBD topic indicate that said 
topic was more central to social media posts discussing multiple IBD topics. Notably, the topics 
networks are comprised only of social media posts that contain two or more IBD topics. Results 
in Table 16 and Table 17 show the unadjusted frequency and proportion of IBD topic co-
occurrences among the social media data. 
 
Table 15. Degree centrality values among IBD topics on Reddit and Twitter. 
 Reddit Twitter 
Symptoms 25,103 5,719 
Medication 17,978 2,953 
Nutrition 15,602 2,306 
IBD procedures 11,448 1,536 
Marijuana 5,371 1,793 
Stigma 2,080 540 
Ostomy 2,693 833 
Intimacy 1,593 96 
Note. Cell values in columns represent each topic’s degree centrality value (i.e., the number of 


















































































































































































































































































































































































































































































































































































































































































































































































































































































































APPENDIX D: INITIAL SET OF SUPPORT MESSAGES 
Self-management domain 1: General IBD symptoms  
Message 1 (validating) Message 2 (advising) 
● IBD symptoms can often be unpredictable, 
which can cause anxiety.  
 
Message ID: A1 
Message topic: Psychological distress 
● Practicing simple breathing or muscle relaxation 
exercises can help reduce stress. For more info about 
IBD and mental health, visit this site: 
https://bit.ly/3hgiGIj  
● It can be difficult managing irritating or 
uncomfortable IBD symptoms.  
 
Message ID: A2 
Message topic: Symptom discomfort 
● Small changes, such as using moist wipes instead of 
traditional toilet paper, can help reduce discomfort 
associated with frequent bowel movements and other 
related symptoms.  
● IBD flares aren’t easy to handle, especially 
when they come out of nowhere.  
 
Message ID: A3 
Message topic: Flare tracking 
● A good way to manage flares is to keep track of 
symptom activity using a phone app such as “MyGut.” 
Being aware of symptom changes can also help doctors 
recommend different treatment options. For more info 
about MyGut, click here: https://bit.ly/2QdlHwY  
● Having IBD can make it tough to get out of bed 
sometimes. 
 
Message ID: A4 
Message topic: Fatigue 
● Building in extra time in the morning by preparing the 
night before, such as by packing lunches or picking out 
clothes, can help you start the day feeling less 
exhausted. Here’s a video for more tips on managing 
fatigue: https://bit.ly/34j7rLC   
● Staying active while having IBD can be hard. 
 
Message ID: A5 
Message topic: Exercise 
● Short exercises, such as going on walks or riding a bike, 
can reduce stress and strengthen your immune system, 




Self-management domain 2: Social aspects of IBD  
Message 1 (validating) Message 2 (advising) 
● It can be stressful going to some events because 
of IBD.  
 
Message ID: B1 
Message topic: Managing IBD in public 
● A helpful way to manage IBD in public, such as at a 
restaurant or when shopping, is to keep track of where 
the nearest restrooms are. That way, you can stay on top 
of certain symptoms if they come out of nowhere.  
● Talking with other people about IBD can be 
challenging.  
 
Message ID: B2 
Message topic: Networking 
● Online IBD communities can be a useful and convenient 
resource if you’re looking for advice about how to cope 
with symptoms, or to meet other people with IBD. You 
can find out about online communities here: 
https://bit.ly/3hhJBDo 
● Managing IBD symptoms around peers can be 
uncomfortable. 
 
Message ID: B3 
Message topic: Support systems 
● Building a support system by talking to reliable friends 
about your IBD can help you navigate difficult 
situations. For example, they can help you find 
restrooms or provide emergency transportation if you 
ever experience unexpected symptoms in public.  
● It’s not always easy to get reliable advice about 
IBD from people who aren’t doctors. 
 
Message ID: B4 
Message topic: Advice seeking 
● If you’re ever uncertain about managing IBD, you can 
use the “Expert Q&A” website, which is run by medical 
professionals trained to answer any questions you may 
have. You can even post questions anonymously. Check 
out the site here: https://bit.ly/3gkhgv0  
● It can be frustrating not knowing other people 
who have IBD.  
 
Message ID: B5 
Message topic: Peer support 
● The “Power of Two” is a peer support program that can 
connect you with someone else with IBD who may 
better understand what you’re going through and can 





Self-management domain 3: IBD and nutrition  
Message 1 (validating) Message 2 (advising) 
● Figuring out what dietary practices work best 
for managing IBD can be challenging. 
 
Message ID: C1 
Message topic: General nutrition 
● Eating smaller meals more times during the day and 
staying hydrated may help keep symptoms under 
control.  
● There are a lot of IBD diets, and it can be 
difficult trying to learn about all of them.  
 
Message ID: C2 
Message topic: IBD diets 
● The low fiber diet eliminates certain foods high in fiber, 
such as leafy vegetables and whole grains, which can 
help reduce cramping and bowel movements. For more 
info about different diets, go here: https://bit.ly/3j0uyys  
● Figuring out what foods to avoid when 
experiencing IBD symptoms can feel like a 
process of trial and error. 
 
Message ID: C3 
Message topic: Trigger foods 
● Avoiding trigger-causing foods, such as products high in 
lactose and fat (greasy foods), as well as sugary foods 
like certain juices, can help keep symptoms under 
control. Watch this video to learn more: 
https://bit.ly/3gkhXV8  
● Knowing what foods to eat during IBD flares 
isn’t easy. 
 
Message ID: C4 
Message topic: Helpful foods 
● Certain nutritious foods, such as low-fiber fruits 
(bananas) and lean proteins (white meat chicken), can be 
easier to digest when experiencing symptoms. For more 
advice, take a look at this webpage: 
https://bit.ly/3iZjBNB  
● It can be tough getting enough daily nutrients 
because of some IBD restrictions.  
 
Message ID: C5 
Message topic: Balanced nutrition 
● Small dietary changes, such as eating regularly balanced 
meals throughout the day, can help reduce feelings of 
tiredness and fatigue. For more info about nutrition, 




Self-management domain 4: Other aspects of IBD self-management 
Message 1 (validating) Message 2 (advising) 
● Regularly taking IBD medication can seem like 
a nuisance, especially when symptoms aren’t 
present.  
 
Message ID: D1 
Message topic: Medication importance 
● Most IBD medication is intended for long-term use. 
Because of this, it’s important for people with IBD to 
keep taking medication they were prescribed for it to be 
most effective. 
● Remembering when and how often to take 
medication for IBD can be hard.  
 
Message ID: D2 
Message topic: Medication reminder 
● If you’re taking medication for IBD, setting phone alerts 
or reminders can help you remember when it’s time to 
take your medicine, which will give you one less thing 
to think about. 
● Having IBD can feel stigmatizing at times.  
 
Message ID: D3 
Message topic: Open communication 
● Talking about IBD with others, such as friends and 
family, can help them understand what you might be 
going through and could help them better support you. 
● Managing IBD during the middle of the 
COVID-19 pandemic can be stressful.  
 
Message ID: D4 
Message topic: COVID-19 and IBD 
● Keeping in touch with friends and family virtually can 
help you cope during this pandemic. For more info about 
navigating IBD during COVID-19, check out this site: 
https://bit.ly/2YheIrd  
● It’s not easy finding a doctor who is trained to 
help treat IBD. 
 
Message ID: D5 
Message topic: Finding a doctor 
● The “Find a Medical Expert” resource can help people 
find an IBD specialist. Just enter a zip code and a list of 
doctors in the area will pop up. Try it out here: 





APPENDIX E: QUESTIONNAIRE FOR THE MESSAGE EVALUATION  
PILOT STUDY 
 






[INSERT CONSENT FORM 
HERE] 
 
I have read and understood the 
consent form. I am at least 18 
years or older, I have an 
inflammatory bowel disease 
diagnosis, and would like to 






Skip logic: If 
no, skip to end 
of survey.  
Prompt First, we are going to ask you 
some questions about your IBD. 
   
A30 
IBD type 
What type of IBD do you have? 1. Ulcerative colitis 
2. Crohn’s disease 
3. Indeterminate 
colitis 
4. Don’t know 
From IBD 
Partners 
(Long et al., 
2012) 
Skip logic: If 
option 5, skip 




At what age were you first 
diagnosed with IBD? 








Have GI specialist 
Do you have a gastroenterologist 
who helps treat your IBD? 
1. Yes 
2. No 
3. Don’t know 
From IBD 
Partners 




Seen GI specialist 
How many times have you seen 
this gastroenterologist over the 
past year? 
1. Never 
2. 1-2 times 
3. 3-4 times 
4. 5 or more times 
5. Don’t know 
From IBD 
Partners 








During the past two weeks, how 
would you rate your IBD 
activity… 




3. Mildly active 
4. Moderately active 
5. Severely active 
From IBD 
Partners 








In general, would you say your 













Do you personally know anyone 
else diagnosed with IBD, such 









IBD distress prompt In the past 2 weeks, how much 
have you felt… 
   
B40_1 
IBD distress – item 
1 
Overwhelmed with the demands 
of living with IBD? 
1. Not at all 
2. Very little 
3. Somewhat 
4. Quite a bit 





(Liu et al., 
2020; 
Polonsky et 
al., 2005)  
 
B40_2 
IBD distress – item 
2 
That you are often failing with 
your IBD routine? 
1. Not at all 
2. Very little 
3. Somewhat 
4. Quite a bit 





(Liu et al., 
2020; 
Polonsky et 
al., 2005)  
 
B40_3 
IBD distress – item 
3 
Discouraged to keep up with 
managing your IBD? 
1. Not at all 
2. Very little 
3. Somewhat 
4. Quite a bit 





(Liu et al., 
2020; 
Polonsky et 
al., 2005)  
 
B50_1.  
IBD distress – item 
4 
Angry, scared, and/or depressed 
when thinking about living with 
IBD? 
1. Not at all 
2. Very little 
3. Somewhat 
4. Quite a bit 





(Liu et al., 
2020; 
Polonsky et 
al., 2005)  
 
B50_2  
IBD distress – item 
5 
That your friends of family don’t 
appreciate how difficult living 
with IBD can be? 
1. Not at all 
2. Very little 
3. Somewhat 
4. Quite a bit 





(Liu et al., 
2020; 
Polonsky et 
al., 2005)  
 
B50_3 
IBD distress – item 
6 
That your friends or family don’t 
give you the emotional support 
that you would like? 
1. Not at all 
2. Very little 
3. Somewhat 
4. Quite a bit 





(Liu et al., 
2020; 
Polonsky et 





Prompt [1-time prompt]     
 
 154 
We are developing a text 
messaging program to help 
people best manage their IBD.  
 
We are now going to show you 
5 short sets of messages. Please 
view the messages carefully 
and note that we will ask 
you questions after each one. 
 
Your feedback is very 
important as it will help us 
select the best messages to use 
in the program.  
 
Please note that messages 
containing web links or URLs 







B. Social  
C. Nutrition 
D. Other 




How much does this message…     
C30_a-d_1-5_1 
PME – item 1 
(knowledge) 
 
give you important information 
about IBD? 
1. Not at all 
2. Very little 
3. Somewhat 
4. Quite a bit 






PME – item 2 (self-
efficacy) 
make you feel more confident in 
managing your IBD? 
1. Not at all 
2. Very little 
3. Somewhat 
4. Quite a bit 






PME – item 3 
(perceived support) 
make you feel supported about 
your IBD? 
1. Not at all 
2. Very little 
3. Somewhat 
4. Quite a bit 






PME – item 4 
(coping) 
give you ideas about how to 
better cope with your IBD? 
1. Not at all 
2. Very little 
3. Somewhat 
4. Quite a bit 






PME – item 5 
(outcome 
expectations) 
make you think that better 
managing IBD can improve your 
symptoms  
1. Not at all 
2. Very little 
3. Somewhat 
4. Quite a bit 










Please describe the main 
purpose of this message in one 

































Is there anything else you would 
like to tell us about the messages 









Is there anything else about IBD 









DEMOGRAPHICS AND BACKGROUND INFORMATION 
 
Prompt We are asking these final 
questions to better understand 
who took our survey.  
   
E20 
Social media use 
Which of the following social 
media platforms do you use to 





















Please select the following IBD 
topics that are most important to 
you when discussing or 
researching information about 
IBD on social media.  
1. Symptoms 









7. Intimacy (e.g., 





















4. Prefer to self-
describe (specify) 
5. Prefer not to say 
E60 
Race 
What is your race? (Select all 
that apply.) 
1. White 
2. Black or African 
American  
3. American Indian 
or Alaska Native  
4. Asian 
5. Native Hawaiian 
or Other Pacific 
Islander 
6. Some other race 
(please specify) 












What is the highest degree or 
level of school you have 
completed? 
1. Less than high 
school  
2. High school 
graduate (or 
equivalent, such as 
GED) 
3. Some college 
4. Associate degree 
5. Bachelor’s degree 
6. Master’s degree 
7. Doctorate degree 










 Skip logic, go 
to end of 
survey if “no” 
selected.  
 
END OF SURVEY 
 
End of survey Thank you for your 
participation. We have your 
responses recorded. Have a nice 
day.  
















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































APPENDIX G: FINAL SET OF SUPPORT MESSAGES 
Self-management domain 1: Physical IBD symptoms 
Message 1 (validating) Message 2 (advising) 
● It can be difficult managing irritating 
IBD symptoms.  
 
Message topic: Symptom discomfort 
● Small changes, such as using moist wipes or a 
bidet instead of toilet paper, can help reduce 
discomfort associated with frequent bowel 
movements.  
● It can be tough getting through the day 
feeling bloated because of IBD.  
 
Message topic: Bloating/gas 
● Eating smaller meals and avoiding caffeine and 
carbonated beverages can help reduce gas and 
make you feel less bloated.  
● IBD flares aren’t easy to handle. 
 
Message topic: Flare tracking 
● A good way to manage flares is to keep track 
of your symptom activity using an app such as 
“MyGut.” Being aware of symptom changes 
can also help doctors recommend treatment 
options. For info about MyGut, go here: 
http://bit.ly/My_Gut  
● Managing IBD can take a lot of energy. 
 
Message topic: Energy  
● Building in extra time in the morning, such as 
by packing lunches or picking out clothes the 
night before, can make starting your day a little 
easier.  
● It’s not always easy to get good advice 
about IBD symptoms. 
 
Message topic: Advice seeking 
● If you’re ever uncertain about how to manage 
IBD, you can use the “Expert Q&A” website, 
which is run by doctors trained to answer any 
questions you may have. You can even post 
questions anonymously. Check out the site 






Self-management domain 2: IBD and mental health 
Message 1 (validating) Message 2 (advising) 
● IBD symptoms can often be 
unpredictable, which can cause anxiety. 
 
Message topic: Anxiety  
● Practicing simple breathing or muscle 
relaxation exercises can help reduce stress. For 
more info about IBD mental health exercises, 
visit this site: http://bit.ly/IBDMentalHealth  
● Stress can make it difficult to manage 
IBD. 
 
Message topic: exercise and stress  
● Short exercises, such as going on walks or 
riding a bike, can improve your mental health 
and strengthen your immune system, which 
can help keep your IBD in check.  
● Staying on top of symptoms can feel 
overwhelming at times.  
 
Message topic: Discouragement  
● It’s important to tackle IBD one day at a time. 
If you’re feeling discouraged about IBD, try 
setting aside some time in your day to focus on 
self-care, such as by doing activities that you 
enjoy and bring you comfort.     
● Managing IBD during the COVID-19 
pandemic can be stressful. 
 
Message topic IBD and COVID-19 
● Staying in touch with friends and family 
virtually can help you cope during this 
pandemic. For more info about managing IBD 
during COVID-19, check out this site: 
http://bit.ly/IBD_covid  
● It’s common for people with IBD to 
struggle with their mental health.  
 
Message topic: Social support 
● Online communities can be a useful and 
convenient resource for finding support from 
other people with IBD. Learn more about 
online IBD communities here: 




Self-management domain 3: IBD and nutrition 
Message 1 (validating) Message 2 (advising) 
● Figuring out what dietary practices 
work best for managing IBD can be 
challenging.  
 
Message topic: General nutrition 
● Avoiding processed foods (such as candy and 
ice cream), eating balanced meals, and staying 
hydrated throughout the day can help keep 
symptoms under control. 
 
● There are a lot of IBD diets, and it can 
be difficult learning about all of them.  
 
Message topic: IBD diets 
● The low fiber diet eliminates certain high fiber 
foods, such as leafy vegetables and whole 
grains, which can help reduce cramping and 
bowel movements. For info about other IBD 
diets, go here: http://bit.ly/IBDDiets  
● Knowing what to eat during an IBD 
flare isn’t always clear. 
 
Message topic: Helpful foods 
● Certain nutritious foods, such as low-fiber 
fruits (bananas) and lean proteins (white meat 
chicken), can be easier to digest when 
experiencing symptoms. For more tips about 
IBD and nutrition, check out this site: 
http://bit.ly/IBDNutrition  
● No two people with IBD react the same 
to eating certain foods. 
 
Message topic: Food journaling 
● Keeping a food journal to track what you eat 
can help you figure out if certain foods make 
your symptoms worse. This can help eliminate 





APPENDIX H: QUESTIONNAIRES FOR THE TEXT4IBD INTERVENTION 
Chapter 5 screener survey questionnaire 
 
Question ID Item Response scale Source Notes 
 
BACKGROUND SCREENER QUESTIONS 
 
Prompt Thank you for your interest in 
the Text4IBD program! 
 
To see if you’re eligible to 
participate, please press the 
next arrow to answer some 
questions.  
   
A50 
Contacted platform 
What social media platform 
were you contacted on about 
participating in this program? 
1. Twitter 
2. Reddit 












Not eligible if 
under 18 
A110 
Living in US 










What State or U.S. territory do 
you currently live in? 











Do you have a smartphone, such 
as an iPhone or Android phone, 
that can send and receive text 
messages?  















4. Other (please 
specify) 




et al., 2012) 
Eligibility: not 




Diagnosed in last 
year 
Were you diagnosed with IBD 







DISTRESS SCREENER QUESTIONS 
 
Distress prompt In the past 2 weeks, how much 
have you felt… 
  Skip logic: if 
weighted mean 







IBD distress – item 1 
overwhelmed with the demands 
of living with IBD? 
1. Not at all 
2. Very little 
3. Somewhat 
4. Quite a bit 










IBD distress – item 2 
that you are often failing with 
your IBD routine? 
1. Not at all 
2. Very little 
3. Somewhat 
4. Quite a bit 










IBD distress – item 3 
discouraged to keep up with 
managing your IBD? 
1. Not at all 
2. Very little 
3. Somewhat 
4. Quite a bit 










IBD distress – item 4 
angry, scared, and/or depressed 
when thinking about living with 
IBD? 
1. Not at all 
2. Very little 
3. Somewhat 
4. Quite a bit 










IBD distress – item 5 
that your friends or family don’t 
appreciate how difficult living 
with IBD can be? 
1. Not at all 
2. Very little 
3. Somewhat 
4. Quite a bit 










IBD distress – item 6 
that your friends or family don’t 
give you the emotional support 
that you would like? 
1. Not at all 
2. Very little 
3. Somewhat 
4. Quite a bit 














You are eligible to participate 
in the Text4IBD program!  
  
Here’s how the program works: 
  
• First, you will first be 
asked to complete an 
online survey. 
• After taking the survey, 
you will receive a text 
1. Yes 
2. No 
 Display logic: 
Only show if 
participant 









message within 24 
hours welcoming you to 
the Text4IBD program. 
• Next, we will send 
support messages to 
your cell phone every 
day for 2 weeks (1-2 
messages per day). 
• At the end of the 2 
weeks, you will be 
asked to complete 
another online survey. 
  
You will receive an Amazon 
gift card upon completion of 
this program.  
 
Would you like to participate in 
this program? If so, please select 






Ineligible prompt Based on your responses, you 
are not eligible to participate in 
this program. Thank you for 
your interest.  
 
If you have any questions, feel 
free to contact me (Jacob Rohde) 
here: jarohde@live.unc.edu  
  Display logic: 











Chapter 5 pretest survey questionnaire 
 
Question ID Item Response scale Source Notes 
 




[Insert consent form here] 1. I want to participate and 
I consent to being in this 
study   
2. I do NOT consent to 




If “2” is 
selected go 
to end of 
survey. 
Participant 





Please answer these first 
questions so we can 
enroll you in the 
Text4IBD program.  
   
B100 
Name 
What is your name? This 
can be your first name, a 
made-up name, or a 
nickname that people call 
you.  






We will use this name in 
some of the text messages 
that we send, and when 
we contact you about 
receiving your gift card 
for participating in this 
study.  
   
B110 
Phone number 
What is your cell phone 
number, beginning with 
area code? 
 
Use this format: 555-555-
5555 






You entered [phone 
number they entered 
here].  
 










What is your email 
address?  
 
We will need your email 
to send you information 
about the Text4IBD 
program, including how 
to receive gift cards and a 
link to take the final 
survey after the text 
messaging portion of the 









You entered [email 
address they entered 
here].  
 










What time zone are you 
in? 
1. Eastern Daylight Time 
2. Central Daylight Time 
3. Mountain Daylight Time 
4. Mountain Standard 
Time 
5. Pacific Daylight Time 











What time of the day 
would you like to receive 
text messages from 
Text4IBD? These 
messages will be local to 
your time zone.  
Drop down list, 12am-








You chose: [insert chosen 
time here] 
 










Prompt Please answer these next 
questions so we can 
better understand who is 
participating in this 
program.  
   
B150 
Gender 









Are you of Hispanic, 
Latino or Spanish origin? 
1. No 
2. Yes 




What is your race?  (select 
all that apply) 
1. White 
2. Black or African 
American  
3. American Indian or 
Alaska Native  
4. Asian 
5. Native Hawaiian or 
Other Pacific Islander 
6. Some other race (please 
specify) 




The next question is about 
your sexual orientation. 
1. Straight or heterosexual 












What is the highest degree 
or level of school you 
have completed? 
1. Less than high school  
2. High school graduate (or 
equivalent, such as GED) 
3. Some college 
4. Associate degree 
5. Bachelor’s degree 
6. Master’s degree 






Which of the following 
categories best describes 
your total household 
income in the last 12 
months? 
 
1. Less than $10,000 
2. $10,000 to $19,999 
3. $20,000 to $29,999 
4. $30,000 to $39,999 
5. $40,000 to $49,999 
6. $50,000 to $59,999 
7. $60,000 to $69,999 
8. $70,000 to $79,999 
9. $80,000 to $89,999 
10. $90,000 to $99,999 
11. $100,000 to $149,999 
12. More than $150,000 
(PATH, 2021)  
 
IBD AND GENERAL HEALTH INFORMATION 
 
Prompt These next questions are 
about your experiences 
living with IBD. 
   
C100 
Age diagnosed 
At what age were you first 
diagnosed with IBD? 
Text entry Adapted from 
IBD Partners 




Has GI specialist 
Do you have a 
gastroenterologist who 
helps you treat your IBD? 
1. Yes 
2. No 
3. Don’t know 
Adapted from 
IBD Partners 




Visits GI specialist 
How many times have 
you seen this 
gastroenterologist over the 
past year? 
1. Never 
2. 1-2 times 
3. 3-4 times 
4. 5 or more times 
Adapted from 
IBD Partners 





Do you currently have an 
ostomy? 
1. Yes – ileostomy 
2. Yes – colostomy 
3. Yes – unsure what type 
4. No 
5. Don’t know 
Adapted from 
IBD Partners 







In the past 6 months, my 
disease has been… 
1. Constantly active, 
giving me symptoms every 
day 
2. Often active, giving me 
symptoms most days  
3. Sometimes active, 
giving me symptoms on 





some days (for instance 1–
2 days/week)  
4. Occasionally active, 
giving me symptoms 1–2 
days/month  
5. Rarely active, giving me 
symptoms on a few days in 
the past 6 months  
6. I was well in the past 6 
months, what I consider a 





When it comes to your 
IBD, how much support 




2. A little 
3. Some 
4. A lot 





Know others with 
IBD 
Do you personally know 
anyone else diagnosed 
with IBD, such as close 










Which of the following 
social media platforms do 
you use to discuss or 
research information 





















Which of the following 
IBD topics are most 
important to you when 
discussing or researching 
information about IBD? 
You may select up to 3 
topics. 
1. Symptoms 
2. Mental health 
3. Nutrition (ex: IBD diets) 
4. Medication 
5. Ostomy-related content 
6. IBD-related procedures 
(ex: colonoscopies) 
7. Intimacy (ex: dating 
with IBD) 








Are you currently taking 
daily oral medication to 






If no, skip 
the rest of 
the block 
Adherence prompt Regarding taking your 
IBD medication over the 
past 2 weeks, how often 
did you...  




Adherence – item 
1 
alter the dose 1. Never 
2. A little 
3. Sometimes 
4. Most of the time 
5. Very often 
MARS-5 scale 




Adherence – item 
2 
forget to take it.  1. Never 
2. A little 
3. Sometimes 
4. Most of the time 
5. Very often 
MARS-5 scale 




Adherence – item 
3 
stop taking it for a while 1. Never 
2. A little 
3. Sometimes 
4. Most of the time 
5. Very often 
MARS-5 scale 




Adherence – item 
4 
decide to miss out on a 
dose 
1. Never 
2. A little 
3. Sometimes 
4. Most of the time 
5. Very often 
MARS-5 scale 




Adherence – item 
5 
take less than instructed 1. Never 
2. A little 
3. Sometimes 
4. Most of the time 
5. Very often 
MARS-5 scale 







We will also be sending 
you daily text messages 
reminding you to take 
your IBD medication.  
 
What time would you like 
to receive those 
messages?  
Drop down list, 12am-









You entered: [insert time 
here] 
 











For these next questions, 
please indicate how 
much you think or 
behave in the following 
ways regarding your 
IBD.  
 
   
Adaptive coping 
strategies prompt 
In the past 2 weeks, how 
much have you…  
   
D100_1 
Adaptive coping – 
item 1 
used relaxation techniques 
to help with your stress? 
1. Not at all 
2. Very little 
3. Somewhat 
4. Quite a bit 
5. A great deal 
Adapted from the 
IBD-COPE 
instrument (A. 






Adaptive coping – 
item 2 
altered your diet in an 
attempt to improve your 
IBD? 
1. Not at all 
2. Very little 
3. Somewhat 
4. Quite a bit 
5. A great deal 
Adapted from the 
IBD-COPE 
instrument (A. 




Adaptive coping – 
item 3 
tried to think positively 
about your IBD (e.g., “it 
makes me a stronger 
person”)?  
1. Not at all 
2. Very little 
3. Somewhat 
4. Quite a bit 
5. A great deal 
Adapted from the 
IBD-COPE 
instrument (A. 






In the past 2 weeks, how 
much have you…  
   
D110_1 
Maladaptive 
coping – item 1 
laid awake worrying 
about your IBD. 
1. Not at all 
2. Very little 
3. Somewhat 
4. Quite a bit 
5. A great deal 
Adapted from the 
IBD-COPE 
instrument (A. 





coping – item 2 
blamed yourself for 
making your IBD worse. 
1. Not at all 
2. Very little 
3. Somewhat 
4. Quite a bit 
5. A great deal 
Adapted from the 
IBD-COPE 
instrument (A. 





coping – item 3 
taken your IBD 
medication. 
1. Not at all 
2. Very little 
3. Somewhat 
4. Quite a bit 
5. A great deal 
Adapted from the 
IBD-COPE 
instrument (A. 










In the past 2 weeks, how 
confident were you in 
your ability to… 
   
D120_1 
Emotions self-
efficacy – item 1 
do something to reduce 
stress from IBD? 
1. Not confident at all 
…  
11. Totally confident 
Adapted from the 
IBD Self-
Efficacy Scale 





efficacy – item 2 
do something to reduce 
discouragement about 
IBD? 
1. Not confident at all 
…  
11. Totally confident 
Adapted from the 
IBD Self-
Efficacy Scale 





efficacy – item 3 
do something to reduce 
sadness from IBD? 
1. Not confident at all 
…  
11. Totally confident 
Adapted from the 
IBD Self-
Efficacy Scale 





In the past 2 weeks, how 
confident were you in 
your ability to… 
   
D130_1 
Medication self-
efficacy – item 1 
follow your IBD 
medication prescription? 
1. Not confident at all 
…  
11. Totally confident 
Adapted from the 
IBD Self-
Efficacy Scale 












efficacy – item 2 
take your IBD medication 
at instructed times? 
1. Not confident at all 
…  
11. Totally confident 
Adapted from the 
IBD Self-
Efficacy Scale 










efficacy – item 3 
take your IBD medication 
as directed to prevent 
flare-up? 
1. Not confident at all 
…  
11. Totally confident 
Adapted from the 
IBD Self-
Efficacy Scale 










In the past 2 weeks, how 
confident were you in 
your ability to… 
   
D140_1 
Symptoms self-
efficacy – item 1 
reduce IBD symptoms? 1. Not confident at all 
…  
11. Totally confident 
Adapted from the 
IBD Self-
Efficacy Scale 





efficacy – item 2 
reduce discomfort or pain 
from IBD? 
1. Not confident at all 
…  
11. Totally confident 
Adapted from the 
IBD Self-
Efficacy Scale 





efficacy – item 3 
decrease fatigue from 
IBD? 
1. Not confident at all 
…  
11. Totally confident 
Adapted from the 
IBD Self-
Efficacy Scale 





In the past 2 weeks, how 
confident were you in 
your ability to…  
   
D150_1 
Remission self-
efficacy – item 1 
manage your IBD? 1. Not confident at all 
…  
11. Totally confident 
Adapted from the 
IBD Self-
Efficacy Scale 





efficacy – item 2 
keep your IBD in 
remission? 
1. Not confident at all 
…  
11. Totally confident 
Adapted from the 
IBD Self-
Efficacy Scale 





efficacy – item 3 
engage in self-care? (e.g., 
exercise, diet, rest) 
1. Not confident at all 
…  
11. Totally confident 
Adapted from the 
IBD Self-
Efficacy Scale 





efficacy – item 4 
engage in a stress 
management activity? 
1. Not confident at all 
…  
11. Totally confident 
Adapted from the 
IBD Self-
Efficacy Scale 







efficacy – item 5 
maintain your sense of 
well-being? 
1. Not confident at all 
…  
11. Totally confident 
Adapted from the 
IBD Self-
Efficacy Scale 






Please respond to the 
following statements. 





If I actively monitor my 
IBD, it would reduce my 
IBD symptoms. 
 
1. Definitely wouldn’t  
2. Probably wouldn’t 
3. Not sure 
4. Probably would 








If I take care of my mental 
health, it would reduce 
my IBD symptoms. 
1. Definitely wouldn’t  
2. Probably wouldn’t 
3. Not sure 
4. Probably would 
5. Definitely would 
Developed for 






If I watch my diet, it 
would reduce my IBD 
symptoms. 
1. Definitely wouldn’t  
2. Probably wouldn’t 
3. Not sure 
4. Probably would 








If I manage my stress, it 
would reduce my IBD 
symptoms 
1. Definitely wouldn’t  
2. Probably wouldn’t 
3. Not sure 
4. Probably would 




Quality of life 
prompt 
Please answer the items 
below: 
   
D170_1 
QoL – item 1 
In the past 2 weeks, I 
found it hard to focus on 
anything other than my 
anxiety.  












QoL – item 2 
In the past 2 weeks, I felt 
hopeless. 












QoL – item 3 
In the past 2 weeks, I was 
satisfied with my ability 
to meet the needs of my 
friends.  
1. Not at all  
2. A little bit 
3. Somewhat 
4. Quite a bit 







Quality of life 
prompt 2 
Please answer the items 
below: 
   
D170_4 
QoL – item 4 
In the past 2 weeks, how 
fatigued were you on 
average? 
1. Not at all  
2. A little bit 
3. Somewhat 
4. Quite a bit 








QoL – item 5 
In the past 2 weeks, how 
much did pain interfere 
1. Not at all  








with work around the 
home? 
4. Quite a bit 




QoL – item 6 
In the past 2 weeks, how 
would you rate your IBD 
activity? 
1. Remission  
2. Minimal symptoms 
3. Mildly active 
4. Moderately active 










Covariates prompt These next questions are 
about some of the people 
in your life.  




Please answer how much 
you agree or disagree with 
the following statements. 
   
E100_1 
Family MSPSS – 
item 1 
My family really tries to 
help me. 
1. Strongly disagree  
2. Somewhat disagree 
3. Neither agree nor 
disagree 
4. Somewhat agree 






& Farley, 1988) 
 
E100_2 
Family MSPSS – 
item 2 
I get the emotional help 
and support I need from 
my family. 
1. Strongly disagree  
2. Somewhat disagree 
3. Neither agree nor 
disagree 
4. Somewhat agree 








Family MSPSS – 
item 3 
I can talk about my 
problems with my family. 
1. Strongly disagree  
2. Somewhat disagree 
3. Neither agree nor 
disagree 
4. Somewhat agree 








Family MSPSS – 
item 4 
My family is willing to 
help me make decisions. 
1. Strongly disagree  
2. Somewhat disagree 
3. Neither agree nor 
disagree 
4. Somewhat agree 










Please answer how much 
you agree or disagree with 
the following statements. 
   
E110_1 
Friends MSPSS – 
item 1 
My friends really try to 
help me. 
1. Strongly disagree  
2. Somewhat disagree 
3. Neither agree nor 
disagree 
4. Somewhat agree 








Friends MSPSS – 
item 2 
I can count on my friends 
when things go wrong. 
1. Strongly disagree  
2. Somewhat disagree 
3. Neither agree nor 
disagree 
4. Somewhat agree 










Friends MSPSS – 
item 3 
I have friends with whom 
I can share my joys and 
sorrows. 
1. Strongly disagree  
2. Somewhat disagree 
3. Neither agree nor 
disagree 
4. Somewhat agree 








Friends MSPSS – 
item 4 
I can talk about my 
problems with my friends. 
1. Strongly disagree  
2. Somewhat disagree 
3. Neither agree nor 
disagree 
4. Somewhat agree 











Please answer how much 
you agree or disagree with 
the following statements. 
   
E120_1 
Special person 
MSPSS – item 1 
There is a special person 
who is around when I am 
in need. 
 
1. Strongly disagree  
2. Somewhat disagree 
3. Neither agree nor 
disagree 
4. Somewhat agree 









MSPSS – item 2 
There is a special person 
with whom I can share my 
joys and sorrows. 
1. Strongly disagree  
2. Somewhat disagree 
3. Neither agree nor 
disagree 
4. Somewhat agree 









MSPSS – item 3 
I have a special person 
who is a real source of 
comfort to me. 
1. Strongly disagree  
2. Somewhat disagree 
3. Neither agree nor 
disagree 
4. Somewhat agree 









MSPSS – item 4 
There is a special person 
in my life who cares about 
my feelings. 
1. Strongly disagree  
2. Somewhat disagree 
3. Neither agree nor 
disagree 
4. Somewhat agree 









Please answer each of 
the following questions 
as they individually 
relate to your: 
 
1) family members 
2) friends 
3) healthcare providers 
4) your significant other 
(if applicable) 
   
E130_1-4 
IBD stigma – item 
1 
My IBD symptoms are 
not taken seriously by... 
1) family members 
2) friends 
3) healthcare providers 
1. Strongly disagree  
2. Somewhat disagree 
3. Neither agree nor 
disagree 
4. Somewhat agree 
Adapted from the 
IBD Perceived 
Stigma Scale 




4) your significant other 
(leave blank if not 
applicable) 
5. Strongly agree 
E140_1-4 
IBD stigma – item 
2 
I keep my IBD symptoms 
hidden from these people 
because they will treat me 
differently. 
1) family members 
2) friends 
3) healthcare providers 
4) your significant other 
(leave blank if not 
applicable) 
1. Strongly disagree  
2. Somewhat disagree 
3. Neither agree nor 
disagree 
4. Somewhat agree 
5. Strongly agree 
Adapted from the 
IBD Perceived 
Stigma Scale 
(Taft et al., 2009) 
 
E150_1-4 
IBD stigma – item 
3 
I do not feel I can be as 
open about my IBD 
symptoms as I’d like to be 
with... 
1) family members 
2) friends 
3) healthcare providers 
4) your significant other 
(leave blank if not 
applicable) 
1. Strongly disagree  
2. Somewhat disagree 
3. Neither agree nor 
disagree 
4. Somewhat agree 
5. Strongly agree 
Adapted from the 
IBD Perceived 
Stigma Scale 
(Taft et al., 2009) 
 
 




This is the last section of 
the survey. Please press 
the next arrow when you 
are ready. 




Who are the people that 
you discuss your health 
with or you can really 
count on for help when 
you have physical or 
emotional problems?  
 
Please write their first 
names in the spaces 
below. Please do not enter 
last names. If 2 people 
have the same first name, 
use the first letter of each 
person's last name.  
 
You may list up to 5 
names 
 
1. Name of person 1 
2. Name of person 2 
3. Name of person 3 
4. Name of person 4 
5. Name of person 5 
 










Please identify the nature 
of your relationship with 
the people you listed. 
Select all that apply.  
 
[Person 1] is a...  
[Person 2] is a...  
[Person 3] is a... 
[Person 4] is a… 
[Person 5] is a... 
 
Options for each are: 










1. Spouse or partner 
2. Family member 
3. Friend 
4. Healthcare provider 




Please identify the age of 
each person you listed in 
the previous questions. If 
you do not know their 
exact age, please give the 
best estimate. Please enter 
a numeric value. 
 
[Name of Person 1 
through 5]  
 
[Insert a drop-down menu 
of ages] 
 










Please identify the gender 
of the people you listed. 
 
[Name of Person 1 
through 5]  
 
[Insert a dropdown menu 
for each person] 
 
1. Male  
2. Female  
3. Transgender  
4. Other or don’t know 










Please indicate how close 
you are to each person 
listed.  
 
[Name of Person 1 
through 5]  
 
[Insert the following scale 
for each name listed here] 
 
1. Not close 
…  
11. Close  
 











Please indicate how 
frequently you are in 
contact with each person 
listed, on a scale from 1 
(almost never) to 5 (very 
often).  
 
[Name of Person 1 
through 5]  
 
[Insert the following scale 
for each name listed] 
 




5. Very often 
 









Alter support role 
When thinking of the 
people listed below, what 
type of support does each 
person provide you? 
Please select all options 
that apply.  
 
[Name of Person 1 
through 5]  
 
[Insert matrix table for the 
following for each name 
listed]  
 
1. Listens to me 
2. Tells me they care for 
me  
3. Makes practical 
suggestions 
4. None of these. 
 













End of pretest 
survey prompt 
Thank you! You have 
now finished this survey. 
 
You will receive a text 
message welcoming you 
to the Text4IBD 
program within 24 
hours.  
 
Feel free to contact 
Jacob Rohde 
(jarohde@live.unc.edu) 
if you have any 
questions in the 
meantime.  




Chapter 5 posttest survey questionnaire 
 







Thank you for again for 
participating in the 
Text4IBD program.  
 
To keep track of who 
completed this study and 
to link your responses 
with the previous survey, 
please provide us with 
the following information 
again.  
   
f_B110 
Phone number 
What is your cell phone 
number, beginning with 
area code? 
 
Please use this format: 
555-555-5555 






You entered: [phone 
number they entered here] 
 










What is your email 
address? 





You entered: [email they 
entered here] 
 









PRIMARY OUTCOME AND MEDICATION ADHERENCE 
 
IBD distress prompt In the past 2 weeks, how 
much have you felt… 
   
f_A160_1 
IBD distress – item 1 
overwhelmed with the 
demands of living with 
IBD? 
1. Not at all 
2. Very little 
3. Somewhat 
4. Quite a bit 




(Liu et al., 2020; 




IBD distress – item 2 
that you are often failing 
with your IBD routine? 
1. Not at all 
2. Very little 
3. Somewhat 
4. Quite a bit 




(Liu et al., 2020; 




IBD distress – item 3 
discouraged to keep up 
with managing your IBD? 
1. Not at all 








4. Quite a bit 
5. A great deal 
(Liu et al., 2020; 
Polonsky et al., 
2005) 
f_A160_4 
IBD distress – item 4 
angry, scared, and/or 
depressed when thinking 
about living with IBD? 
1. Not at all 
2. Very little 
3. Somewhat 
4. Quite a bit 




(Liu et al., 2020; 




IBD distress – item 5 
that your friends or family 
don’t appreciate how 
difficult living with IBD 
can be? 
1. Not at all 
2. Very little 
3. Somewhat 
4. Quite a bit 




(Liu et al., 2020; 




IBD distress – item 6 
that your friends or family 
don’t give you the 
emotional support that you 
would like? 
1. Not at all 
2. Very little 
3. Somewhat 
4. Quite a bit 




(Liu et al., 2020; 




General IBD support 
When it comes to your 
IBD, how much support in 
general do you feel you 
have? 
1. None at all 
2. A little 
3. Some 
4. A lot 







Are you currently taking 
daily oral medication to 
treat your IBD symptoms 






If no, skip the 
rest of the 
block 
Adherence prompt Regarding taking your IBD 
medication over the past 2 
weeks, how often did 
you…  
   
f_C200_1 
Adherence – item 1 
alter the dose. 1. Never 
2. A little 
3. Sometimes 
4. Most of the time 
5. Very often 
MARS-5 scale 




Adherence – item 2 
forget to take it.  1. Never 
2. A little 
3. Sometimes 
4. Most of the time 
5. Very often 
MARS-5 scale 




Adherence – item 3 
stop taking it for a while. 1. Never 
2. A little 
3. Sometimes 
4. Most of the time 
5. Very often 
MARS-5 scale 




Adherence – item 4 
decide to miss out on a 
dose. 
1. Never 
2. A little 
3. Sometimes 
4. Most of the time 
5. Very often 
MARS-5 scale 






Adherence – item 5 
take less than instructed. 1. Never 
2. A little 
3. Sometimes 
4. Most of the time 
5. Very often 
MARS-5 scale 








For these next questions, 
please indicate how much 
you think or behave in 
the following ways 
regarding your IBD.  
   
Adaptive coping 
strategies prompt 
In the past 2 weeks, how 
much have you… 
   
D100_1 
Adaptive coping – 
item 1 
used relaxation techniques 
to help with your stress? 
1. Not at all 
2. Very little 
3. Somewhat 
4. Quite a bit 








Adaptive coping – 
item 2 
altered your diet in an 
attempt to improve your 
IBD? 
1. Not at all 
2. Very little 
3. Somewhat 
4. Quite a bit 








Adaptive coping – 
item 3 
tried to think positively 
about your IBD? (ex: “it 
makes me a stronger 
person”) 
1. Not at all 
2. Very little 
3. Somewhat 
4. Quite a bit 









In the past 2 weeks, how 
much have you… 
   
D110_1 
Maladaptive coping – 
item 1 
laid awake worrying about 
your IBD? 
1. Not at all 
2. Very little 
3. Somewhat 
4. Quite a bit 








Maladaptive coping – 
item 2 
blamed yourself for 
making your IBD worse? 
1. Not at all 
2. Very little 
3. Somewhat 
4. Quite a bit 








Maladaptive coping – 
item 3 
In the past 2 weeks, how 
much have you taken your 
IBD medication? 
1. Not at all 
2. Very little 
3. Somewhat 
4. Quite a bit 




M. McCombie et 
al., 2016) 
Display logic: 
only for those 





in the past 2 weeks, how 
confident were you in your 
ability to…  
   
f_D120_1 
Emotions self-
efficacy – item 1 
do something to reduce 
stress from IBD? 
1. Not sure at all 
… 











efficacy – item 2 
do something to reduce 
discouragement about 
IBD? 
1. Not sure at all 
… 









efficacy – item 3 
do something to reduce 
sadness from IBD? 
1. Not sure at all 
… 









In the past 2 weeks, how 
confident were you in your 
ability to…  
   
f_D130_1 
Medication self-
efficacy – item 1 
follow your IBD 
medication prescription? 
1. Not sure at all 
… 














efficacy – item 2 
take your IBD medication 
at instructed times? 
1. Not sure at all 
… 














efficacy – item 3 
take you IBD medication 
as directed to prevent 
flare-up? 
1. Not sure at all 
… 














In the past 2 weeks, how 
confident were you in your 
ability to…  
   
f_D140_1 
Symptoms self-
efficacy – item 1 
reduce IBD symptoms? 1. Not sure at all 
… 









efficacy – item 2 
reduce discomfort or pain 
from IBD? 
1. Not sure at all 
… 









efficacy – item 3 
decrease fatigue from 
IBD? 
1. Not sure at all 
… 









In the past 2 weeks, how 
confident were you in your 
ability to…  
   
f_D150_1 
Remission self-
efficacy – item 1 
manage your IBD? 1. Not sure at all 
… 











efficacy – item 2 
keep your IBD in 
remission? 
1. Not sure at all 
… 









efficacy – item 3 
engage in self-care? (e.g., 
exercise, diet, rest) 
1. Not sure at all 
… 









efficacy – item 4 
engage in a stress 
management activity? 
1. Not sure at all 
… 









efficacy – item 5 
maintain your sense of 
well-being? 
1. Not sure at all 
… 









Please respond to the 
following statements: 
   
f_D160_1 
Outcome 
expectations – item 1 
If I actively monitor my 





2. Probably wouldn’t 
3. Not sure 
4. Probably would 






expectations – item 2 
If I take care of my mental 




2. Probably wouldn’t 
3. Not sure 
4. Probably would 






expectations – item 3 
If I watch my diet, it would 
reduce my IBD symptoms. 
1. Definitely 
wouldn’t  
2. Probably wouldn’t 
3. Not sure 
4. Probably would 






expectations – item 4 
If I manage my stress, it 




2. Probably wouldn’t 
3. Not sure 
4. Probably would 




Quality of life prompt Please answer the items 
below: 
   
f_D170_1 
QoL – item 1 
In the past 2 weeks, I 
found it hard to focus on 
anything other than my 
anxiety.  














QoL – item 2 
In the past 2 weeks, I felt 
hopeless. 












QoL – item 3 
In the past 2 weeks, I was 
satisfied with my ability to 
meet the needs of my 
friends.  
1. Not at all  
2. A little bit 
3. Somewhat 
4. Quite a bit 







Quality of life prompt 
2 
Please answer the items 
below: 
   
f_D170_4 
QoL – item 4 
In the past 2 weeks, how 
fatigued were you on 
average? 
1. Not at all  
2. A little bit 
3. Somewhat 
4. Quite a bit 








QoL – item 5 
In the past 2 weeks, how 
much did pain interfere 
with work around the 
home? 
1. Not at all  
2. A little bit 
3. Somewhat 
4. Quite a bit 








QoL – item 6 
In the past 2 weeks, how 
would you rate your IBD 
activity? 
1. Remission  
2. Minimal 
symptoms 
3. Mildly active 
4. Moderately active 












Please answer these final 
questions about being in 
this study.  
   
Z100 
Study ease 
How difficult or easy did 
you find participating in 
this study to be? 
1. Very difficult 
2. Somewhat 
difficult 
3. Neither difficult 
nor easy 
4. Somewhat easy 
5. Very easy 





If you had the chance, 




2. Probably wouldn’t 
3. Not sure 
4. Probably would 
5. Definitely would 





Recommend to others  
 
Would you recommend 




2. Probably wouldn’t 
3. Not sure 
4. Probably would 
5. Definitely would 





Throughout this study, we 
sent you text messages 
1. Too little 
2. About right  
   
 
 186 
 about IBD management 
every day for 2 weeks. 
Would you say that 
amount was… 




How useful was the 
medication reminder that 
we sent you?  
1. Not at all useful 
2. A little useful 
3. Somewhat 
useful 




(Noar et al., 
2019) 
Display logic: 





Throughout this study, did 
you ever have problems 
receiving any of the 
message we sent you at the 









Of the messages we sent 
you the past 2 weeks, how 
many of the messages did 
you read? 
1. None 
2. Very few 
3. Some 
4. A lot 
5. All of them 





Please tell us more 
about how 
often and when you would 
prefer that we send you 
text messages. 




App or text 
messaging 
 
If you had a choice, would 
you rather get surveys and 
messages on your cell 
phone by text message, or 
would you prefer an 
app that would conduct the 
same functions? 
1. Text messages  
2. App 
3. No preference 




App or text 
messaging explain 
 
Please tell us why you 
prefer text messages, an 
app, or have no preference 
below. 





The messages used in the 
current study were 
designed to provide 
support to people with 
IBD. 
   
Z200 
Aided recall 
Of the messages we sent 
you the past 2 
weeks, which topics do 
you remember reading 
about? (select all that 
apply) 
1. Food journaling 
2. IBD and mental 
health 
3. IBD diets 
4. Exercise stress 
5. IBD nutrition 
6. IBD symptom 
tracking 
7. IBD management  
8. IBD procedures 
(ex: colonoscopies) 
9. IBD and ostomies 





10. IBS vs. IBD 
symptoms 
11. I don’t remember 
reading about any of 
these topics. 
Z210 
Content – liked 
Tell us below what you 
liked about the content of 
the messages that we sent 
you. Please be as detailed 
as possible: 




Content – improve on  
Tell us below how we 
could improve the content 
of the messages that we 
sent you. Please be as 
detailed as possible: 





Were there any message 
topics that you felt were 
missing? Please be as 
detailed as possible: 






Overall, how satisfied 
were you with the content 
of the messages you 
received? 
1. Not at all satisfied 
2. A little satisfied 
3. Somewhat 
satisfied 
4. Very satisfied 
5. Extremely 
satisfied 






Some of the messages we 
sent you included links to 
online resources from 
various Crohn's disease 
and ulcerative colitis 
foundations.  
 
Which of the following 
links did you click? (select 
all that apply) 
 
1. MyGut (symptom 
tracker app) 
2. IBD Expert Q&A 
3. Coping Strategies 
to Improve Mental 
Health 
4. COVID-19 & 
Mental Health 
5. Online IBD 
Community 
6. Special IBD Diets 
7. IBD Nutrition and 
What to Eat 
8. I didn’t click any 
of the links.  






In general, how satisfied 
were you with the content 
of the online resources that 
you clicked? 
1. Not at all satisfied 
2. A little satisfied 
3. Somewhat 
satisfied 
4. Very satisfied 
5. Extremely 
satisfied 





Overall, would you say 
participating in this study 
was…  




Attitudes – item 1 
Not helpful – Helpful  1. Not helpful  
….  
10. Helpful 






Attitudes – item 2 
Not informative – 
Informative  
1. Not informative  
….  
10. Informative 




Attitudes – item 3 
Not supportive – 
Supportive  
1. Not supportive  
….  
10. Supportive 




Attitudes – item 4 
Not useful – Useful  1. Not useful  
….  
10. Useful 





If you have ideas of how to 
improve the messages in 
the Text4IBD program, 
please tell us below. 





If you have anything else 
you want to tell us about 
this study, please do so 
below. 




END OF POSTTEST SURVEY 
 
End of posttest 
survey prompt 
Thank you! You have 
now finished this study. 
 
Feel free to contact Jacob 
Rohde 
(jarohde@live.unc.edu) if 
you have any questions in 
the meantime.  
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